WO2014168210A1 - Chemical injection device - Google Patents

Chemical injection device Download PDF

Info

Publication number
WO2014168210A1
WO2014168210A1 PCT/JP2014/060415 JP2014060415W WO2014168210A1 WO 2014168210 A1 WO2014168210 A1 WO 2014168210A1 JP 2014060415 W JP2014060415 W JP 2014060415W WO 2014168210 A1 WO2014168210 A1 WO 2014168210A1
Authority
WO
WIPO (PCT)
Prior art keywords
injection
pattern
chemical
display
screen
Prior art date
Application number
PCT/JP2014/060415
Other languages
French (fr)
Japanese (ja)
Inventor
根本 茂
Original Assignee
株式会社根本杏林堂
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 株式会社根本杏林堂 filed Critical 株式会社根本杏林堂
Priority to JP2015511299A priority Critical patent/JP6338190B2/en
Publication of WO2014168210A1 publication Critical patent/WO2014168210A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/16804Flow controllers
    • A61M5/16827Flow controllers controlling delivery of multiple fluids, e.g. sequencing, mixing or via separate flow-paths
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/1407Infusion of two or more substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • A61M5/145Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons
    • A61M5/1452Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons pressurised by means of pistons
    • A61M5/14566Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons pressurised by means of pistons with a replaceable reservoir for receiving a piston rod of the pump
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/50General characteristics of the apparatus with microprocessors or computers
    • A61M2205/502User interfaces, e.g. screens or keyboards
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2209/00Ancillary equipment
    • A61M2209/08Supports for equipment
    • A61M2209/084Supporting bases, stands for equipment

Definitions

  • the present invention relates to a drug solution injection device that injects at least a contrast medium as a drug solution into a patient, and in particular, a single drug solution injection device can use various injection protocol setting methods, and the injection protocol can be simplified and The present invention relates to a chemical injection device that can be created in various ways.
  • CT Computer Tomography
  • MRI Magnetic Resonance Imaging
  • PET PET
  • ultrasound diagnostic devices angiographic imaging devices
  • medical diagnostic imaging devices a patient may be injected with a contrast medium, physiological saline, or the like (hereinafter also simply referred to as “medical solution”).
  • Patent Document 1 relates to a technique for automatically injecting a chemical solution using a chemical solution injection device, and an operator corrects an injection pattern displayed on an injection graph on a screen as needed, and a final injection protocol. Is completed.
  • injection protocol setting methods there are various types of injection protocol setting methods depending on, for example, the examination site and the contrast purpose.
  • which injection protocol setting method is used may be determined depending on the preference of the doctor (operator).
  • An object of the present invention is to provide a chemical solution injection device and the like that can use various injection protocol setting methods with a single chemical solution injection device, and that can easily create various injection protocols. .
  • a chemical solution injection device is as follows: A piston drive mechanism for operating the piston member of the syringe; A control unit for controlling the operation of the piston drive mechanism; A display unit for displaying predetermined information; An input device that receives input from the operator; A chemical injection device comprising: The controller is a: causing the display unit to display a setting initial screen including at least a mode selection display unit for selecting one of a plurality of injection protocol setting modes; b: After a predetermined injection protocol setting mode is selected, one of the vertical axis and the horizontal axis is the injection speed, the other is the injection time, and the input of the injection pattern from the operator to the injection graph including at least one phase.
  • “Chemical solution” refers to, for example, a contrast agent, physiological saline, or a mixture thereof.
  • Specific examples of the “contrast agent” include a contrast agent having an iodine concentration of 240 mg / ml (for example, a viscosity of 3.3 Pa ⁇ s and a specific gravity of 1.268 to 1.296 at 37 ° C.), a contrast agent having an iodine concentration of 300 mg / ml ( For example, a contrast agent having a viscosity of 6.1 mPa ⁇ s and a specific gravity of 1.335 to 1.371 at 37 ° C.
  • physiological saline a physiological saline containing 180 mg of sodium chloride in 20 mL of physiological saline (for example, a viscosity of 0.9595 mPa ⁇ s at 20 ° C., a specific gravity of 1.004 to 1.04). 006) and the like.
  • the “infusion protocol” indicates what kind of chemical solution is to be infused, how much, and at what rate. If multiple injection protocols prepared in advance are stored in the system, the operator can select one of them and make corrections as necessary, and improve the inspection efficiency by setting conditions. Can be planned.
  • the information in the injection protocol may be one or a plurality selected from the type of chemical, the injection speed, the injection time, the injection pressure, and the injection timing (including pause, hold, etc.).
  • the “injection pattern” basically indicates the injection conditions of the chemical solution, and when used in connection with the injection protocol setting screen, a straight line (line segment) or a curve displayed on the injection graph is displayed. May also be shown.
  • “Setting Method” In this specification, “setting method” may be synonymous with “setting mode”.
  • “Patient” As used herein, “patient” may be synonymous with “subject”.
  • “Operator” In this document, “operator” may be synonymous with “user”.
  • Body classification refers to a high-order item representing a classification of the body such as the head, chest, and abdomen.
  • the “imaging part” refers to an imaging target such as a lower item included in the body classification, for example, heart, liver, blood vessel and the like.
  • Data may be synonymous with “information”.
  • Connection when a given device is said to be connected to another device, it may be either wired or wireless. In addition, a configuration in which one-way or two-way connection is made so that other devices can be controlled can also be expressed as “operably connected / linked”. “Electrically connected” means that components are connected so that electrical signals can be transmitted in one direction or in both directions, and may be in either a wired connection or a wireless connection. . In addition to the components directly connected to each other, the case where the components are indirectly connected via other elements is also included.
  • terminal refers to a computer system that performs data processing, connected to a network or used stand-alone, and includes a desktop computer, a laptop computer, a tablet computer, or the like.
  • the “control unit” includes a CPU, a memory, and the like, and performs arithmetic processing.
  • the “controller”, “processor”, “controller unit (control unit)”, “controller circuit (control circuit)”, “controller” It can also be called “module (control module)”, “processor unit”, “processor unit”, “processor module”, and the like.
  • the “controller” can be configured with a microcomputer, a microcontroller, a programmable logic controller, an application specific integrated circuit, and other programmable circuits. In the present specification, the “control unit” may physically have one configuration, but two or more control units functionally cooperate to form one “control unit”. It may be.
  • the basic processing in the control unit is an example.
  • the computer program stored in the memory is read, then data is received from the input device or the storage device according to the instructions of the computer program, and the data is calculated and processed.
  • the data is output to a storage device such as a memory or an output device such as a display.
  • the “computer program” may be a program that reads a storage medium storing the program using a predetermined device, device, mechanism, or the like, and operates the computer with a predetermined function.
  • the storage medium storing the computer program constitutes one aspect of the present invention.
  • the computer program may be provided via a communication network (in the example, the Internet).
  • the computer program may be a so-called differential program that can be realized in combination with a program already recorded in the computer.
  • a nonvolatile memory card flash memory
  • a hard disk an optical disk
  • a magneto-optical disk for example, a CD, a DVD, or the like
  • various media such as a magnetic recording medium and an optical recording medium can be used.
  • “Input device” (input means for the computer system) may be a keyboard, mouse, touch panel, trackball, physical switch operated manually or by machine, microphone, voice input, graphical user interface, etc. Good.
  • the movement of the operator may be recognized (non-contact in one example) and a predetermined input corresponding to the movement may be recognized.
  • Part can also be expressed as“ element ”or“ module ”or the like”) ”— in this specification, for example,“ (function name) ”+“ part ”can be realized as a function of a computer. .
  • Such “parts (elements), modules, etc.” may be provided in any device in the system. In addition, it is not always necessary to have one device, and the corresponding function may be distributed to two or more devices. Furthermore, only one or more predetermined “units” may be provided in an external server or the like via a communication network (for example, the Internet). Such “parts (elements), modules, etc.” may be various functions logically possessed by the computer.
  • the various components do not have to be individually independent, and a plurality of components are formed as a single member.
  • One component is made up of multiple members, one component is a part of another component, and one component is a part of another component , Etc.
  • the various constituent elements may be formed so as to realize their functions, and may be realized by hardware or realized by a computer program.
  • a certain component can be realized as dedicated hardware that exhibits a predetermined function, a processing device in which the predetermined function is realized by a computer program, a combination thereof, or the like.
  • “Graphical user interface” means an interface that can be visually operated by touching an icon, an image button, a pull-down menu, or a numerical input window on the screen with a cursor or in the case of a touch panel. That means.
  • the “icon” is (i) one that displays predetermined information and can be selected by the operator, and (ii) only displays predetermined information and is configured to be selectable. It may include both those that are not. All or some of the icons displayed on the screen can be selected by touching each display location with a touch pen, an operator's finger, or the like, or by a cursor on the screen.
  • the “chemical solution injector” includes the following components: a piston drive mechanism, a control unit (control unit), a display, and the like.
  • these components may be provided in any device constituting the chemical liquid injector. That is, when the chemical liquid injector includes an injection head, a console, and the like, (i) the injection head may be provided with a piston drive mechanism, and the console may be provided with a control unit and a display, or (ii) the injection head A control unit may be provided on both the console and the console. (Iii) A display may be provided on both the injection head and the console.
  • a control unit control unit
  • Such a control unit may be provided as a part of an imaging apparatus such as a CT scanner, an MRI apparatus, a PET apparatus, an ultrasonic diagnostic apparatus, or an angiographic imaging apparatus.
  • the “injection head” includes a syringe holding unit that holds the syringe and a piston drive mechanism that moves the piston of the syringe forward and / or backward.
  • the syringe mounting method mainly includes (i) a so-called side loading type in which the syringe holding portion is formed as a semi-cylindrical concave portion on the upper surface of the head and the syringe is set therein; and (ii) the syringe holding portion is There is a so-called front loading type in which the base end portion of the syringe is held on the front surface of the head.
  • One form of the present invention includes any type of injection head.
  • the chemical injection device may have one or more of the following: one or more pressure sensors, one or more syringe detection sensors (magnet sensors, Hall sensors, etc.), one or Multiple tilt sensors, one or more rotary encoders, one or more motor current detectors, and the like.
  • a pressure sensor is for detecting the pressure which pushes a piston member, for example, By this, the pressure estimated value of a chemical
  • the pressure sensor may be a load cell, for example.
  • the load cell should just be provided in the position which can detect the pressure which the ram member of a piston drive mechanism pushes a piston member.
  • the calculation is performed by calculating the resistance of the injection circuit (eg, the size of the needle), the concentration of the chemical solution, the injection It may be performed in consideration of conditions.
  • a pressure sensor that directly detects the pressure of the chemical solution may be included.
  • Syringe detection sensor detects whether a syringe, adapter, and / or protective case is attached, or what type of syringe, adapter, and / or protective case is attached. It is used for judgment.
  • a sensor may be either a contact type or a non-contact type, and for example, the following can be used: a contact sensor using physical contact, an electric for electrically detecting an object. Sensor, magnetic sensor, Hall sensor, optical sensor, proximity sensor, etc.
  • Tilt sensor detects the tilt of the injection head.
  • this type of injection head performs the suction of the chemical solution into the syringe in such a posture that the front end side (that is, the syringe side) is upward.
  • the chemical liquid injection is performed in such a posture that the front end side of the injection head is relatively downward (a posture in which the tip side is directed slightly downward).
  • Rotary encoder A rotary encoder or the like for detecting the rotation speed and / or rotation direction of the motor of the piston drive mechanism and the feed screw may be provided.
  • Motor current detector It is also possible to calculate the estimated pressure value of the chemical based on the motor current without using a load cell or the like. In this system, the motor current is monitored by the motor current detector during operation of the motor, and the estimated pressure value of the chemical solution is obtained based on the motor current.
  • the chemical injection device may further include one or more of the following: one or more head displays, one or more head status indicators, one or more physical buttons, One or more RFID communication devices, one or more data receivers, one or more data transmitters, etc.
  • a display for displaying predetermined information may be provided in the injection head.
  • the display may be provided, for example, in a part of the casing of the injection head. Alternatively, a sub display prepared separately from the housing may be used.
  • the display is LCD (Liquid A display unit using a crystal display (Organic Electro-Luminescence) display or the like may be used, but an LED (Light It may be a display unit using Emitting Diode).
  • the contents displayed on the display are not particularly limited, but may be as follows: a predetermined state display during the injecting operation, conditions for injecting the liquid to be injected, conditions for injecting the liquid to be injected, liquid chemicals to be injected Injection volume, chemical pressure, injection speed, etc.
  • a predetermined light emitting unit for notifying an operator of a predetermined state of the injection head may be provided in a part of the casing of the injection head.
  • the light source LED (Light Emitting Diode) can be used.
  • Such a light emitting unit has a function as a head status display unit, and can notify the operator of various situations of the injection head by changing a light emission color or a light emission pattern.
  • the physical button is not particularly limited, but may be as follows. Advance button for advancing the ram member, Treatment button for retracting the ram member, Accelerator button for increasing the moving speed of the ram member by pressing simultaneously with the advance button or the retract button, and a stop for stopping the head operation Buttons etc. These physical buttons can be appropriately arranged on the upper surface, side surface, lower surface, rear end surface and the like of the casing of the injection head. In the case of a two-cylinder injection head, the physical button arrangement for one piston drive mechanism and the physical button arrangement for the other piston drive mechanism may be asymmetric.
  • RFID communication device When a data holding unit such as an IC tag is attached to the syringe, adapter, or protective cover, a wireless communication device that reads information on the tag may be provided.
  • This wireless communication device may be an RFID reader that simply reads data from an IC tag, or may be an RFID reader / writer that can also write data to an IC tag.
  • the data receiver is for receiving data transmitted from the outside to the injection head by wire or wireless.
  • the data receiver may receive data such as the following from the outside: any data generated by the imaging device, any data generated by the hospital system, and so on.
  • the data transmitter is for sending predetermined data from the injection head or the like to the outside by wire or wireless.
  • a suitable protocol may be adopted in consideration of a communication system with another device which is a communication partner.
  • a data transmitter or the like that communicates with an external device may be provided in a console or other device.
  • the data that can be transmitted from the injection head to the outside by the data transmitter may be one or more of the following: the name of the contrast agent used (contrast agent identification information), the total injection amount of the contrast agent Contrast agent injection time, contrast agent injection pressure, contrast agent injection speed, set injection protocol, etc.
  • patient identification information for example, patient ID
  • examination identification information for example, examination ID
  • information regarding imaging time and the like. Such information may be transmitted in combination with the information regarding the contrast agent described above.
  • the injection head and console are provided with a communication unit for communicating with external devices.
  • the piston drive mechanism may be configured to control the operation so as to adjust the injection amount of the contrast agent, the injection speed, and the like according to the injection conditions input from the external device via the communication unit.
  • Abnormality detection It is preferable that one or a plurality of injection abnormalities can be detected using the various sensors as described above. -Injection failure due to malfunction of piston drive mechanism, -Injection abnormalities due to the syringe not being properly mounted on the injection head, -Abnormal injection due to insufficient contrast agent remaining in the syringe to perform the injection operation, -Abnormal injection due to the catheter or needle not being properly inserted in the patient-Abnormal injection due to kinks occurring in the middle of the drug solution path, -An injection abnormality such that the pressure value of the detected chemical is not within a predetermined range (a predetermined range having an upper limit and a lower limit, or a predetermined upper limit, a predetermined lower limit, etc.), etc.
  • a predetermined range having an upper limit and a lower limit, or a predetermined upper limit, a predetermined lower limit, etc.
  • the driving force of the piston drive mechanism exceeds the predetermined range.
  • the driving force falls below a predetermined range.
  • the detection result may be transmitted from the communication unit to the outside.
  • a pressure sensor for measuring pressure may be provided in the middle of the extension tube to detect whether the chemical solution is injected at a predetermined pressure.
  • the following screen may be displayed regarding chemical injection and condition setting.
  • the system may have the following graphical image or may have a storage device in which such a graphical image is stored.
  • the “self-check screen” is a screen for displaying the self-check result of the head immediately after the power is turned on.
  • “Calibration screen” is a screen for calibrating the touch panel.
  • the “service maintenance screen” is a screen that allows the console settings to be changed as necessary.
  • the “part selection screen” is a screen for selecting a protocol registered in each part.
  • “Injection condition setting screen” is a screen for setting the injection conditions of the protocol.
  • “Setting confirmation screen” is a screen for confirming the injection conditions immediately before injection and finely adjusting the injection conditions.
  • the “injection screen” is a screen for displaying the pressure during the injection.
  • “Protocol setting screen” is a screen for creating and editing a protocol.
  • the “environment setting screen” is a screen that displays function setting items that can be adjusted by the operator.
  • the “injection result screen” is a screen for displaying the injection result.
  • the imaging device may be, for example, an X-ray CT scanner or the like.
  • an imaging unit a gantry in one example
  • a bed on which a patient is placed
  • an operation control unit that controls the operations thereof
  • a data collecting unit for collecting fluoroscopic imaging data a main controller for controlling the entire operation, and the like.
  • the main controller may be provided as a console, for example.
  • the imaging device may also have one or more displays that display predetermined information.
  • an X-ray irradiation unit that has an X-ray tube, a collimator, etc.
  • the bed is configured to be movable using, for example, a motor as a drive source, and the movement operation is controlled by the operation control unit.
  • Various communication protocols between devices such as between the imaging device and the chemical injection device, between the other devices of the imaging device, and between the chemical injection device and other devices can be used.
  • CANopen Protocols such as HL7 and DICOM are listed.
  • FIG. 1 It is a figure which shows the relationship between a parameter, a change, and an injection
  • FIG. 10B is a perspective view of a mixing device used in the extension tube of FIG. 10A. It is sectional drawing of the mixing device used for the extension tube of FIG. 10A. It is a figure which shows an example of the screen for confirming the set injection
  • FIG. 3 is a diagram illustrating an example of a graphical user interface for changing an injection pattern.
  • FIG. 6 is a diagram illustrating another example of a graphical user interface for changing an injection pattern.
  • 1 is a block diagram of an example of a computer system according to an embodiment of the present invention. It is a schematic diagram of the system which performs condition setting with the console by the side of an imaging device.
  • the chemical injection system 1000 includes a chemical injection device 100 that injects at least a contrast medium as a chemical into a patient, and an imaging device 300 that captures a fluoroscopic image of the patient.
  • the chemical injection device 100 includes an injection head 110 held on an upper part of a movable stand or a part of a ceiling-suspended arm, and a console 150 connected thereto. Two syringes 200C and 200P may be detachably attached to the injection head 110 in parallel. Note that the injection head and the console may be connected in a wireless manner.
  • the specific configuration of the injection head and the console is not particularly limited, but a specific example as one embodiment will be described later with reference to other drawings (FIG. 7 to FIG. 7). (See FIG. 9B).
  • syringes 200C and 200P may be simply referred to as “syringe 200” without being distinguished.
  • An “injection head” is also called an injector or an injection head.
  • Examples of the chemical solution filled in the syringes 200C and 200P include a contrast medium and physiological saline.
  • one syringe 200C may be filled with a contrast medium
  • the other syringe 200P may be filled with physiological saline.
  • the syringe 200 has a hollow cylindrical cylinder member 221 and a piston member 222 that is slidably inserted into the cylinder member 221.
  • the cylinder member 221 may have a cylinder flange 221a formed at the base end portion thereof and a conduit portion 221b formed at the tip end portion thereof.
  • the extension tube 230 is connected to the conduit portion 221b of each syringe 200.
  • the extension tube 230 may be a so-called T-shaped tube or Y-shaped tube.
  • the tube 231a extends from the conduit portion 221b of one syringe 200C to the branch portion, and the tube extends from the conduit portion 221b of the other syringe 200P to the branch portion. It may have 231b and the tube 231c extended toward a patient from a branch part.
  • an injection needle is connected to the distal end side (not shown) of the tube 231c.
  • This injection needle is punctured into a patient's blood vessel, and the chemical solution is injected into the blood vessel by pushing out the chemical solution in the syringe 200C and / or the syringe 200P.
  • the syringe may be a prefilled type that is pre-filled with a chemical solution, or may be a suction type that sucks and uses a chemical solution in an empty syringe.
  • An IC tag 225 may be attached to a part of the cylinder member 221.
  • the IC tag 225 may store at least one of the following information: -Information about the syringe (one or more of syringe identification information, syringe pressure resistance, cylinder member inner diameter, piston member stroke, etc.), -Information (one or more of name (for example, product name), component information such as iodine amount, expiry date, chemical volume, etc.) of the chemical filled in the syringe.
  • IC tag may have a unique ID unique to the tag.
  • the IC tag may have at least one information selected from a syringe size, a syringe serial number, and a drug standardization code.
  • IC tag 225 for example, an RFID (Radio frequency identification) tag can be used.
  • the position where the IC tag 225 is attached may be, for example, the outer peripheral surface of the cylinder member 221. Specifically, the IC tag 225 may be near the cylinder flange on the outer peripheral surface.
  • the injection head 110 has a casing that extends long in the front-rear direction, and two recesses on which the syringes 200C and 200P are respectively placed are formed on the top end side of the casing. Also good.
  • a recessed part is a part which functions as a syringe holding part.
  • the syringe 200 may be directly attached to the recess, or may be attached via a predetermined syringe adapter.
  • the injection head 110 also has a piston drive mechanism 130 having at least a function of pushing the piston member 222 of the syringe 200.
  • Two systems of piston drive mechanisms 130 are provided, and each mechanism 130 operates independently.
  • the piston drive mechanism 130 may have a function of retracting the piston member 222, for example, for sucking a chemical solution into the syringe.
  • the two piston drive mechanisms 130 may be driven simultaneously, or may be driven at different timings.
  • the piston drive mechanism 130 is connected to a drive motor (not shown), a motion conversion mechanism (not shown) that converts the rotational output of the drive motor into a linear motion, and the motion conversion mechanism. It may have a syringe presser (ram member) for moving the piston member 222 forward and / or backward.
  • a piston drive mechanism a known mechanism generally used in a chemical liquid injector can be used.
  • An actuator other than the motor may be used as the drive source.
  • Typical operation of the piston drive mechanism includes the following: chemical injection (ram member advance) and chemical suction (ram member reverse).
  • chemical solution injection a chemical solution is injected in accordance with a set injection protocol (injection condition) by operating the motor in accordance with a predetermined motor control signal and moving the ram member forward.
  • chemical solution suction a chemical solution is sucked into a syringe by operating a motor in accordance with a predetermined control signal to retract a piston member. In the case of a prefilled syringe, the chemical liquid suction need not be performed.
  • the piston drive mechanism 130 may have a load cell (not shown) for detecting the force with which the syringe press presses the piston member 220.
  • a load cell for detecting the force with which the syringe press presses the piston member 220.
  • the estimated value of the pressure of the chemical solution when the chemical solution is being injected can be obtained using the detection result of the load cell.
  • the calculation of the estimated value is performed in consideration of the needle size, the concentration of the drug solution, the injection conditions, and the like.
  • the pressure may be calculated based on a motor current of a drive motor (not shown).
  • the injection head 110 When the IC tag 225 is attached to the syringe, the injection head 110 includes a reader / writer 145 that reads information from the IC tag 225 and / or writes information to the IC tag 225, as shown in FIG. You may have.
  • the reader / writer 145 may be provided in the recess 120a in which the syringe 200 is mounted. Note that the reader / writer 145 may have only a function of reading information from the IC tag 225.
  • the injection head 110 may have a control unit 144 for controlling operations of the piston drive mechanism 130 and the reader / writer 145.
  • a storage unit 146 that temporarily stores information read from the IC tag 225 may be included.
  • a plurality of physical buttons for causing the injection head 110 to perform various operations are also provided on the top and side surfaces of the casing of the injection head 110.
  • some of these physical buttons may be configured to emit light in order to notify the operator of predetermined information.
  • the console 150 may be used by being placed in an operation room adjacent to the examination room.
  • the console 150 includes a display unit 151 that displays a predetermined image, an operation panel 159 provided on the front surface of the casing, a control circuit (detailed below) arranged in the casing, and the like.
  • the operation panel 159 is a portion where one or a plurality of physical buttons are arranged, and is operated by the user.
  • the display unit 151 may be a touch panel display or a simple display.
  • the console 150 may include a speaker or the like (not shown) for outputting sound and / or sound.
  • the console 150 is depicted as having a control unit 153 that controls the operation of each connected unit and a storage unit 154 that stores various data.
  • the console 150 may have an interface for connection to the injection head 110 and an interface (not shown) for connection to the imaging apparatus.
  • the console 150 may have a hand unit 157 (input device 157 in FIG. 1) that is connected to the console by wire or wirelessly and is operated by the user.
  • the console 150 may have an interface to which an information storage medium is connected.
  • the console 150 has a slot disposed on the front surface, side surface, or rear surface of the housing. You may have.
  • the control unit 153 may include a memory, a processor, and the like, and may perform various processes according to a computer program.
  • a computer program may be stored in advance in a predetermined storage area of the console, downloaded from the outside through a network or the like, and stored in the predetermined storage area, or The information may be read from an information storage medium inserted in the slot.
  • control unit 153 may include a setting screen display unit 153a, an injection protocol creation unit 153b, an injection control unit 153c, a history generation unit 153d, and a history output unit 153e, as shown in FIG.
  • the setting screen display unit 153a may correspond to a function for displaying a screen for setting an injection protocol, specifically, an initial setting screen 360 (see FIG. 4A) as described later. Although the details will be described later, the setting screen display unit 153a displays an initial setting screen 360 including at least a mode selection display unit 363 for selecting one of a plurality of injection protocol setting modes on the display unit 151. It may correspond to the function to be performed. Data relating to the setting initial screen 360 and the like may be stored in a storage device of a chemical liquid injector, an imaging device, a hospital system, or other computers.
  • the protocol creation unit 153b may correspond to, for example, a function of accepting an input operation on the touch panel of the display unit 151 by the user and creating an injection protocol reflecting the contents.
  • the conditions input by the user in this way are, for example, at least one selected from the type of the chemical solution, the injection rate of the chemical solution, the injection amount of the chemical solution, the patient's physical information, the body classification of the patient to be imaged, the imaging region, and the like. It may be one.
  • the protocol creation unit 153b -After a predetermined injection protocol setting mode has been selected, one of the vertical axis and the horizontal axis is the injection rate and the other is the injection time, and the input of the injection pattern from the operator to the injection graph 361 including at least one phase.
  • An injection pattern input receiving unit for receiving;
  • An injection protocol generation unit for creating a chemical liquid injection protocol based on an injection pattern input on the injection graph 361;
  • a pop-up screen display for displaying a pop-up screen 371 on the screen; It may have a protocol change processing unit that accepts protocol changes and reflects the contents thereof.
  • the console computer system -Accept selection of a predetermined injection protocol setting mode, -Displaying an injection graph including at least one phase, one of the vertical and horizontal axes being the injection rate and the other being the injection time; -Accepting the injection pattern input from the operator to the injection graph, -Create a chemical injection protocol based on the injection pattern entered on the injection graph, -Display a pop-up screen (details below) on the screen, -Accept protocol changes and reflect their contents. And have the graphical user interface data required for it or configured to obtain it externally.
  • the injection control unit 153c may correspond to a function of controlling the operation of the piston drive mechanism 130 according to the created injection protocol.
  • the injection control unit 153b may operate only one of the piston drive mechanisms 130 and operate both at the same time.
  • the history generation unit 153d may correspond to a function for generating injection history data.
  • the “injection history data” includes, for example, an injection operation ID that is unique identification information for each injection operation, injection start and end dates and times, identification information of the chemical injection device, and identification of the chemical solution and the imaging region that are the injection conditions described above. It may be information. These may be text data. Further, image data of a time-dependent graph in which one of the horizontal axis and the vertical axis is the elapsed time and the other is the injection rate may be used.
  • the history output unit 153e may correspond to a function of transmitting injection history data to the outside. Specifically, data may be transmitted to a predetermined external device and / or network. Information on the liquid medicine obtained from the IC tag of the syringe or manually input by the operator or input from an external network or the like is transmitted from the liquid injector to the medical information system in the hospital. A system configuration in which a system having an accounting processing function performs accounting processing based on the information is also possible.
  • the storage unit 154 may store, for example, image data displayed on the display unit 151. Further, an algorithm including a calculation formula for setting injection conditions, and data of injection protocol may be stored. The injection rate may be constant or may change with time. In the case of injecting contrast medium and physiological saline, information on the order of injecting these drug solutions is also included in the injection protocol.
  • console 150 may have a slot (not shown), and the console 150 may be inserted into and input from the information storage medium.
  • the imaging apparatus 300 is, for example, an X-ray CT scanner, an MRI apparatus, an angiography apparatus, a PET apparatus, an ultrasonic diagnostic apparatus, or the like. As shown in FIG. 3, an imaging unit 303b that captures a fluoroscopic image of a patient, And a bed 304 on which the robot is placed and a control unit 303a that controls the operation of the bed 304 may be provided.
  • the injection head 110 and the console 150 may be connected by a cable, but as described above, they may be connected via a wireless communication unit or the like.
  • the communication unit may be externally attached to the injection head 110 or may be built therein.
  • the communication unit may be externally attached to the console 150 or may be built therein.
  • A2 In the above description, an injection head to which two syringes are attached is shown, but an injection head to which only one injection head is attached may be used.
  • the chemical injection device 100 is not limited to the CT examination, but may be an apparatus for MR examination, angiography examination, PET examination, ultrasonic diagnosis, or the like.
  • A4 As a contrast agent injection pattern, a variable pattern in which the injection speed is linearly reduced and thereafter the injection speed is kept constant, and / or the injection speed is linearly reduced and thereafter the injection speed is linearized again. It is also possible to use variable patterns that increase in number. Furthermore, you may use what abbreviate
  • A5 In the above description, for example, as shown in FIG. 1, the chemical injection device in which the injection head and the console are configured separately is shown. However, a chemical injection device such as the following may be used: -A chemical injection device in which the injection head and the console are integrated, in other words, a single device is used to set the injection protocol, display various states during chemical injection, and control the operation of the piston drive mechanism.
  • Such as a chemical injection device Such as a chemical injection device.
  • a chemical injection device in which the injection head and the console are integrated as one casing, and further comprising a separate battery unit.
  • a battery unit may be an AC power source, may be installed at any location in the examination room, or may be held in a part of a movable stand.
  • a chemical injection device capable of controlling a predetermined operation of the chemical injection device from the outside of the examination room using, for example, a wired or wireless remote controller.
  • the wireless system may be a system using infrared rays, or a wireless LAN, Wi-Fi (registered trademark), Bluetooth (registered trademark), ZigBee (registered trademark), or the like. Good.
  • the controlled operation may be any operation including, for example, power on / off of the apparatus.
  • the start and / or stop of any operation of the injection head may be controlled with a remote controller.
  • a control unit such as a miniaturized console (e.g. having one or more buttons and / or a display)
  • such a control unit is held on a movable stand together with an injection head.
  • such a control unit is held on a ceiling-suspended arm together with an injection head.
  • it is integrated with the injection head.
  • the controller 144 of the injection head may have at least one of the functions of the units 153a, 153b, and 153c in FIG. That is, in the present invention, the “control unit” responsible for the screen display function and the injection protocol creation function is not particularly limited, and may be a control unit in the injection head or in the console. It may be a control unit or a combination thereof.
  • B1-1) In addition to the configuration in which the setting screen (graphical user interface) for setting the injection protocol is displayed on the console display, the following configuration can also be adopted. -The injection head has a sub-display on which a setting screen (graphical user interface) as described above for setting the protocol is displayed.
  • the injection head 110 may include a component corresponding to the control unit 153.
  • the “chemical injection device” in the present invention includes a device in which at least a part of the function of the console 150 is incorporated in the injection head 110.
  • the setting screen as described above for setting the protocol may be displayed on the display of the imaging apparatus. That is, in this case, the imaging apparatus provides a graphical user interface, and the operator can set conditions via this interface. And it is also preferable that the data of the conditions set on the imaging device side in this way is transmitted to the chemical injection device by wire or wireless, and the setting is performed from the imaging device side.
  • B1-3 As described above for setting a protocol in any device (for example, a chemical injection device, an imaging device, a database server, or other computer system) in the system in order to realize the configuration as described above Data for various setting screens (graphical user interface).
  • the chemical injection device of this embodiment may operate as follows as an example:
  • the user installs the syringes 200 ⁇ / b> P and 200 ⁇ / b> C on the injection head 110 with the power supply of the chemical injection device 100 turned on.
  • the user connects the extension tube to the syringes 200P and 200C via the extension tube 230, and punctures the patient with an injection needle (not shown) provided at the distal end of the extension tube.
  • an injection needle not shown
  • one or a plurality of screens for setting the injection protocol are displayed on the display unit 151.
  • at least one of the following parameters may be entered, selected or changed: -Body segment to be imaged-Region to be imaged (referred to as imaging region) -Information such as patient weight-Type of medicinal solution to be injected, etc.
  • Images for selecting these parameters may be displayed sequentially or collectively.
  • the input, selection, or change of the parameters as described above may be automatically performed according to the function of the apparatus or may be performed by a user operation.
  • a predetermined button for example, a confirmation button
  • creating an injection protocol for example, (i) select one of several basic patterns prepared in advance according to the image for creating the injection protocol displayed on the screen, and confirm or need its contents. (Ii) by creating a desired injection protocol by plotting several reference points in the injection graph displayed on the screen.
  • pharmacokinetic analysis when the patient and contrast medium injection conditions (for example, height, weight, sex, cardiac output, contrast medium concentration, injection speed, injection volume, etc.) are changed
  • This can be implemented using simulation software or the like that can estimate changes in the temporal contrast curve of the aorta (which may be the right heart, left heart, artery, pulmonary circulation, systemic circulation, etc.).
  • a CT value (HU) of 1 mgI / ml may also be set.
  • the injection condition to be changed may be the amount of iodine per body weight, the amount of iodine per body weight per time, or the like.
  • the various conditions in the simulation software may be input / output through two-way data communication with PACS, HIS, RIS, imaging device, workstation, etc.
  • the imaging device may acquire a complex injection protocol, the imaging device may set the injection protocol, or change the speed and / or amount while viewing the CT value.
  • -CANopen standards -HL7 standard, which is the standard for medical information exchange -DICOM (Digital Imaging and Communication in Medicine) standard, etc.
  • DICOM Digital Imaging and Communication in Medicine
  • the operation of the piston drive mechanism 130 is controlled based on the injection protocol, and the drug solution is injected into the patient.
  • FIG. 3 is a flowchart showing an example of an injection protocol setting procedure and the like.
  • 4A to 4H are examples of screens displayed on the display unit 151 of the console 150.
  • FIG. 3 is a flowchart showing an example of an injection protocol setting procedure and the like.
  • a screen 360 as shown in FIG. 4A is displayed on the display unit 151 (step S1).
  • This screen 360 is basically for selecting one of a plurality of injection protocol setting modes, and is also referred to as a setting initial screen 360 in the following description.
  • the console reads the data of the initial setting screen 360 from a storage device (not shown) and displays the image on the display.
  • injection graph 361 (detailed below) is already displayed on the screen of FIG. 4A, this injection graph 361 may appear after selecting the mode selection icon 363 (detailed below), for example. .
  • each display of the setting initial screen 360 of FIG. 4A will be described.
  • an injection graph 361 for creating a protocol is displayed.
  • the horizontal axis represents elapsed time and the vertical axis represents injection speed.
  • the vertical axis displays the speed up to 5.0 ml / sec (in the example, every 1.0 ml / sec), and the horizontal axis includes five phases. It is shown.
  • the number of phases to be displayed is not limited to five, and may be one, two, three, four, or six or more.
  • the scale concerning the speed on the vertical axis and the display mode of the phase on the horizontal axis may be appropriately changed.
  • the vertical axis is speed and the horizontal axis is time, but the vertical axis may be time and the horizontal axis may be speed.
  • various icons 361a, 361b, 362a, 362b, and 363 to 366 are displayed above the injection graph 361 (an example). All or some of the icons displayed on the screen can be selected by touching each display location with a touch pen or an operator's finger or the like, or with a cursor on the screen.
  • Icons 361a and 361b respectively indicate a contrast medium and physiological saline.
  • the contrast medium is represented by “A”
  • the physiological saline is represented by “B”.
  • the icon 361a contrast agent
  • a contrast agent injection pattern can be created in the injection graph 361.
  • the icon 361b saline injection pattern can be created in the injection graph 361.
  • these icons 361a and 361b are for selecting which of the contrast medium and the physiological saline is to be performed.
  • Icons 362a and 362b are for displaying a basic pattern of a predetermined injection protocol.
  • the number of icons for displaying the basic pattern of the injection protocol can be appropriately changed according to the number of selectable injection protocols, and three or more such icons can be displayed. It may be.
  • an image (for example, an image obtained by simplifying the shape of the protocol) may be displayed on the icon so that the injection protocol can be easily recognized visually. . Further, by touching one icon, two or three or more injection protocol candidates may be sequentially displayed.
  • predetermined character information is input or a predetermined target image is operated with a cursor by operating a mouse or the like. Or may be selected.
  • the mode selection icon 363 is basically for an operator to manually create an arbitrary injection pattern (injection profile). In this case, this icon 363 is used to select the injection protocol setting mode. Examples of setting modes for the injection protocol include (i) flow rate mode, (ii) standard / weight input mode, (iii) heart / weight input mode, and the like. Details of each will be described later. When the mode selection icon 363 is pressed, at least two, preferably three of them may be switched sequentially.
  • the icon 364 displays the weight of the patient, and is “60” Kg as an example here. Although not limited, when the icon 364 is pressed, a predetermined pop-up screen (not shown) or pull-down screen (not shown) is displayed, and the weight can be changed by pressing the numeric keypad or the increase / decrease button in the screen. It may be like this.
  • the icon 365 displays the amount of iodine per patient's body weight, and here is “450” mgI / Kg as an example.
  • the numerical value of 450 mg I / Kg is an example of the amount of iodine in the standard / weight input mode. In the case of the heart / weight input mode, for example, 24.5 mg I / Kg / sec may be displayed.
  • a predetermined pop-up screen (not shown) or pull-down screen (not shown) is displayed as described above. By pressing a numeric keypad or an increase / decrease button in the screen, this is displayed.
  • the numerical value may be changeable.
  • the icon 366 may display a pressure limit value, and may be displayed as “10.0” Kg / cm 2 or the like as an example. Although not limited thereto, when the icon 365 is pressed, a predetermined pop-up screen (not shown) or pull-down screen (not shown) is displayed as described above. By pressing a numeric keypad or an increase / decrease button in the screen, this is displayed. The numerical value may be changeable.
  • the screen can also display information such as patient information other than the subject's ID and weight, and information such as the imaging site. Further, a predetermined delete button may be displayed, and a part or all of the injection protocol displayed in the graph 361 may be deleted by pressing this delete button.
  • step S2-1 and S2-2 the patient's weight and iodine amount are input, respectively. Any of the order of step S2-1 and step S2-2 may be first or may be simultaneous. Further, in the flowchart of FIG. 3, such an input is performed after the initial setting screen 360 is displayed. Of course, such an input is performed before the initial setting screen 360 is displayed. Also good. Alternatively, one of step S2-1 and step S2-2 may be performed before step S1, and the other may be performed after step S1.
  • body classification and / or imaging region input may be performed, which will be described later.
  • the input of the patient weight (for example, 60 kg) can be performed by, for example, a conventionally implemented method.
  • the operator may input the weight through a predetermined input (see below) through the display unit 151 (here, a touch panel that also serves as an input device): -Numeric keypad input, -Two, three or more weight category icons are displayed on the screen, and the operator selects one of them, -A preset default value or default weight category is displayed, and the operator changes the value or category as necessary, etc.
  • patient weight data may be automatically input to the console 150 via an external network.
  • patient information including at least body weight data may be obtained from a database server (for example, hospital information system, HIS, Hospital Information System) connected via a LAN (Local Area Network) or the Internet. Good.
  • the chemical injection device is an example, as shown in FIG. 12, such as PACS (Picture Archiving and Communication Systems), HIS (Hospital Information System), RIS (Radiologic Information System, image printer, workstation image, etc.). It may be wired or wirelessly connected to a network to which some or all of them are connected.
  • an electronic weight scale (not shown) to the chemical injection device online, measure the patient's weight with the electronic weight scale, and input the result to the chemical injection device.
  • an electronic weight scale (not shown) to the chemical injection device online, measure the patient's weight with the electronic weight scale, and input the result to the chemical injection device.
  • a bed in the imaging apparatus, for example, it is possible to measure the weight of the subject on the bed and provide data to the drug solution injector.
  • Examples of the input of the iodine amount include the iodine content (for example, 300 mg / ml) of the contrast agent and the iodine amount required per body weight (for example, 450 mg I / Kg).
  • the iodine content of the contrast agent may also be input by the operator making a predetermined input through the display unit 151 (for example, a touch panel) of the console 150, or may be automatically read from the IC tag of the syringe. It may be entered.
  • the amount of iodine required per body weight may also be input by the operator performing numeric keypad input or the like through the display unit 151 (for example, a touch panel). Alternatively, when a body segment or an imaging region is selected, a value set in advance according to the selected body segment or imaging region may be automatically set.
  • an icon 373a displayed as “300” appears in the upper part of the screen (an example), which indicates that the iodine content of the contrast medium is 300 mg / ml.
  • other iodine content candidates for example, 240, 330, 350, 370, etc.
  • a configuration may be adopted in which when this icon is pressed, a small amount is injected in order to confirm in advance the arrival time of the drug solution from the contrast medium or the contrast medium by saline. At that time, the remaining amount may be checked to determine whether the remaining amount necessary for the main plot injection is affected.
  • the icon displayed as “root button” when this icon is pressed, a configuration may be used in which a small amount is injected in order to confirm whether the blood vessel is properly secured with a raw diet or a contrast medium. At that time, the remaining amount may be checked to determine whether the remaining amount necessary for the main plot injection is affected.
  • step S3 When the input of the patient's weight and iodine amount is completed, in step S3, one or both of the injection amount (ml) and the initial velocity (ml / sec) of the contrast medium to be injected into the patient are calculated.
  • This calculation is an example, and is performed by the control unit 153 of the console 150 based on a command of the computer program.
  • the calculation may be performed by a computer system on the imaging apparatus side or another computer system.
  • a predetermined calculation for setting an injection protocol or a predetermined setting screen is displayed, the operation effect thereof is exhibited. Therefore, from such a viewpoint, which computer system performs the calculation or which display monitor displays the screen may be arbitrarily changed.
  • the “heart / weight input mode” is a mode used in the case of cardiography or the like, and the operator inputs an injection pattern in one or a plurality of phases on the injection graph as a whole. This is a setting method for creating a pattern.
  • I A iodine amount required per second unit time (mgI / Kg / sec)
  • I CM Iodine content of contrast agent (mgI / ml)
  • W Weight (Kg)
  • the “iodine amount required per unit time per second” is also input, for example, by an operator inputting a numeric keypad through the display unit 151 (for example, a touch panel), in the same manner as the “iodine amount required per unit weight” described above. Also good. Alternatively, it may be automatically read from the IC tag of the syringe. When selecting a body segment or an imaging region, a preset value corresponding to the selected segment or region may be automatically set.
  • step S4 the operator presses the setting mode selection icon 363 to select the setting mode of the injection protocol.
  • step S5 an example of creating an injection protocol will be described.
  • the operator creates an injection pattern for each phase (a single phase when there is one phase) on the injection graph 361.
  • a pop-up screen 371 appears. Instead of touching the area 374, for example, a pop screen 371 may appear by selecting a predetermined icon (not shown) on the screen.
  • a variable constant display unit 371a In the pop-up screen 371, a variable constant display unit 371a, an injection time display unit 371b, and the like are displayed. Further, a flash button 372a, a dilution button 372b, a final speed fixed pattern button 372c, and the like are displayed. An OK button for confirming the input content and a cancel button for discarding the input content are also displayed.
  • variable constant display unit 371a includes a character display unit that indicates a numerical value of the variable constant and an adjustment button for increasing or decreasing the value.
  • the adjustment button may include an image button (up button) for increasing the numerical value of the variable constant and an image button (down button) for decreasing the numerical value of the variable constant.
  • variable constant is a parameter related to the gradient of the contrast agent injection pattern, and refers to the ratio between the final velocity and the initial velocity in the phase.
  • the display unit 371b indicating the injection time includes a character display unit indicating a numerical value of the injection time of the phase and an adjustment button for increasing or decreasing the value.
  • the adjustment button may have the same configuration as that of the variable constant display unit 371a. By operating the adjustment button, the current injection time (“10” sec in one example) can be changed to, for example, “20” sec or “5” sec.
  • the flush button 372a is a button for creating a constant rate injection of physiological saline in the next phase of the phase.
  • the physiological saline injection speed may be an initial speed of the contrast medium in the phase.
  • the same speed as the sum of the contrast medium injection speed and the physiological saline injection speed may be used.
  • the injection speed at which the effect of flash injection can be obtained for example, ⁇ 20%, preferably ⁇ 10% of the reference speed (the initial speed of the contrast medium or the total speed of the two drug solutions) as described above.
  • the speed may be within a range.
  • the dilution button 372b is a button for creating an injection pattern of physiological saline injected simultaneously with the contrast agent in the phase.
  • the following injection pattern may be created: (I) When the injection speed of the contrast agent is constant, a constant-rate saline injection pattern is displayed. (Ii) A pattern in which the contrast agent injection rate decreases, specifically, a pattern in which the injection rate decreases with time as illustrated in FIG. 4D as an example, and the final rate is zero and not substantially zero. In the case of crossing the contrast agent injection pattern, specifically, the sum of the contrast agent injection rate and the saline injection rate is constant or substantially constant in the phase.
  • the reference line (vertical or horizontal reference line that passes through the approximate center of the line segment of the injection pattern in one example) is displayed as a reference and the contrast medium injection pattern and the physiological saline injection pattern are displayed.
  • a physiological saline injection pattern that crosses the contrast agent injection pattern in a line symmetrical manner is displayed, as in (ii) above.
  • the final speed fixed pattern button 372c is a button for creating an injection pattern having a shape that changes from a predetermined initial speed to a zero or substantially zero final speed in the phase.
  • the injection speed being zero basically means that the motor (not shown) of the piston drive mechanism 130 is not operated. Such speed setting may be performed. However, the operation of the motor is continued by setting the injection rate to substantially zero, for example, in the range of 0.01 ml / sec to 0.5 ml / sec, or in the range of 0.05 ml / sec to 0.2 ml / sec. However, it may be controlled that the chemical liquid injection is not substantially performed.
  • FIG. 4C shows an example of an injection pattern that is displayed when the OK button on the pop-up screen 371 is pressed while the variable constant is 1.0 and the flash button 372a is selected.
  • a constant rate contrast agent injection pattern (line segment) 368a is displayed in the first phase
  • a constant rate saline injection pattern (line segment) 368b is displayed in the second phase.
  • the injection rate is 4.0 ml / sec, which is the same as an example.
  • the amount of contrast medium to be injected into the patient has already been calculated (as a specific example, 80 ml).
  • the injection speed is calculated as 4.0 ml / sec by dividing the injection amount by the injection time.
  • the injection speed is automatically calculated, it is not necessary for the operator to calculate the injection amount and input it.
  • the rate of the physiological saline in the second phase is also 4.0 ml / second as in the example of FIG. 4C. sec.
  • FIG. 4D shows an example of an injection pattern created when the variable constant is 0.5 and the dilution button 372b is selected.
  • the contrast agent injection pattern 368a in which the speed decreases from 4.0 ml / sec to 2.0 ml / sec, and the physiology in which the speed increases from 2.0 ml / sec to 4.0 ml / sec.
  • a saline injection pattern (line segment) 368b is displayed. That is, in this phase, the contrast agent injection rate and the physiological saline injection rate are not constant, but the total rate of both is constant at 4.0 ml / sec.
  • the first phase injection pattern may be combined with the second phase flush injection with physiological saline.
  • the injection speed of the physiological saline of the second phase may be set to be the same as the initial speed of the contrast agent of the first phase.
  • FIG. 4E shows an example of a state in which the dilution button 372b is selected on the pop-up screen 371 when the variable constant is 1.0.
  • the display unit 371c indicating the mixing ratio may appear.
  • a character display portion indicating the numerical value of the ratio and an adjustment button for increasing or decreasing the value are displayed.
  • the adjustment button may have the same configuration as that of the variable constant display unit 371a.
  • FIG. 4F shows an example in which a contrast medium and physiological saline are injected at a constant rate of 50:50 in the first phase.
  • the total injection rate of the contrast medium and the physiological saline is 4.0 ml / sec.
  • the present invention is not limited to such a display mode, and each of the contrast agent injection pattern and the physiological saline injection pattern may be displayed at a height of 2.0 ml / sec.
  • FIG. 4G shows an example of an injection pattern created by selecting the final speed fixed pattern button 372c.
  • a contrast agent injection pattern 368a in which the speed is reduced from 4.0 ml / sec to 0.1 ml / sec (substantially zero) is displayed in the first phase.
  • the end speed fixing pattern button 372c may be as follows: That is, in the case of mixed injection of contrast medium and physiological saline as shown in FIG. 4F, the end speed fixing pattern button 372c. Is selected so that the contrast agent injection pattern changes from a predetermined initial velocity (here, 4.0 ml / sec in the example) to a substantially zero final velocity so that it crosses the injection pattern. In addition, a physiological saline injection pattern that changes from an initial velocity of zero to a predetermined final velocity (here, 4.0 ml / sec as an example) appears.
  • a predetermined initial velocity here, 4.0 ml / sec in the example
  • the predetermined initial speed here, 4.0 ml / sec in this example
  • the predetermined final speed in this example, 4.0 ml / sec
  • An injection pattern of contrast medium to be injected, and an injection of physiological saline that changes from a substantially zero initial speed to a predetermined final speed (in this example, 4.0 ml / sec) so as to cross the injection pattern A pattern may appear.
  • the fixed speed fixed pattern button 372c when the variable constant is less than 1.0, the contrast medium injection pattern changes from a predetermined initial speed to a substantially zero final speed as described above.
  • a pattern to be displayed may appear.
  • the display of the injection graph 361 is not limited to the one illustrated in FIGS. 4A to 4G, and various changes can be made.
  • an interruption icon 369a is displayed at the start point of the phase or at the end point of the phase, and when this icon is operated (for example, long pressing the icon), the chemical solution is interrupted at a predetermined time interval.
  • a phase may be inserted.
  • a time display unit 369b indicating the injection time of each phase may be displayed.
  • the display unit 369b may be a simple character display or a selectable icon.
  • a speed display portion 369 indicating the speed of the end portion of the injection pattern (here, only the initial speed “4.0” is shown as an example) may be displayed.
  • the injection amount display part 369d which shows each injection amount of the contrast agent and chemical
  • the input of one injection pattern is completed as a whole by setting the injection pattern of one or a plurality of phases through the pop-up screen 371 as described above (step S5).
  • step S6 the injection protocol is completed through confirmation by the operator and pattern correction as necessary (details will be described later) (step S6).
  • step S7 the piston drive mechanism 130 is controlled based on the injection protocol, and the medical solution is injected into the patient.
  • a third phase to the injection protocol (for example, consisting of two phases) registered in advance in the icons 362a, 362b, etc. via the operation of the pop-up screen 371.
  • the basic pattern of the registered injection protocol may be appropriately corrected through the operation of the pop-up screen 371.
  • the operator can create an arbitrary injection pattern by operating the pop-up screen 371 on the injection graph 361 as in the standard / weight input mode.
  • the initial velocity of the contrast medium is determined in advance in the heart / weight input mode, the starting point of the first phase injection pattern (segment) is automatically determined, and the operator inputs the initial velocity. There is no need to do.
  • Other procedures for creating the injection pattern can be the same as those in the standard / weight input mode described above.
  • B2-3 Flow rate input mode
  • the operator operates the setting mode selection icon 363 on the screen.
  • the contrast agent injection amount and the initial velocity are not calculated as in the above two setting modes, and the operator inputs an arbitrary injection pattern, so that one injection pattern as a whole is input. Can be created.
  • this mode other procedures for creating the injection pattern can be the same as those in the standard / weight input mode described above.
  • the contrast medium injection amount and the initial velocity are not calculated. Therefore, when the flow rate input mode is selected with the icon 363, the icons 364 and 365 on the screen (FIG. 4A) are displayed. It may be configured to disappear. It will be described later that other input methods may be displayed on the screen and appropriately selected.
  • FIG. 5A shows a case where the injection amount is changed from V to V ′.
  • the injection time t is not changed, and the initial speed f 1 and the final speed f 2 are changed.
  • the weight of the observer is changed (increased) from W to W ′, or the iodine amount is changed (increased) from a to a ′.
  • this corresponds to the case where the weight is changed by pressing the icon 364, or the case where the iodine amount is changed by pressing the icon 365.
  • the displayed injection pattern may be automatically changed. That is, the initial speed of the contrast agent is automatically changed from 4.0 ml / sec to 2.0 ml / sec, for example, while maintaining the injection time and variable constant, and the final speed is 2.0 ml / sec to 1.0 ml. / Sec (see injection patterns 368a and 368a ').
  • the saline injection pattern 368b is automatically changed to the injection pattern 368b '.
  • FIG. 5B shows a case where the variable constant is changed from C to C ′.
  • the contrast agent injection pattern displayed in the injection graph is automatically changed in the manner exemplified above correspondingly. May be. Further, the physiological saline injection pattern may be automatically changed correspondingly.
  • FIG. 5C shows a case where the injection time is changed from t to t ′.
  • the injection pattern of the contrast agent displayed on the injection graph may be automatically changed in the manner illustrated above correspondingly.
  • the physiological saline injection pattern may be automatically changed correspondingly.
  • Figure 5D illustrates the case of changing the f 1 'of the initial velocity from the f 1.
  • the contrast agent injection pattern displayed on the injection graph is automatically changed in the above manner in response to the change.
  • the physiological saline injection pattern may be automatically changed correspondingly.
  • the operation for changing the shape of the injection pattern (line segment) displayed on the injection graph 361 is not particularly limited, and any input method may be used.
  • one or both ends of the injection pattern can be selected by a GUI (Graphical User Interface) function, and the end of the injection pattern is moved by moving the selected end in the vertical direction and / or the horizontal direction.
  • the position of the part may be changed, and at least one of the injection speed and the injection time may be automatically changed accordingly.
  • the injection pattern (line segment) may be moved in any direction (at least one of the vertical direction and the horizontal direction), and the condition may be automatically changed accordingly.
  • an injection pattern once set for example, a pattern in which a contrast agent injection pattern and a physiological saline injection pattern intersect
  • a pop-up screen 371 is displayed, and the pop-up screen 371 may be operated to change the condition.
  • the operator can freely input a desired injection pattern on the injection graph 361.
  • medical solution injection apparatus may be comprised so that the data may be preserve
  • the storage unit may be a storage area of a chemical injection device (for example, in the console), a storage medium inserted into a slot of the console, or a chemical injection by wired or wireless. It may be a storage area of an external network connected to the device.
  • the control unit of the chemical solution injector may be stored in a locked state so that the contents of the injection protocol are not changed or overwritten later. The lock may be released by inputting a password.
  • the chemical injection device performs chemical injection in accordance with an injection protocol created based on such an injection pattern.
  • an injection protocol created based on such an injection pattern.
  • various modes including a conventionally known mode can be taken. .
  • the chemical injection device 100 may have a configuration as shown in FIG.
  • the chemical injection device 100 includes a two-tube injection head 110 that is rotatably held on an upper portion of a movable stand 111.
  • a syringe is attached to each recess 120 a via syringe adapters S 121 and S 122 that hold the cylinder flange of the syringe and the vicinity thereof.
  • the console 150 is connected to the injection head 110 by a cable 102 as an example.
  • the display unit 151 is a touch panel display.
  • a plurality of physical buttons are arranged as the operation panel 159.
  • a home button physical button
  • a home screen on which a plurality of icons are arranged may be displayed on the screen.
  • a “PLOT” icon may be displayed as such an icon, and by selecting this icon, an initial setting screen 360 as shown in FIG. 4A may be displayed.
  • the hand unit 157 is wired to the console 150 and used on a work table.
  • This syringe includes a cylinder member 501 and a piston member 502.
  • a cylinder flange 501a of the cylinder member 501 has an I-cut contour shape, and two notches 505 (only one of them is provided on the outer peripheral portion of the flange 501a. Is formed).
  • the conduit portion 501b at the tip of the cylinder member 501 may be for luer lock connection having two inner and outer cylindrical portions arranged coaxially.
  • a ring-shaped protrusion 501c may be formed on the rear surface of the cylinder flange 501a.
  • the other of the two syringes may be a syringe as shown in FIGS. 8B (a) and (b), and this syringe is for, for example, 200 ml.
  • this syringe also includes a cylinder member 501 and a piston member 502, and the cylinder flange 501a of the cylinder member 501 may have an I-cut contour.
  • Two notches 505 are formed on the outer periphery of the cylinder flange 501a.
  • the conduit portion 501b at the tip of the cylinder member 501 may be for luer lock connection having two inner and outer cylindrical portions arranged coaxially.
  • a ring-shaped protrusion 501c and a plurality of ribs 501d extending outward from the protrusion 501c may be formed on the rear surface of the cylinder flange 501a.
  • the cylinder flange 501a is formed with both the notch 505 and the rib 501d, but only one of them is formed (for example, the notch S505 is formed). May not be).
  • the rib S501d may have a shape in which only two upper and lower ribs are left out of the plurality of ribs arranged in the vertical direction in the figure, and the other ribs are omitted.
  • Such a rib group may be a syringe formed on only one of the left and right sides of the flange portion.
  • two ribs at both upper ends or two ribs at both lower ends may be used.
  • connection connectors 509 and 509 are attached to the end of the tube connected to each syringe, and another form of connection connector 510 is attached to the end of the tube toward the patient.
  • Each connection connector 509 may have a cylindrical portion 509a having a screw portion 509b formed at the tip, and may be connected to the syringe conduit portion 501b by a luer lock method.
  • the connection connector 509 may have a function as a one-way valve, in particular, as disclosed in WO2012 / 060365.
  • the connection connector 510 may be connected to a catheter or an indwelling needle (not shown).
  • the ceiling-suspended holding arm 111 ′ may be a combination of horizontal rotation and vertical movement as shown in FIG. 9A. In this example, it has a base part attached to the ceiling and an articulated arm part extending from the base part, and the injection head 110 has a support bar (in one example, a bar shape extending in the vertical direction) on the terminal side of the arm part. Member).
  • a chemical liquid injection device in which a sub-display 149 is attached to a part of the holding arm 111 ′, specifically, in the vicinity of a part holding the injection head 110 may be used.
  • the sub-display 149 may be electrically connected to the injection head 110 or electrically connected to the console 150, and may be configured to be able to display various information related to the chemical solution injection.
  • the sub display 149 may be a touch panel display, or may be a simple display without a touch panel function.
  • such a sub-display 149 may be provided directly on a part of the injection head 110.
  • such a sub display 149 may be provided on the side or rear of the casing of the injection head 110.
  • the sub display 149 may be attached to a part of the movable stand 111.
  • a control unit (not shown) may be mounted on the movable stand 111 separately from the injection head 110.
  • the control unit of the chemical injection device may be configured as follows: (S1) The injection graph 361 as illustrated in FIGS. 4A to 4H is displayed on the sub-display 149. (S2) Accepting an injection pattern input from the operator in the injection graph 361; (S3) In the injection graph 361, an input from an operator for correcting the injection pattern created once is received. (S4) A new injection pattern is displayed reflecting the correction contents. Note that only one of s2 and s3 may be performed. That is, the injection pattern created on the console side may be modified only on the sub display side.
  • the mode selection icon 363 is displayed on the initial setting screen 360 as shown in FIG. 4A, and the operator operates the icon 363. Then, you can select the protocol setting mode that you use. Therefore, for example, even when the content of the injection protocol to be set changes according to the imaging purpose or the like, the protocol setting mode can be changed as appropriate, and the conditions can be set in the protocol setting mode suitable for the inspection. .
  • the doctor on site may not use the function if it cannot be changed easily, for example, if a complicated operation is required on the screen.
  • the mode can be changed by simply pressing the display unit (mode selection icon 363 here) displayed on the screen. Can be done intuitively on the screen.
  • a display unit for setting a protocol called “slip injection protocol” may be displayed on the screen.
  • This injection protocol can be suitably used for imaging a wide range, for example, a blood vessel extending from the heart.
  • contrast agent and saline are injected under the following conditions: (I) First phase, from time t 0 to time t 1 : The contrast agent injection rate decreases monotonically from velocity Vc 0 to velocity Vc 1 The diluent injection rate increases monotonically from rate Vp 0 to rate Vp 1 The speed Vc 1 and the speed Vp 1 are substantially the same.
  • the injection rate of the contrast agent is 0 ml / sec.
  • “Monotonically increasing / decreasing” includes not only a mode in which the injection rate increases / decreases linearly but also a mode in which the injection rate is curved or stepped but increases / decreases substantially linearly. Intended. “Substantially the same” is intended to include not only the case where two speeds are the same, but also the case where the difference between one speed and the other speed is within 10%, for example.
  • the time of the first phase basically depends on the imaging speed and the imaging time, but as an example, it may be the same as or slightly shorter than the imaging time (scan time).
  • the time of the second phase may be calculated from the amount of saline injected and the rate of injection. For example, when the injection volume is 30 ml and the speed is 5.0 ml / sec as an example, it is 6.0 sec.
  • the contrast agent velocity decreases linearly from velocity Vc 0 to velocity Vc 1 .
  • the speed Vc 0 may be 2 ml / sec or more, 3 ml / sec or more, or 4 ml / sec or more, for example.
  • the speed Vc 0 may be 4.8 ml / sec.
  • the upper limit speed may be, for example, 6.0 ml / sec.
  • the variable constant (Vc 1 / Vc 0 ) representing the speed change from the speed Vc 0 to the speed Vc 1 is an example, and may be in the range of 0.6 to 0.4.
  • Vc 1 is 2.4 ml / sec.
  • the speed Vp 0 may be 0 ml / sec as an example.
  • the physiological saline velocity Vp from velocity Vp 0 to velocity Vp 1 may gradually increase in response to a decrease in the contrast agent injection rate.
  • the speed Vp is during the time t0 to the time t1
  • the speed Vc + speed Vp may be set to be constant (rate V ttl).
  • the saline velocity Vp 2 after time t 1 may be the same as the velocity Vc 0 at time t 0 of the contrast agent in one example. Alternatively, it may be within the range of +/ ⁇ 20% or +/ ⁇ 10% with respect to this value.
  • the width of the phase to be displayed may be changed corresponding to the injection time (short time) of each phase, or how the injection time of each phase is Even if it is a thing, it is good also as a structure by which the width of a phase is displayed uniformly.
  • the display unit on the screen for changing the protocol setting mode is not limited to the mode of switching with one icon 363. For example, an icon is prepared for each mode candidate, and one of the icons is selected. It is good also as an aspect. (B6) In the above, the example in which the injection pattern of each phase is created through the input to the pop-up screen 371 has been described.
  • an injection pattern (such as an injection pattern 368a as an example) can be created sequentially in sequence. Also good.
  • One or more of the display units 371a to 371c and 372a to 372c in the pop-up screen 371 described above may be displayed in another pop-up screen or on a screen that is not a pop-up screen It may be displayed at a predetermined position. In the pop-up screen 371, it is not always necessary to display all of the display portions 371a to 371c and 372a to 372c, and only one or only a part of them may be displayed.
  • Conversion from a straight line to a curved line is performed by analyzing the input injection pattern shape by the calculation function of the control unit, so that the change rate of the injection rate is equal to or less than the allowable change rate. It may be connected with a curve. In this case, the degree of curvature of the connecting curve may be at least within a range that can be followed by the piston drive mechanism, and is preferably adjusted in consideration of the load and power consumption on the piston drive mechanism. Conversion from a straight line to a curve can be preferably performed by spline curve interpolation.
  • (C1) You may acquire operation conditions (for example, chemical
  • curd medium which is an information storage medium to a chemical
  • Various products can be used as the information storage medium.
  • the injection protocol information or the like stored in an external database server can be downloaded online.
  • the pressure of the injected contrast medium and physiological saline can be calculated from the pressure that presses the piston member of the chemical syringe.
  • a pressure sensitive element is installed inside the chemical syringe or the extension tube to contrast It is also possible to directly detect the injection pressure of an agent or the like.
  • the previous setting of the type of contrast agent is stored, and a liquid injector that can make the type input operation unnecessary can be used as long as the contrast agent is not changed.
  • the previous setting of the imaging part can be stored.
  • the environment where the drug solution injector is used may only capture the brain, and in cardiac surgery, only the heart may be imaged. It is also useful to eliminate input operations until they need to be saved and changed.
  • the basic pattern information of a variable pattern for decreasing the injection rate linearly and maintaining the injection rate constant thereafter, or increasing the injection rate linearly thereafter is stored in advance. The basic pattern may be displayed by selecting a predetermined icon.
  • (C7) In the case of having a region selection function, a schematic image of a plurality of body sections expressed as a horizontal or vertical human body shape may be displayed on the screen.
  • (C8) In the case of having a site selection function, the configuration may be such that the selection of the imaging site and the input operation of the body weight and the type of contrast medium are necessary.
  • the injection rate / total amount / time can be set as data without inputting the type of contrast medium. This may be the case when there is only one type of contrast agent, when there is no substantial difference between the various contrast agents, when the contrast agent to be used is specified and registered in advance, This is effective when imaging only a subject having a proper weight, and can further reduce the work load.
  • the various components (devices, apparatuses, etc.) referred to in this specification do not have to be independent of each other, but a plurality of components are formed as a single member. It is formed of a plurality of members, a certain component is a part of another component, a part of a certain component overlaps a part of another component, etc. May be.
  • the components need only be formed so as to realize their functions, and may be realized by hardware or realized by software.
  • a certain component can be realized as dedicated hardware that exhibits a predetermined function, a processing device in which the predetermined function is realized by a computer program, a combination thereof, or the like.
  • each unit may be logically realized as various functions of the chemical injection device (control unit) by operating the processor in response to the computer program, but various means (each part, each unit) May be formed as unique hardware, or may be a combination of a part realized by software and a part realized by hardware.
  • the chemical liquid injector and the system including the same are not limited to the above contents, and various modifications can be made as follows, for example:
  • the IC tag of the syringe may include information on whether or not to heat the syringe.
  • D1-2 Print at least some items of information read from the IC tag of the syringe using a printer or the like. Alternatively, data including at least some items of information read from the IC tag of the syringe and chemical injection history data is printed using a printer or the like.
  • D2 Information on whether the used syringe has been discarded is managed by a predetermined management server in the system.
  • the controller of the chemical liquid injector may calculate the estimated value of the chemical liquid pressure during the injection using both the load cell and the motor current.
  • a predetermined help button is displayed on the screen, and when this button is pressed, help text on operation and display on the screen, help image as audio, help guidance as these, or these
  • the controller of the chemical liquid injector is configured so that the combination is displayed.
  • the units of various numerical data displayed on the initial setting screen can be changed as appropriate. For example, the pressure may be “psi” instead of “Kg / cm 2 ”.
  • the contrast agent name (product name, etc.) is displayed on a part of the console screen (eg, icon 373, see FIG. 4A).
  • the control unit of the chemical liquid injector has such a function.
  • a status such as whether the console is connected to another device or connected and linked is displayed on a part of the console screen.
  • the control unit of the chemical liquid injector has such a function.
  • the chemical solution injection device may be configured as follows: -With the syringe set in the injection head and the tube connected to a chemical bottle etc., press the predetermined button to advance the gasket and release the air.
  • the predetermined button may be an autofill button as a specific example.
  • the chemical solution is then aspirated. As this step, first, the chemical solution is aspirated halfway (ie, only a part is drawn, not the whole target amount). -Next, the air bleeding operation is performed again. -After that, continue sucking the chemical until the target amount is reached. This suction may be the same as the initial suction speed or may be faster. Thereafter, the preparation is completed by advancing the piston member of the syringe by a small amount.
  • a chemical solution injector in which an inclination sensor is built in the injection head may be used.
  • the control unit performs part or all of the following processing: -It is determined whether or not the injection head is in a substantially vertical state (in other words, the front of the head on which the syringe is mounted faces vertically upward). -Allow the autofill operation to be performed if the injection head is in a substantially vertical state. Otherwise, autofill operation is prohibited. Determine if the injection head is in a horizontal position or a position where the front is relatively low. -In these postures, the liquid injection operation is allowed. Otherwise, the injection operation is prohibited.
  • D8-1 As a device (input device) for an operator to perform a predetermined input, a mouse, a trackball, a desktop controller, a keyboard, a pen tablet, or the like can be used. In addition, a voice input or an input from a touch panel can be used as an input device in combination with or alone.
  • D8-2) As another example, a physical button or the like provided on an injection head, a console, a head display, or the like may be used. Moreover, voice input, a touch sensor, or the like may be used.
  • E1 One mode of extension tube
  • the piston drive mechanism on the A syringe (contrast medium) side may be operated, and then the piston drive mechanism on the B syringe (physiological saline) side may be operated.
  • the piston drive mechanism on the A syringe (contrast medium) side and the piston drive mechanism on the B syringe (physiological saline) side may be operated simultaneously.
  • a liquid pool cap may be provided on the connector 510 at the end of the tube. The liquid storage cap receives the chemical solution from the tube and prevents the chemical solution from dripping on the floor or other medical devices.
  • extension tube (E2: Other embodiment of extension tube)
  • E2 Other embodiment of extension tube
  • FIGS. 10A to 10C an example of an extension tube provided with a mixing device so that two chemical solutions are mixed well will be described.
  • the extension tube includes a first tube 231a that connects the syringe filled with the first drug solution (for example, contrast medium) and the mixing device 241, and a syringe filled with the second drug solution (for example, physiological saline). It has the 2nd tube 231b which connects the mixing device 241, and the 3rd tube 231c which is connected to the liquid outlet (detailed below) of the mixing device 241 and extends to the patient side.
  • the first drug solution for example, contrast medium
  • the mixing device 241 for example, physiological saline
  • first and second tubes 231a and 231b may be connected to the conduit portion of the syringe via the connection connectors 239a and 239b, respectively.
  • the third tube 231c may be connected to a catheter or the like via the connection connector 239c.
  • priming for the purpose of releasing air is performed before the injection of the chemical solution by the chemical solution injection device.
  • the extension tube is filled with either a physiological saline solution or a contrast medium.
  • the contrast agent is pushed out from the contrast agent syringe, and the first tube up to the mixing device is filled with the contrast agent.
  • the physiological saline is pushed out from the physiological saline syringe, and the second tube, the mixing device, the third tube, and the catheter are filled with the physiological saline.
  • the entire street is filled with the chemical solution and the air is removed.
  • the chemical injection device may have a function for automatically performing the priming operation as described above, and the trigger for starting the priming operation may be an input operation by an operator, for example.
  • the mixing device 241 includes a first chamber that is a swirl flow generation chamber 242a that generates a swirl flow, and a second chamber that is a constriction chamber 242b that concentrates the swirl flow in the axial direction.
  • a main body 242 is provided.
  • the swirl flow generation chamber 242a has a cylindrical inner space
  • the constriction chamber 242b has a conical inner space coaxial with the swirl flow generation chamber 242a.
  • the cross-sectional shape in the short direction of the swirl flow generating chamber may be various shapes formed from a circle, an ellipse, or other curves.
  • the swirl flow generation chamber can be configured to have a narrowed shape that narrows as it approaches the narrowed chamber.
  • a conduit portion 243a to which the first tube 231a is connected is provided on the upstream side of the main body portion 242 of the mixing device 241, and a conduit portion 243c to which the third tube 231c is connected is provided on the downstream side.
  • the conduit portion 243b to which the second tube 231b is connected is disposed at a position upstream from the center of the swirl flow generation chamber 242a (details below).
  • the contrast agent flows from the conduit portion 243a and the physiological saline flows from the conduit portion 243b, and both drug solutions are mixed in the mixing device. Thereafter, the mixed drug solution of the contrast medium and physiological saline flows out from the conduit portion 243c as a liquid outlet.
  • the conduit portion 243a into which a high specific gravity chemical solution flows is provided in the central portion of the upstream side wall surface of the swirl flow generation chamber 242a on the upstream side in the flow direction.
  • the conduit portion 243c serving as the liquid outlet is provided so that the center line of the conduit portion 243c and the center line of the conduit portion 243a coincide, that is, both are coaxial.
  • the conduit portion 243b into which the chemical liquid having a small specific gravity flows is disposed on the side surface of the swirl flow generation chamber 242a and extends in the tangential direction of the circumference of the swirl flow generation chamber 242a having a circular cross section.
  • the conduit portion 243b is provided at a position shifted to the peripheral side from the central axis of the cylindrical space included in the swirl flow generation chamber 242a, and thereby, the chemical liquid having a small specific gravity flowing from the conduit portion 243b.
  • the swirl flow is generated. More specifically, as shown in FIG.
  • the flow path 241fb is configured to extend in the circumferential tangential direction of the curved inner surface of the swirl flow generation chamber 242a, and thereby flows from this flow path.
  • the chemical becomes a swirl flow.
  • the constriction chamber 242b has an inclined inner surface that swells toward the downstream side in the flow direction, so that the generated swirling flow is concentrated in the direction of the central axis of the vortex. Become.
  • the conduit portion 243a into which the contrast agent flows is in communication with the swirling flow generation chamber 242a through the flow path 241fa.
  • the chemical liquid having a large specific gravity can be introduced into the swirling flow generating chamber in a direction parallel to the central axis of the swirling flow of the chemical liquid having a small specific gravity. That is, the chemical liquid having a large specific gravity is introduced in a direction parallel to the central axis of the cylindrical space included in the swirl flow generation chamber.
  • the conduit part into which the physiological saline flows is in communication with the swirl flow generation chamber via the flow path 241fb.
  • the inner diameter of the flow path 241fb may be smaller than the inner diameter of the flow path 241fa into which the contrast agent (one example) flows.
  • the flow rate of the chemical solution having a small specific gravity flowing from the flow path 241fb having a relatively small cross-sectional area becomes faster than the flow rate of the chemical solution having a large specific gravity. Therefore, it is possible to avoid a decrease in the mixing efficiency between the chemical solutions due to the attenuation of the inertial force of the swirling flow and the accompanying lack of swirling strength, which can occur when the flow rate of the chemical solution having a small specific gravity is low.
  • the mixing device 241 configured as described above, for example, when a contrast agent and physiological saline are flowed into the device, the contrast agent that has flowed into the swirl flow generation chamber from the flow channel fa flows toward the downstream side in the axial direction. Become.
  • the physiological saline flowing into the swirl flow generation chamber from the flow path 241fb becomes a swirl flow swirling along the curved inner surface of the same chamber, and the swirl flow of the physiological saline is guided to the stenosis chamber and swirls. Concentrate in the direction of the central axis of the flow.
  • a vortex is known as a Rankine vortex, and the inertial force of the swirling flow can be concentrated in the vicinity of the rotation axis of the vortex.
  • both chemicals will be mixed well. That is, in this example, it is possible to obtain a diluted contrast agent in which the contrast agent and physiological saline are well mixed, and as a result, there is no unevenness in the concentration of the contrast agent. Therefore, an excellent contrast effect can be expected.
  • a status bar 721-1 is displayed at the top of the screen, another status bar 721-2 is displayed below it, and a graph of the injection pattern set below it is displayed.
  • an icon 722a for shifting to the timing test screen and an icon 722b for shifting to the route confirmation screen may be displayed.
  • the status bar 721-2 one or more of patient weight information, information on the contrast medium iodine amount required per unit weight, and information on injection time are displayed.
  • a human body-shaped part display icon 723 is displayed so that the part of the patient selected by the part selection can be visually recognized.
  • the part display icon 723 is displayed in the lower status bar 721-2 is shown, but this icon 723 can be displayed at an arbitrary position on the screen.
  • the region display icon 723 When the region display icon 723 is pressed, the screen returns to the screen for selecting the imaging region. Therefore, when the operator wants to change the imaging region on the confirmation screen as shown in FIG. A part can be reselected by pressing the icon 723. Further, the part selection icon 723 can be recognized by highlighting the currently selected part, for example, so that the operator can confirm the selected part when viewing the screen of FIG. Easy to do.
  • the injection pattern (line segment) 368 displayed on the injection graph may be changeable by a method as shown in FIGS. 13A and 13B.
  • FIG. 13A (a) shows an injection pattern 368 with a variable constant of 1.0 and an injection speed of 3.0 ml / sec in the first phase as an example.
  • the operator touches the end 368q of the injection pattern.
  • the touch panel is not a touch panel, the end 368q may be selected by a cursor on the screen.
  • the position of the end 368q can be changed (for example, a marker display surrounding the end 368q may appear).
  • FIG. 13A (c) when the operator touches, for example, the vicinity of a lattice point of 2.0 ml / sec in this state, the position of the end portion 368q is changed, and the terminal velocity of the injection pattern (line segment) 368 is changed. Will be changed. Note that the same change method can be used to change the starting speed of the implantation pattern.
  • the operator can intuitively correct the injection speed on the injection graph.
  • a pop-up window 377 as shown in FIG. 13B (b) may be displayed.
  • the pop-up window 377 has at least one of a numerical value input unit 377a for directly inputting a numerical value and an increase button and a decrease button 377b.
  • the injection rate is “3.0”, but when it is desired to change it to “4.0”, the numerical value input unit 377a is selected as shown in the drawing to 4.0. Enter.
  • This input can be performed via, for example, a numeric keypad on the screen.
  • the injection speed is changed from “3.0” to “4.0”, and although not shown, the display position of the injection pattern (line segment) 368 is changed.
  • the speed may be changed by changing to a predetermined speed with the increase button and the decrease button 377b and touching a return key (decision key).
  • FIG. 14 is a block diagram of a computer system according to one embodiment of this invention.
  • the computer system 1500 constitutes a console of the chemical liquid injector by way of example, but is not limited thereto.
  • the computer system 1500 may include some or all of the following components: a main controller 1510 that performs overall control, a display control unit (screen display circuit) 1530, and the like. , A storage device 1520, an output interface 1512a for outputting data to a display monitor (not shown), an input means 1513 enabling various inputs from an operator, and a slot 1515 for reading data from a computer readable medium And an input interface 1512b for performing communication with an external device.
  • a main controller 1510 that performs overall control
  • a display control unit (screen display circuit) 1530 and the like.
  • a storage device 1520 for a display monitor (not shown)
  • an output interface 1512a for outputting data to a display monitor (not shown)
  • an input means 1513 enabling various inputs from an operator
  • a slot 1515 for reading data from a computer readable medium
  • an input interface 1512b for performing communication with an external device.
  • the main controller 1510 may be a processor unit having a CPU, a memory, a computer program, and the like, and is illustrated as one in the drawing, but may be configured by a plurality of controllers. .
  • the display control unit 1530 may be provided as a software function, may be provided as an electric circuit, or may be a combination thereof.
  • the main controller 1510 gives a predetermined operation signal to the display control unit 1530 as a trigger,
  • the control unit 1530 performs a certain operation to display a predetermined screen, icon, warning message, graphical user interface, etc. on the display monitor.
  • the display monitor may be any display monitor as long as it can display information.
  • a liquid crystal display (LCD) or an organic EL display may be used.
  • the number of monitors is not particularly limited, and may be one or more.
  • One or more monitors may be located at any location, separate from the computer system (at a distance). In this case, the connection between the computer system and these monitors may be, for example, a wired connection or a wireless connection.
  • the input means 1513 may be one or two or more selected from a keyboard, mouse, trackball, voice input, graphical user interface, and the like. A command from a doctor or the like can be input through the input unit 1513.
  • the slot 1515 can be called a medium reading unit. That is, it may be a unit that can read data from a computer-readable medium in a contact type or a non-contact type.
  • the console C150 can also be configured as a common console that controls the operations of both the imaging device C300 and the injection head C110.
  • the storage device 1520 may store various data such as graphical user interface data and data tables and mathematical formulas used when setting the injection protocol.
  • an injection protocol setting screen (graphical user interface) can be provided.
  • an injection protocol setting screen graphical user interface
  • the computer system can be configured to be incorporated in the imaging apparatus or to function as a console of the imaging apparatus.
  • Imaging device console In FIG. 15, an imaging device C300 including a gantry C303 and a bed C304, an imaging device console C150 that controls the operation of the imaging device C300, and an injection head C110 of a chemical injection device are illustrated.
  • the computer system may be an imaging device console C150.
  • the injection protocol set at the imaging device console C150 may be transferred from the imaging device console C150 to the injection head C110, and the injection head C110 may operate accordingly.
  • a piston drive mechanism (130) for operating the piston member of the syringe Control units (144, 153) for controlling the operation of the piston drive mechanism;
  • Input devices (151 and 157) for receiving input from the operator;
  • a chemical injection device (100) comprising: The control units (144, 153) a: causing the display unit to display a setting initial screen (360) including at least a mode selection display unit (363) for selecting one of a plurality of injection protocol setting modes;
  • a flow rate mode in which an injection pattern is created as a whole by inputting an injection pattern in one phase or a plurality of phases on the injection graph;
  • the contrast amount of the drug solution is determined in advance based on at least the weight of the patient, and then an injection pattern is created as a whole by inputting the injection pattern in one phase or a plurality of phases on the injection graph.
  • a first weight input mode (Iii) The initial velocity of the drug solution is determined in advance based on at least the patient's weight, and then an injection pattern is created as a whole by inputting the injection pattern in one phase or a plurality of phases on the injection graph.
  • a second weight input mode The said chemical
  • Two piston drive mechanisms (130) that operate independently, and configured to inject a contrast medium and physiological saline as the drug solution;
  • the control unit (144, 153) displays a pop-up screen (371) for an operator to create an injection pattern in one phase of the injection graph,
  • the pop-up screen (371) A display unit (371a) for inputting parameters relating to the inclination of the implantation pattern in the phase; -A display (371b) for inputting the injection time of the phase, and -A display for entering the injection rate of the phase,
  • medical solution injection device containing at least 1 among these.
  • pouring apparatus of the said description whose said parameter regarding the inclination of an injection
  • Two piston drive mechanisms (130) that operate independently, and configured to inject a contrast medium and physiological saline as the drug solution;
  • the control unit (144, 153) displays a pop-up screen (371) for an operator to create an injection pattern in one phase of the injection graph,
  • the pop-up screen (371) A display unit (372a) for creating the physiological saline injection pattern, and when the display unit (372a) is selected when the injection rate of the contrast medium is constant, Including a dilution injection display (372b) in which a constant rate saline injection pattern is displayed within the phase;
  • the above-mentioned chemical injection device is described in which a constant rate saline injection pattern is displayed within the phase.
  • the injection pattern of the contrast medium is an inclined pattern and the dilution injection display section (372b) is selected, the sum of the contrast medium injection speed and the physiological saline injection speed is substantially constant in the phase. As shown, a saline injection pattern (368b) that is symmetrical with the contrast agent injection pattern with respect to a predetermined reference line is displayed.
  • Two piston drive mechanisms (130) that operate independently, and configured to inject a contrast medium and physiological saline as the drug solution;
  • the control unit (144, 153) displays a pop-up screen (371) for an operator to create an injection pattern in one phase of the injection graph,
  • the pop-up screen (371) -Including a flash infusion display (372a) for adding an infusion pattern for flush infusion with saline within the next phase of the phase;
  • Two piston drive mechanisms (130) that operate independently, and configured to inject a contrast medium and physiological saline as the drug solution;
  • the control unit (144, 153) displays a pop-up screen (371) for an operator to create an injection pattern in one phase of the injection graph,
  • the pop-up screen (371) A display unit (372c) for creating an injection pattern of a contrast agent, and when the display unit is selected, injection is performed such that the speed changes from a predetermined initial speed to a zero or substantially zero final speed.
  • the control unit (144, 153) further includes Accepts input of information on at least one of the body category and imaging category of the patient to be examined, Calculate the infusion volume to be infused into the patient based at least on the input body segment or imaging segment information; The above-mentioned chemical injection device.
  • the control unit (144, 153) further includes Accept at least patient weight input from patient physical information, Calculating an infusion volume to be infused into the patient based at least on the inputted weight information; The above-mentioned chemical injection device.
  • the control unit (144, 153) further includes Accept the input of the contrast medium iodine amount, Calculating an infusion volume to be infused into the patient based at least on the input iodine amount information; The above-mentioned chemical injection device.
  • the control unit (144, 153) further includes Accept at least the patient's body weight information and the contrast medium iodine amount information of the patient's physical information, Calculate the initial velocity of the contrast agent based at least on those information entered, The above-mentioned chemical injection device.
  • console has a touch panel display (151) as the display unit that also has a function as the input device.
  • the syringe is It has a hollow cylinder member and a piston member slidably inserted in it,
  • the present invention is not limited to a chemical solution injection device as long as it can set a protocol as exemplified with reference to the drawings, and can be applied to a computer device having no injection function. is there. This means that the above A1.
  • the present invention can be combined with other technical matters disclosed in the present specification as well as the technical matters defined in the above.
  • a system having a graphical user interface for configuring an infusion protocol is a: an initial setting screen including at least a mode selection display (for example, an icon) for selecting one of a plurality of injection protocol setting modes; b: After a predetermined injection protocol setting mode is selected, one of the vertical axis and the horizontal axis is the injection speed, the other is the injection time, and the input of the injection pattern from the operator to the injection graph including at least one phase.
  • a flow rate mode in which an injection pattern is created as a whole by inputting an injection pattern in one phase or a plurality of phases on the injection graph;
  • the contrast amount of the drug solution is determined in advance based on at least the weight of the patient, and then an injection pattern is created as a whole by inputting the injection pattern in one phase or a plurality of phases on the injection graph.
  • a first weight input mode (Iii) The initial velocity of the drug solution is determined in advance based on at least the patient's weight, and then an injection pattern is created as a whole by inputting the injection pattern in one phase or a plurality of phases on the injection graph.
  • a second weight input mode At least two of which are selectable.
  • An injection protocol setting method a: causing the display unit to display a setting initial screen including at least a mode selection display unit for selecting one of a plurality of injection protocol setting modes; b: After a predetermined injection protocol setting mode is selected, one of the vertical axis and the horizontal axis is the injection speed, the other is the injection time, and the input of the injection pattern from the operator to the injection graph including at least one phase. Accepting steps, c: creating an infusion protocol for the medicinal solution based on the infusion pattern input on the infusion graph; Having a method.
  • a flow rate mode in which an injection pattern is created as a whole by inputting an injection pattern in one phase or a plurality of phases on the injection graph;
  • the contrast amount of the drug solution is determined in advance based on at least the weight of the patient, and then an injection pattern is created as a whole by inputting the injection pattern in one phase or a plurality of phases on the injection graph.
  • a first weight input mode (Iii) The initial velocity of the drug solution is determined in advance based on at least the patient's weight, and then an injection pattern is created as a whole by inputting the injection pattern in one phase or a plurality of phases on the injection graph.
  • a second weight input mode The method as described above, wherein at least two of the options are selectable.
  • a step of displaying a pop-up screen for an operator to create an injection pattern in one phase of the injection graph The pop-up screen -A display for inputting parameters relating to the inclination of the implantation pattern in the phase; -A display for entering the injection time of the phase, and -A display for entering the injection rate of the phase,
  • a method comprising at least one of:
  • D1.1 A computer program for causing one or more computers to perform the method according to one aspect of the present invention.
  • a piston drive mechanism for operating the piston member of the syringe; a display unit for displaying predetermined information; a display controller for controlling the content displayed on the display unit; and an input device for receiving input from an operator.
  • a system operating method comprising: a: a step of causing the display controller to display an initial setting screen (360) including at least a mode selection display unit (363) for selecting one of a plurality of injection protocol setting modes on the display unit; , b1: After the predetermined injection protocol setting mode is selected, the display controller displays an injection graph (361) including at least one phase in which one of the vertical axis and the horizontal axis is the injection speed and the other is the injection time.
  • b2 a step in which the input device receives an input of an injection pattern from an operator to the injection graph; A method of operating the system.
  • the method further comprises a step in which the computer (control unit) creates an injection protocol based on the input injection pattern.

Landscapes

  • Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

A control unit is configured so as to: (a) make a display unit (151) display an initial setup screen (360) that contains at least a mode-selection display section (363) for selecting one of a plurality of injection-protocol setting modes; (b) accept injection-pattern input from an operator, after a given injection-protocol setting mode is selected, via an injection graph (361) that contains at least one phase, either the vertical axis or the horizontal axis of said injection graph being injection rate and the other axis being injection time; (c) create a chemical injection protocol on the basis of the injection pattern inputted via the aforementioned injection graph (361); and (d) inject a chemical by operating a piston-driving mechanism (130) in accordance with the created injection protocol.

Description

薬液注入装置Chemical injection device
 本発明は、患者に薬液として少なくとも造影剤を注入する薬液注入装置等に関し、特には、1つの薬液注入装置で様々な注入プロトコルの設定方式を利用することができ、しかも注入プロトコルを簡単にかつ多様に作成することができる薬液注入装置等に関する。 The present invention relates to a drug solution injection device that injects at least a contrast medium as a drug solution into a patient, and in particular, a single drug solution injection device can use various injection protocol setting methods, and the injection protocol can be simplified and The present invention relates to a chemical injection device that can be created in various ways.
 現在、医療用の画像診断装置として、CT(Computed Tomography)スキャナ、MRI(Magnetic Resonance Imaging)装置、PET(Positron Emission Tomography)装置、超音波診断装置、血管造影(アンギオグラフィ)撮像装置等が知られている。このような撮像装置を使用する際、患者に造影剤や生理食塩水など(以下、これらを単に「薬液」とも言う)を注入することがある。 Currently, CT (Computed Tomography) scanners, MRI (Magnetic Resonance Imaging) devices, PET (Positron Emission Tomography) devices, ultrasound diagnostic devices, angiographic imaging devices, etc. are known as medical diagnostic imaging devices. ing. When using such an imaging apparatus, a patient may be injected with a contrast medium, physiological saline, or the like (hereinafter also simply referred to as “medical solution”).
 特許文献1には、薬液注入装置を用いて薬液を自動的に注入する技術に関し、画面上の注入グラフ上に表示された注入パターンを操作者が必要に応じて修正して最終的な注入プロトコルを完成させること等が記載されている。 Patent Document 1 relates to a technique for automatically injecting a chemical solution using a chemical solution injection device, and an operator corrects an injection pattern displayed on an injection graph on a screen as needed, and a final injection protocol. Is completed.
WO2008/072636WO2008 / 072636
 ところで、注入プロトコルの設定方式としては、例えば検査部位や造影目的等の違い等によって様々な種類がある。また、医師(操作者)の好みによっていずれの注入プロトコル設定方式を使用するかが決まる場合もある。 By the way, there are various types of injection protocol setting methods depending on, for example, the examination site and the contrast purpose. In addition, which injection protocol setting method is used may be determined depending on the preference of the doctor (operator).
 本発明の目的は、1つの薬液注入装置で様々な注入プロトコルの設定方式を利用することができ、しかも注入プロトコルを簡単にかつ多様に作成することができる薬液注入装置等を提供することにある。 An object of the present invention is to provide a chemical solution injection device and the like that can use various injection protocol setting methods with a single chemical solution injection device, and that can easily create various injection protocols. .
 上記課題を解決するための本発明の一形態の薬液注入装置は下記の通りである:
 シリンジのピストン部材を動作させるピストン駆動機構と、
 そのピストン駆動機構の動作を制御する制御部と、
 所定の情報を表示するための表示ユニットと、
 操作者からの入力を受け付ける入力装置と、
 を備える薬液注入装置であって、
 前記制御部は、
a:前記表示ユニットに、複数の注入プロトコル設定モードの中から1つを選択するためのモード選択用表示部を少なくとも含む設定用初期画面を表示させ、
b:所定の注入プロトコル設定モードが選択された後、縦軸および横軸の一方が注入速度で他方が注入時間であり少なくとも1つのフェーズを含む注入グラフへの操作者からの注入パターンの入力を受け付け、
c:前記注入グラフ上に入力された注入パターンに基づいて薬液の注入プロトコルを作成し、
d:作成された前記注入プロトコルに従って前記ピストン駆動機構を動作させ、薬液を注入する。
In order to solve the above-mentioned problems, a chemical solution injection device according to one embodiment of the present invention is as follows:
A piston drive mechanism for operating the piston member of the syringe;
A control unit for controlling the operation of the piston drive mechanism;
A display unit for displaying predetermined information;
An input device that receives input from the operator;
A chemical injection device comprising:
The controller is
a: causing the display unit to display a setting initial screen including at least a mode selection display unit for selecting one of a plurality of injection protocol setting modes;
b: After a predetermined injection protocol setting mode is selected, one of the vertical axis and the horizontal axis is the injection speed, the other is the injection time, and the input of the injection pattern from the operator to the injection graph including at least one phase. Accept,
c: Create a chemical injection protocol based on the injection pattern entered on the injection graph,
d: Operate the piston drive mechanism in accordance with the created injection protocol to inject a chemical solution.
(用語の説明)
「薬液」とは、例えば、造影剤、生理食塩水、またはそれらを混合したものをいう。
「造影剤」の具体例としては、ヨード濃度240mg/mlの造影剤(例えば、37℃において粘度3.3Pa・s、比重1.268~1.296)、ヨード濃度300mg/mlの造影剤(例えば、37℃において粘度6.1mPa・s、比重1.335~1.371)、ヨード濃度350mg/mlの造影剤(例えば、37℃において粘度10.6mPa・s、比重1.392~1.433)等がある。
「生理食塩水」の生理食塩水の具体例としては、生理食塩水20mL中に塩化ナトリウム180mgを含有した生理食塩水(例えば、20℃において粘度0.9595mPa・s、比重1.004~1.006)等がある。
(Explanation of terms)
“Chemical solution” refers to, for example, a contrast agent, physiological saline, or a mixture thereof.
Specific examples of the “contrast agent” include a contrast agent having an iodine concentration of 240 mg / ml (for example, a viscosity of 3.3 Pa · s and a specific gravity of 1.268 to 1.296 at 37 ° C.), a contrast agent having an iodine concentration of 300 mg / ml ( For example, a contrast agent having a viscosity of 6.1 mPa · s and a specific gravity of 1.335 to 1.371 at 37 ° C. and an iodine concentration of 350 mg / ml (for example, a viscosity of 10.6 mPa · s at 37 ° C. and a specific gravity of 1.392 to 1.37). 433).
As a specific example of the physiological saline of “physiological saline”, a physiological saline containing 180 mg of sodium chloride in 20 mL of physiological saline (for example, a viscosity of 0.9595 mPa · s at 20 ° C., a specific gravity of 1.004 to 1.04). 006) and the like.
「注入プロトコル」とは、どのような薬液を、どれくらいの量、どれくらいの速度で注入するかを示すものである。予め用意された複数の注入プロトコルがシステムに記憶されている場合、操作者がそれらの中から所望のものを1つ選び必要に応じて修正を行い、条件設定を行うことで検査効率の向上を図ることができる。注入プロトコル内の情報としては、薬液の種類、注入速度、注入時間、注入圧力、注入タイミング(一時停止、ホールド等を含む)から選ばれる1つまたは複数であってもよい。
「注入パターン」とは、基本的には薬液の注入条件を示すものであり、注入プロトコル設定画面との関連で用いられる場合には、注入グラフに表示される直線(線分)もしくは曲線等を示すこともある。
「設定方式」-本明細書においては、「設定方式」は「設定モード」と同義であることがある。
「患者」-本明細書においては、「患者」は「被検者」と同義であることがある。
「操作者」-本明細書においては、「操作者」は「ユーザ」と同義であることがある。
The “infusion protocol” indicates what kind of chemical solution is to be infused, how much, and at what rate. If multiple injection protocols prepared in advance are stored in the system, the operator can select one of them and make corrections as necessary, and improve the inspection efficiency by setting conditions. Can be planned. The information in the injection protocol may be one or a plurality selected from the type of chemical, the injection speed, the injection time, the injection pressure, and the injection timing (including pause, hold, etc.).
The “injection pattern” basically indicates the injection conditions of the chemical solution, and when used in connection with the injection protocol setting screen, a straight line (line segment) or a curve displayed on the injection graph is displayed. May also be shown.
“Setting Method” —In this specification, “setting method” may be synonymous with “setting mode”.
“Patient” —As used herein, “patient” may be synonymous with “subject”.
“Operator” —In this document, “operator” may be synonymous with “user”.
「身体区分」とは、例えば頭部、胸部、腹部などの身体の区分を表す上位項目のことをいう。
「撮像部位」とは、身体区分に含まれる下位項目、例えば心臓、肝臓、血管等といった撮像対象のことをいう。
「データ」-本明細書においては、「データ」は「情報」と同義であることがある。
“Body classification” refers to a high-order item representing a classification of the body such as the head, chest, and abdomen.
The “imaging part” refers to an imaging target such as a lower item included in the body classification, for example, heart, liver, blood vessel and the like.
“Data” —In this specification, “data” may be synonymous with “information”.
「接続」-本明細書において、所定の機器と他の機器とが接続されていると言った場合には、有線接続または無線接続のいずれの態様であってもよい。また、他の機器を制御することができるように一方向または双方向に接続されている形態は、「操作可能に接続(operably connected/linked)」と表すこともできる。
「電気的に接続」とは、一方向または双方向に電気的信号の送信が行えるように構成要素どうしが接続されていることをいい、有線接続または無線接続のいずれの形態であってもよい。また、構成要素どうしが互いに直接接続されているものに加え、他の要素を介して間接的に接続されている場合も含む。
“Connection” —In this specification, when a given device is said to be connected to another device, it may be either wired or wireless. In addition, a configuration in which one-way or two-way connection is made so that other devices can be controlled can also be expressed as “operably connected / linked”.
“Electrically connected” means that components are connected so that electrical signals can be transmitted in one direction or in both directions, and may be in either a wired connection or a wireless connection. . In addition to the components directly connected to each other, the case where the components are indirectly connected via other elements is also included.
「端末」とは、ネットワークに接続されまたはスタンドアロンで使用される、データ処理を行うコンピュータシステムのことをいい、デスクトップ型コンピュータ、ラップトップ型コンピュータ、またはタブレット型コンピュータ等を含む。 The “terminal” refers to a computer system that performs data processing, connected to a network or used stand-alone, and includes a desktop computer, a laptop computer, a tablet computer, or the like.
「制御部」とは、CPUおよびメモリ等を有し演算処理を行うものであり、「コントローラ」、「プロセッサ」、「コントローラユニット(制御ユニット)」、「コントローラ回路(制御回路)」、「コントローラモジュール(制御モジュール)」、「プロセッサ部」、「プロセッサユニット」、「プロセッサモジュール」等と呼ぶこともできる。「制御部」は、マイクロコンピュータ、マイクロコントローラ、プログラマブル論理コントローラ、特定応用向け集積回路、および他のプログラム可能な回路などで構成することができる。本明細書において、「制御部」は、物理的に1つの構成であってもよいが、2つまたは3以上の制御部が機能的に協働して1つの「制御部」を構成するものであってもよい。 The “control unit” includes a CPU, a memory, and the like, and performs arithmetic processing. The “controller”, “processor”, “controller unit (control unit)”, “controller circuit (control circuit)”, “controller” It can also be called “module (control module)”, “processor unit”, “processor unit”, “processor module”, and the like. The “controller” can be configured with a microcomputer, a microcontroller, a programmable logic controller, an application specific integrated circuit, and other programmable circuits. In the present specification, the “control unit” may physically have one configuration, but two or more control units functionally cooperate to form one “control unit”. It may be.
 制御部における基本的は処理は、一例で、まずメモリに記憶されたコンピュータプログラムを読み込み、次にコンピュータプログラムの指示に従って入力装置や記憶装置からデータを受け取り、そのデータを演算・加工した上で、データをメモリなどの記憶装置やディスプレイなどの出力装置に出力するというものである。 The basic processing in the control unit is an example. First, the computer program stored in the memory is read, then data is received from the input device or the storage device according to the instructions of the computer program, and the data is calculated and processed. The data is output to a storage device such as a memory or an output device such as a display.
「コンピュータプログラム」は、それを記憶した記憶媒体を所定の装置・デバイス・機構等で読み出し、それらのコンピュータを所定の機能で動作させるものであってもよい。この場合、コンピュータプログラムを記憶した記憶媒体は本発明の一形態を構成することになる。また、コンピュータプログラムは、通信ネットワーク(一例でインターネット)を介して提供されるものであってもよい。コンピュータプログラムは、コンピュータにすでに記録されているプログラムとの組合せで実現できるもの、いわゆる差分プログラムであってもよい。 The “computer program” may be a program that reads a storage medium storing the program using a predetermined device, device, mechanism, or the like, and operates the computer with a predetermined function. In this case, the storage medium storing the computer program constitutes one aspect of the present invention. Further, the computer program may be provided via a communication network (in the example, the Internet). The computer program may be a so-called differential program that can be realized in combination with a program already recorded in the computer.
「記憶媒体」としては、例えば、不揮発性のメモリカード(フラッシュメモリ)、ハードディスク、光ディスク、光磁気ディスク、一例で、CDやDVD等などを用いることができる。記憶媒体としては、磁気的記録媒体や光学的記録媒体等、種々のものを利用できる。 As the “storage medium”, for example, a nonvolatile memory card (flash memory), a hard disk, an optical disk, a magneto-optical disk, for example, a CD, a DVD, or the like can be used. As the storage medium, various media such as a magnetic recording medium and an optical recording medium can be used.
「入力装置」(コンピュータシステムに対する入力手段)としては、キーボード、マウス、タッチパネル、トラックボール、手動によりまたは機械によって操作される物理的スイッチ、マイク、音声入力、グラフィカル・ユーザ・インターフェース等であってもよい。操作者の動きを認識(一例で非接触)してその動きに応じた所定の入力を認識するものであってもよい。 “Input device” (input means for the computer system) may be a keyboard, mouse, touch panel, trackball, physical switch operated manually or by machine, microphone, voice input, graphical user interface, etc. Good. The movement of the operator may be recognized (non-contact in one example) and a predetermined input corresponding to the movement may be recognized.
「部(「エレメント」または「モジュール」等としても表現できる)」-本明細書で例えば「(機能の名称)」+「部」で表わされるものは、コンピュータの機能として実現可能なものである。このような「部(エレメント)、モジュール等」」は、システムにおけるいずれの機器に備わっていてもよい。また、必ずしも1つの機器内に備わっている必要はなく、相当する機能が2つ以上の機器に分散して備えられていてもよい。さらに、通信ネットワーク(例えばインターネット)を介して、所定の1つまたは複数の「部」のみが外部のサーバ等に備えられていてもよい。このような「部(エレメント)、モジュール等」」は、コンピュータが論理的に有する各種の機能であってもよい。 “Part (can also be expressed as“ element ”or“ module ”or the like”) ”— in this specification, for example,“ (function name) ”+“ part ”can be realized as a function of a computer. . Such “parts (elements), modules, etc.” may be provided in any device in the system. In addition, it is not always necessary to have one device, and the corresponding function may be distributed to two or more devices. Furthermore, only one or more predetermined “units” may be provided in an external server or the like via a communication network (for example, the Internet). Such “parts (elements), modules, etc.” may be various functions logically possessed by the computer.
 なお、本明細書で云う各種の構成要素(デバイス、装置、部、モジュールなど)は、個々に独立した存在である必要はなく、複数の構成要素が一個の部材として形成されていること、一つの構成要素が複数の部材で形成されていること、ある構成要素が他の構成要素の一部であること、ある構成要素の一部と他の構成要素の一部とが重複していること、等であってもよい。各種構成要素は、その機能を実現するように形成されていればよく、ハードウェアにより実現するものでも、コンピュータプログラムにより実現されるものでも何れでも構わない。例えば、ある構成要素が、所定の機能を発揮する専用のハードウェア、所定の機能がコンピュータプログラムにより実現された処理装置、これらの組合せ、等として実現することができる。 Note that the various components (devices, apparatuses, units, modules, and the like) referred to in this specification do not have to be individually independent, and a plurality of components are formed as a single member. One component is made up of multiple members, one component is a part of another component, and one component is a part of another component , Etc. The various constituent elements may be formed so as to realize their functions, and may be realized by hardware or realized by a computer program. For example, a certain component can be realized as dedicated hardware that exhibits a predetermined function, a processing device in which the predetermined function is realized by a computer program, a combination thereof, or the like.
「グラフィカル・ユーザ・インターフェース」とは、例えば、画面上のアイコン、画像ボタン、プルダウンメニュー、または数値入力ウィンドウなどを、カーソルによりまたはタッチパネルの場合にはタッチすることにより、視覚的に操作できるインターフェースのことをいう。 “Graphical user interface” means an interface that can be visually operated by touching an icon, an image button, a pull-down menu, or a numerical input window on the screen with a cursor or in the case of a touch panel. That means.
「アイコン」とは
、(i)所定の情報を表示しかつ操作者によって選択することができるものと、(ii)単に所定の情報を表示するためのものであって選択できるようには構成されていないものとの両方を含むものであってもよい。画面に表示される全てまたは一部のアイコンは、それぞれの表示箇所をタッチペンあるいは操作者の指等でタッチすることで、または、画面上のカーソルによって、選択可能である。
The “icon” is (i) one that displays predetermined information and can be selected by the operator, and (ii) only displays predetermined information and is configured to be selectable. It may include both those that are not. All or some of the icons displayed on the screen can be selected by touching each display location with a touch pen, an operator's finger, or the like, or by a cursor on the screen.
(I.薬液注入装置の一般的説明)
「薬液注入装置」は、一形態では、次の構成要素を備えている:ピストン駆動機構、制御部(制御ユニット)、および、ディスプレイ等。
ここで、これらの構成要素は、薬液注入装置を構成するいずれの機器に備えられていてもよい。すなわち、薬液注入装置が注入ヘッドおよびコンソール等を備える場合には、(i)注入ヘッドにピストン駆動機構が備えられ、コンソールに制御ユニットとディスプレイとが備えられてもよいし、(ii)注入ヘッドとコンソールの双方に制御ユニットが設けられもよいし、(iii)注入ヘッドとコンソールの双方にディスプレイが設けられもよい。このような制御部(制御ユニット)が、例えば、CTスキャナ、MRI装置、PET装置、超音波診断装置、血管造影撮像装置のような撮像装置の一部として設けられていてもよい。
(I. General description of the chemical injection device)
In one embodiment, the “chemical solution injector” includes the following components: a piston drive mechanism, a control unit (control unit), a display, and the like.
Here, these components may be provided in any device constituting the chemical liquid injector. That is, when the chemical liquid injector includes an injection head, a console, and the like, (i) the injection head may be provided with a piston drive mechanism, and the console may be provided with a control unit and a display, or (ii) the injection head A control unit may be provided on both the console and the console. (Iii) A display may be provided on both the injection head and the console. Such a control unit (control unit) may be provided as a part of an imaging apparatus such as a CT scanner, an MRI apparatus, a PET apparatus, an ultrasonic diagnostic apparatus, or an angiographic imaging apparatus.
「注入ヘッド」は、シリンジを保持するシリンジ保持部と、そのシリンジのピストンを前進および/または後退させるピストン駆動機構を有する。シリンジの装着方法としては、主に、(i)シリンジ保持部が、ヘッド上面の半円柱状の凹部として形成されそこにシリンジがセットされるいわゆるサイドローディングのタイプと、(ii)シリンジ保持部がヘッド前面に形成されシリンジの基端部が保持されるいわゆるフロントローディングのタイプとがある。本発明の一形態においては、いずれのタイプの注入ヘッドをも含む。 The “injection head” includes a syringe holding unit that holds the syringe and a piston drive mechanism that moves the piston of the syringe forward and / or backward. The syringe mounting method mainly includes (i) a so-called side loading type in which the syringe holding portion is formed as a semi-cylindrical concave portion on the upper surface of the head and the syringe is set therein; and (ii) the syringe holding portion is There is a so-called front loading type in which the base end portion of the syringe is held on the front surface of the head. One form of the present invention includes any type of injection head.
 薬液注入装置は、次のようなもののうち1つまたは複数を有してもよい:1つまたは複数の圧力センサ、1つまたは複数のシリンジ検出センサ(磁石センサ、ホールセンサ等)、1つまたは複数の傾斜センサ、1つまたは複数のロータリエンコーダ、および、1つまたは複数のモータ電流検出器、等。 The chemical injection device may have one or more of the following: one or more pressure sensors, one or more syringe detection sensors (magnet sensors, Hall sensors, etc.), one or Multiple tilt sensors, one or more rotary encoders, one or more motor current detectors, and the like.
・圧力センサ:圧力センサは、例えばピストン部材を押す圧力を検出するためのものであり、これにより、薬液の圧力推定値を求めることができる。圧力センサは、一例でロードセルであってもよい。ロードセルは、ピストン駆動機構のラム部材がピストン部材を押す圧力を検出できるような位置に設けられていればよい。ロードセルの検出結果を利用して、例えば、薬液を注入しているときの薬液の圧力の推定値を求める場合、その算出は、注入回路の抵抗(例えば針のサイズ等)、薬液の濃度、注入条件なども考慮して行われてもよい。他の態様では、薬液の圧力を直接的に検出する圧力センサなどを有していてもよい。 -Pressure sensor: A pressure sensor is for detecting the pressure which pushes a piston member, for example, By this, the pressure estimated value of a chemical | medical solution can be calculated | required. The pressure sensor may be a load cell, for example. The load cell should just be provided in the position which can detect the pressure which the ram member of a piston drive mechanism pushes a piston member. For example, when calculating the estimated value of the pressure of the chemical solution when injecting the chemical solution using the detection result of the load cell, the calculation is performed by calculating the resistance of the injection circuit (eg, the size of the needle), the concentration of the chemical solution, the injection It may be performed in consideration of conditions. In another aspect, a pressure sensor that directly detects the pressure of the chemical solution may be included.
・シリンジ検出センサ:シリンジ検出センサは、シリンジ、アダプタ、および/または保護ケースが装着されたか否かを検出する、あるいは、どのような種類のシリンジ、アダプタ、および/または保護ケースが装着されたかを判定するのに用いられるものである。このようなセンサとしては、接触式または非接触式のいずれであってもよく、例えば次のようなものを利用できる:物理的な接触を利用した接触センサ、電気的に対象物を検出する電気センサ、磁気センサ、ホールセンサ、光センサ、近接センサ、等。 • Syringe detection sensor: The syringe detection sensor detects whether a syringe, adapter, and / or protective case is attached, or what type of syringe, adapter, and / or protective case is attached. It is used for judgment. Such a sensor may be either a contact type or a non-contact type, and for example, the following can be used: a contact sensor using physical contact, an electric for electrically detecting an object. Sensor, magnetic sensor, Hall sensor, optical sensor, proximity sensor, etc.
・傾斜センサ:傾斜センサは、注入ヘッドの傾きを検出する。一般に、この種の注入ヘッドは、その前端側(つまりシリンジ側)が上方となるような姿勢でシリンジ内への薬液吸引が実施される。一方、薬液注入は、注入ヘッドの前端側が相対的に下方となるような姿勢(先端側をやや下に向けた姿勢)で実施される。傾斜センサの検出結果を用いることで、例えば、望ましくない姿勢での薬液吸引または薬液注入することを防止することも可能である。 Tilt sensor: The tilt sensor detects the tilt of the injection head. In general, this type of injection head performs the suction of the chemical solution into the syringe in such a posture that the front end side (that is, the syringe side) is upward. On the other hand, the chemical liquid injection is performed in such a posture that the front end side of the injection head is relatively downward (a posture in which the tip side is directed slightly downward). By using the detection result of the tilt sensor, it is possible to prevent, for example, chemical liquid suction or chemical liquid injection in an undesirable posture.
・ロータリエンコーダ:ピストン駆動機構のモータや送りネジの回転数および/または回転方向を検出するためのロータリエンコーダ等が設けられていてもよい。 Rotary encoder: A rotary encoder or the like for detecting the rotation speed and / or rotation direction of the motor of the piston drive mechanism and the feed screw may be provided.
・モータ電流検出器:ロードセル等を用いずモータ電流に基づいて薬液の圧力推測値を算出することも可能である。この方式においては、モータ電流検出器により、モータの動作中、モータ電流を監視し、そのモータ電流に基づいて薬液の圧力推定値を求める。 Motor current detector: It is also possible to calculate the estimated pressure value of the chemical based on the motor current without using a load cell or the like. In this system, the motor current is monitored by the motor current detector during operation of the motor, and the estimated pressure value of the chemical solution is obtained based on the motor current.
 薬液注入装置は、さらに、次のようなもののうち1つまたは複数を有してもよい:1つまたは複数のヘッドディスプレイ、1つまたは複数のヘッド状況表示部、1つまたは複数の物理ボタン、1つまたは複数のRFID通信デバイス、1つまたは複数のデータレシーバ、1つまたは複数のデータトランスミッタ等。 The chemical injection device may further include one or more of the following: one or more head displays, one or more head status indicators, one or more physical buttons, One or more RFID communication devices, one or more data receivers, one or more data transmitters, etc.
・ディスプレイ:所定の情報を表示するためのディスプレイが注入ヘッドに設けられていてもよい。ディスプレイは、例えば、注入ヘッドの筐体の一部に設けられていてもよい。あるいは、筐体とは別体に用意されたサブディスプレイであってもよい。ディスプレイは、LCD(Liquid
Crystal Display)や有機EL(Organic Electro-Luminescence)ディスプレイ等を利用した表示部であってもよいが、LED(Light
Emitting Diode)を利用した表示部であってもよい。このディスプレイに表示される内容としては、特に限定されないが、次のようなものであってもよい:注入動作中の所定の状態表示、注入予定の薬液注入条件、注入された薬液注入条件、薬液注入量、薬液圧力、注入速度、等。
Display: A display for displaying predetermined information may be provided in the injection head. The display may be provided, for example, in a part of the casing of the injection head. Alternatively, a sub display prepared separately from the housing may be used. The display is LCD (Liquid
A display unit using a crystal display (Organic Electro-Luminescence) display or the like may be used, but an LED (Light
It may be a display unit using Emitting Diode). The contents displayed on the display are not particularly limited, but may be as follows: a predetermined state display during the injecting operation, conditions for injecting the liquid to be injected, conditions for injecting the liquid to be injected, liquid chemicals to be injected Injection volume, chemical pressure, injection speed, etc.
 例えば、注入ヘッドの筐体の一部に、注入ヘッドの所定の状態を操作者に知らせるための所定の発光部が設けられていてもよい。光源としては、一例でLED(Light
Emitting Diode)等を利用できる。このような発光部は、ヘッド状況表示部としての機能を有し、発光色や発光パターンを変化させることにより、注入ヘッドの種々の状況を操作者に知らせることができる。
For example, a predetermined light emitting unit for notifying an operator of a predetermined state of the injection head may be provided in a part of the casing of the injection head. As an example of the light source, LED (Light
Emitting Diode) can be used. Such a light emitting unit has a function as a head status display unit, and can notify the operator of various situations of the injection head by changing a light emission color or a light emission pattern.
・物理ボタン:物理ボタンとしては、特に限定されないが、次のようなものであってもよい。ラム部材を前進させるための前進ボタン、ラム部材を後退させるための後退ボタン、前進ボタンまたは後退ボタンと同時に押すことでラム部材の移動速度を早くするアクセラレータボタン、および、ヘッドの動作を停止させる停止ボタン等。これらの物理ボタンは注入ヘッドの筐体の上面、側面、下面、後端面等に適宜配置可能である。二筒式の注入ヘッドの場合、一方のピストン駆動機構のための物理ボタンの配置と、他方のピストン駆動機構のための物理ボタンの配置とが非対称となっていてもよい。 Physical button: The physical button is not particularly limited, but may be as follows. Advance button for advancing the ram member, Retreat button for retracting the ram member, Accelerator button for increasing the moving speed of the ram member by pressing simultaneously with the advance button or the retract button, and a stop for stopping the head operation Buttons etc. These physical buttons can be appropriately arranged on the upper surface, side surface, lower surface, rear end surface and the like of the casing of the injection head. In the case of a two-cylinder injection head, the physical button arrangement for one piston drive mechanism and the physical button arrangement for the other piston drive mechanism may be asymmetric.
・RFID通信デバイス:シリンジ、アダプタ、または保護カバーにICタグなどのデータ保持手段が付されている場合には、同タグの情報を読み取る無線通信デバイスが設けられていてもよい。この無線通信デバイスは、単にICタグからデータの読取りを行うRFIDリーダであってもよいし、または、ICタグにデータの書込みを行うことも可能なRFIDリーダ/ライタであってもよい。 RFID communication device: When a data holding unit such as an IC tag is attached to the syringe, adapter, or protective cover, a wireless communication device that reads information on the tag may be provided. This wireless communication device may be an RFID reader that simply reads data from an IC tag, or may be an RFID reader / writer that can also write data to an IC tag.
・データレシーバ:データレシーバは、有線または無線により、外部から注入ヘッドに対して送信されたデータを受けるためのものである。データレシーバは、一例で、次のようなデータを外部から受けるようになっていてもよい:撮像装置によって生成された任意のデータ病院システムによって生成された任意のデータ、等。 Data receiver: The data receiver is for receiving data transmitted from the outside to the injection head by wire or wireless. For example, the data receiver may receive data such as the following from the outside: any data generated by the imaging device, any data generated by the hospital system, and so on.
・データトランスミッタ:データトランスミッタは、有線または無線により、注入ヘッド等から外部に対して所定のデータを送り出すためのものである。データレシーバおよびデータトランスミッタの通信プロトコルは、通信の相手方である他の機器との通信方式を考慮して適宜好適なものを採用すればよい。なお、外部機器との通信を行うデータトランスミッタ等はコンソールまたはその他の機器に設けられていてもよい。データトランスミッタにより注入ヘッドから外部に送信可能なデータとしては、次のようなものの1つまたは複数であってもよい:使用された造影剤の名称等(造影剤識別情報)、造影剤の注入総量、造影剤の注入時間、造影剤の注入圧力、造影剤の注入速度、設定した注入プロトコル等。また、次のようなものの1つまたは複数:患者の識別情報(例えば患者ID)、検査識別情報(例えば検査ID)、撮像時刻に関する情報、等。このような情報は、上述した造影剤に関する情報と組み合わせて送信されてもよい。 Data transmitter: The data transmitter is for sending predetermined data from the injection head or the like to the outside by wire or wireless. As a communication protocol for the data receiver and the data transmitter, a suitable protocol may be adopted in consideration of a communication system with another device which is a communication partner. Note that a data transmitter or the like that communicates with an external device may be provided in a console or other device. The data that can be transmitted from the injection head to the outside by the data transmitter may be one or more of the following: the name of the contrast agent used (contrast agent identification information), the total injection amount of the contrast agent Contrast agent injection time, contrast agent injection pressure, contrast agent injection speed, set injection protocol, etc. Also, one or more of the following: patient identification information (for example, patient ID), examination identification information (for example, examination ID), information regarding imaging time, and the like. Such information may be transmitted in combination with the information regarding the contrast agent described above.
 注入ヘッドおよびコンソールは、外部機器と通信を行うための通信部が設けられている。この通信部を介して外部機器から入力された注入条件に応じて、造影剤の注入量や注入の速度等を調節するようにピストン駆動機構が動作制御されるように構成されていてもよい。 The injection head and console are provided with a communication unit for communicating with external devices. The piston drive mechanism may be configured to control the operation so as to adjust the injection amount of the contrast agent, the injection speed, and the like according to the injection conditions input from the external device via the communication unit.
・異常検出について:上記のような各種センサを利用して、次のようなもののうち1つまたは複数の注入異常を検出可能に構成されていることが好ましい。
-ピストン駆動機構が正常に動作しないことによる注入異常、
-シリンジが注入ヘッドに正常に搭載されていないことによる注入異常、
-シリンジ内に注入動作を行うに足りる造影剤が残存していないことによる注入異常、
-カテーテルや注射針が患者に正常に挿入されていないことによる注入異常
-薬液経路の途中でキンクが生じているなどに起因した注入異常、
-検出される薬液の圧力値が所定の範囲(上限および下限を有する所定範囲、または、所定の上限リミット、所定の下限リミットなど)にないという注入異常、等。
Abnormality detection: It is preferable that one or a plurality of injection abnormalities can be detected using the various sensors as described above.
-Injection failure due to malfunction of piston drive mechanism,
-Injection abnormalities due to the syringe not being properly mounted on the injection head,
-Abnormal injection due to insufficient contrast agent remaining in the syringe to perform the injection operation,
-Abnormal injection due to the catheter or needle not being properly inserted in the patient-Abnormal injection due to kinks occurring in the middle of the drug solution path,
-An injection abnormality such that the pressure value of the detected chemical is not within a predetermined range (a predetermined range having an upper limit and a lower limit, or a predetermined upper limit, a predetermined lower limit, etc.), etc.
-薬液注入時、例えば、薬液経路が詰まったりしている場合には、ピストン駆動機構の駆動力が所定範囲を上回ることとなる。他方、注入針が患者から抜けているような場合には、駆動力が所定範囲を下回ることとなる。このような駆動力の変化をみることによって、薬液が正常に注入されているか否を検知できる。
-センサにより、所定量の薬液が正常に装填されていないことが検知された場合、その検知結果が通信部から外部に送信されてもよい。
-その他、例えば、延長チューブの途中に圧力を測定する圧力センサを設け、薬液が所定の圧力で注入されているかを検知してもよい。
-When the chemical solution is injected, for example, when the chemical solution path is clogged, the driving force of the piston drive mechanism exceeds the predetermined range. On the other hand, when the injection needle is removed from the patient, the driving force falls below a predetermined range. By seeing such a change in driving force, it is possible to detect whether or not the chemical solution is normally injected.
-When the sensor detects that a predetermined amount of chemical solution is not normally loaded, the detection result may be transmitted from the communication unit to the outside.
-In addition, for example, a pressure sensor for measuring pressure may be provided in the middle of the extension tube to detect whether the chemical solution is injected at a predetermined pressure.
(グラフィカル画像/グラフィカル・ユーザ・インターフェースについて)
 薬液注入や条件設定に関し、次のような画面が表示されるようになっていてもよい。別の言い方をすれば、システムが次のようなグラフィカル画像を有する、または、そのようなグラフィカル画像が記憶された記憶デバイスを有していてもよい。
・「セルフチェック画面」は、電源起動直後にヘッドのセルフチェック結果の表示を行うための画面である。
・「キャリブレーション画面」は、タッチパネルのキャリブレーションを行うための画面である。
・「サービスメンテナンス画面」は、必要に応じてコンソール設定の変更を可能とする画面である。
・「部位選択画面」は、各部位に登録されているプロトコルを選択するための画面である。
・「注入条件設定画面」は、プロトコルの注入条件を設定するための画面である。

・「設定確認画面」は、注入直前に注入条件を確認し注入条件の微調整を行うための画面である。
・「注入画面」は、注入中の圧力を表示するための画面である。
・「プロトコル設定画面」は、プロトコルを作成、編集するための画面である。

・「環境設定画面」は、操作者が調整できる機能設定項目を表示する画面である。
・「注入結果画面」は、注入結果を表示するための画面である。
(About graphical images / graphical user interfaces)
The following screen may be displayed regarding chemical injection and condition setting. In other words, the system may have the following graphical image or may have a storage device in which such a graphical image is stored.
The “self-check screen” is a screen for displaying the self-check result of the head immediately after the power is turned on.
“Calibration screen” is a screen for calibrating the touch panel.
-The “service maintenance screen” is a screen that allows the console settings to be changed as necessary.
The “part selection screen” is a screen for selecting a protocol registered in each part.
“Injection condition setting screen” is a screen for setting the injection conditions of the protocol.

“Setting confirmation screen” is a screen for confirming the injection conditions immediately before injection and finely adjusting the injection conditions.
The “injection screen” is a screen for displaying the pressure during the injection.
“Protocol setting screen” is a screen for creating and editing a protocol.

The “environment setting screen” is a screen that displays function setting items that can be adjusted by the operator.
The “injection result screen” is a screen for displaying the injection result.
(II.撮像装置の一般的説明)
 撮像装置としては、例えばX線CTスキャナ等であってもよく、一般的には、撮像部(一例でガントリ)と、患者を載せるベッド(寝台)と、それらの動作を制御する動作制御部と、透視撮像データを収集処理するデータ収集部と、全体の動作を制御するメインコントローラ等を有している。メインコントローラは、例えばコンソールとして設けられることもある。撮像装置は、また、所定の情報を表示する1つまたはそれ以上のディスプレイを有することもある。CTスキャナの場合、ガントリの内部には、X線管やコリメータ等を有しX線を患者に向けて照射するX線照射部と、患者を透過したX線の検出を行う検出部等が配置される。X線照射部および検出部は、それらの位置関係を保ったまま患者の体軸の周りを回転しながらスキャンを行い、データ収集部によって透視撮像データ(投影データ)の収集が行われる。ベッドは、例えばモータを駆動源として移動可能に構成され、その移動動作は動作制御部によって制御される。
(II. General Description of Imaging Device)
The imaging device may be, for example, an X-ray CT scanner or the like. Generally, an imaging unit (a gantry in one example), a bed (bed) on which a patient is placed, and an operation control unit that controls the operations thereof A data collecting unit for collecting fluoroscopic imaging data, a main controller for controlling the entire operation, and the like. The main controller may be provided as a console, for example. The imaging device may also have one or more displays that display predetermined information. In the case of a CT scanner, an X-ray irradiation unit that has an X-ray tube, a collimator, etc. and irradiates the patient with X-rays, and a detection unit that detects X-rays transmitted through the patient are arranged inside the gantry Is done. The X-ray irradiation unit and the detection unit scan while rotating around the patient's body axis while maintaining their positional relationship, and fluoroscopic imaging data (projection data) is collected by the data collection unit. The bed is configured to be movable using, for example, a motor as a drive source, and the movement operation is controlled by the operation control unit.
 撮像装置と薬液注入装置との間、撮像装置のその他の機器との間、薬液注入装置とその他の機器との間といった、機器間の通信プロトコルとしては種々のものを利用でき、例えば、CANopen、HL7、DICOM等のプロトコルが挙げられる。 Various communication protocols between devices such as between the imaging device and the chemical injection device, between the other devices of the imaging device, and between the chemical injection device and other devices can be used. For example, CANopen, Protocols such as HL7 and DICOM are listed.
 本発明によれば、1つの薬液注入装置で様々な注入プロトコルの設定方式を利用することができ、しかも注入プロトコルを簡単にかつ多様に作成することができる薬液注入装置等が提供される。 According to the present invention, it is possible to provide a chemical solution injection device and the like that can use various injection protocol setting methods with one chemical solution injection device and can easily and variously create injection protocols.
薬液注入装置の全体構成を模式的に示すブロック図である。It is a block diagram which shows typically the whole structure of a chemical injection device. 薬液注入装置の制御部の構成の一部を示すブロック図である。It is a block diagram which shows a part of structure of the control part of a chemical injection device. 注入プロトコルの設定および薬液注入等の手順を示すフローチャートである。It is a flowchart which shows procedures, such as an injection protocol setting and chemical | medical solution injection | pouring. 画面に表示される設定用初期画面の一例を示す図である。It is a figure which shows an example of the initial screen for a setting displayed on a screen. 画面に表示されたポップアップ画面の一例を示す図である。It is a figure which shows an example of the pop-up screen displayed on the screen. 注入グラフ上に作成された注入パターンの一例を示す図である。It is a figure which shows an example of the injection | pouring pattern produced on the injection | pouring graph. 注入グラフ上に作成された注入パターンの他の例を示す図である。It is a figure which shows the other example of the injection | pouring pattern produced on the injection | pouring graph. 注入グラフ上に作成された注入パターンのさらに他の例を示す図である。It is a figure which shows the further another example of the injection | pouring pattern produced on the injection | pouring graph. 注入グラフ上に作成された注入パターンの別の例を示す図である。It is a figure which shows another example of the injection | pouring pattern produced on the injection | pouring graph. 注入グラフ上に作成された注入パターンのさらに別の例を示す図である。It is a figure which shows another example of the injection | pouring pattern produced on the injection | pouring graph. 注入グラフの他の表示態様の例を示す図である。It is a figure which shows the example of the other display mode of an injection | pouring graph. パラメータと変更と注入プロトコルとの関連を示す図である(体重またはヨード量の変更)。It is a figure which shows the relationship between a parameter, a change, and an injection | pouring protocol (change of a body weight or the amount of iodine). パラメータと変更と注入プロトコルとの関連を示す図である(可変定数の変更)。It is a figure which shows the relationship between a parameter, a change, and an injection | pouring protocol (change of a variable constant). パラメータと変更と注入プロトコルとの関連を示す図である(注入時間の変更)。It is a figure which shows the relationship between a parameter, a change, and an injection | pouring protocol (injection time change). パラメータと変更と注入プロトコルとの関連を示す図である(初速度の変更)。It is a figure which shows the relationship between a parameter, a change, and an injection | pouring protocol (change of initial velocity). 注入パターンの自動的修正の一例を示す図である。It is a figure which shows an example of the automatic correction of an injection | pouring pattern. 薬液注入装置の一実施形態を示す斜視図である。It is a perspective view which shows one Embodiment of a chemical injection device. シリンジの他の例を示す斜視図である。It is a perspective view which shows the other example of a syringe. シリンジのさらに別の例を示す斜視図である。It is a perspective view which shows another example of a syringe. 延長チューブの他の例を示す図である。It is a figure which shows the other example of an extension tube. 天井懸垂型の保持アームの一例を示す図である。It is a figure which shows an example of a ceiling suspension type holding arm. サブディスプレイの一例を示す図である。It is a figure which shows an example of a sub display. 本発明の一形態に係る延長チューブを模式的に示す図である。It is a figure which shows typically the extension tube which concerns on one form of this invention. 図10Aの延長チューブに使用されるミキシングデバイスの斜視図である。FIG. 10B is a perspective view of a mixing device used in the extension tube of FIG. 10A. 図10Aの延長チューブに使用されるミキシングデバイスの断面図である。It is sectional drawing of the mixing device used for the extension tube of FIG. 10A. 設定した注入条件を確認するための画面の一例を示す図である。It is a figure which shows an example of the screen for confirming the set injection | pouring conditions. 病院システムの模式図である。It is a schematic diagram of a hospital system. 注入パターンを変更するためのグラフィカル・ユーザ・インターフェースの一例を示す図である。FIG. 3 is a diagram illustrating an example of a graphical user interface for changing an injection pattern. 注入パターンを変更するためのグラフィカル・ユーザ・インターフェースの他の例を示す図である。FIG. 6 is a diagram illustrating another example of a graphical user interface for changing an injection pattern. 本発明の一形態に係るコンピュータシステムの一例のブロック図である。1 is a block diagram of an example of a computer system according to an embodiment of the present invention. 撮像装置側のコンソールで条件設定を行うシステムの模式図である。It is a schematic diagram of the system which performs condition setting with the console by the side of an imaging device.
 本発明の実施の形態を図面を参照して以下に説明する。 Embodiments of the present invention will be described below with reference to the drawings.
 本実施形態の薬液注入システム1000は、図1に示すように、患者に薬液として少なくとも造影剤を注入する薬液注入装置100と、患者の透視画像を撮像する撮像装置300とを備えている。薬液注入装置100は、具体例については後述するが、可動式スタンドの上部にもしくは天井懸垂型アームの一部に保持された注入ヘッド110と、それに接続されたコンソール150と、を備えている。注入ヘッド110には、2つのシリンジ200C、200Pが並列に取外し自在に装着されてもよい。なお、注入ヘッドとコンソールとは無線方式で接続されていてもよい。 As shown in FIG. 1, the chemical injection system 1000 according to the present embodiment includes a chemical injection device 100 that injects at least a contrast medium as a chemical into a patient, and an imaging device 300 that captures a fluoroscopic image of the patient. Although a specific example will be described later, the chemical injection device 100 includes an injection head 110 held on an upper part of a movable stand or a part of a ceiling-suspended arm, and a console 150 connected thereto. Two syringes 200C and 200P may be detachably attached to the injection head 110 in parallel. Note that the injection head and the console may be connected in a wireless manner.
 なお、本発明においては注入ヘッドやコンソールの具体的構成は特に限定されるものではないが、一実施形態としての具体例については、他の図面を参照しつつ後述するものとする(図7~図9Bを参照)。 In the present invention, the specific configuration of the injection head and the console is not particularly limited, but a specific example as one embodiment will be described later with reference to other drawings (FIG. 7 to FIG. 7). (See FIG. 9B).
 以下の説明では、シリンジ200C、200Pを区別せずに単に「シリンジ200」ということもある。「注入ヘッド」は、インジェクタまたはインジェクションヘッドなどとも呼ばれる。また、以下の説明では、図面に表された1つの具体的な形態に基づいて説明を行うが、薬液注入装置やシリンジ等については下記に説明するもの以外にも種々変更可能である。 In the following description, the syringes 200C and 200P may be simply referred to as “syringe 200” without being distinguished. An “injection head” is also called an injector or an injection head. Moreover, in the following description, although it demonstrates based on one specific form represented by drawing, about a chemical | medical solution injection device, a syringe, etc., various changes other than what is demonstrated below are possible.
〔A1.シリンジ〕
 シリンジ200C、200Pに充填される薬液としては、造影剤および生理食塩水などが挙げられる。例えば、一方のシリンジ200Cに造影剤が充填され、もう一方のシリンジ200Pに生理食塩水が充填されていてもよい。
[A1. Syringe〕
Examples of the chemical solution filled in the syringes 200C and 200P include a contrast medium and physiological saline. For example, one syringe 200C may be filled with a contrast medium, and the other syringe 200P may be filled with physiological saline.
 シリンジ200は、中空筒状のシリンダ部材221と、そのシリンダ部材221にスライド自在に挿入されたピストン部材222とを有している。シリンダ部材221は、その基端部にシリンダフランジ221aが形成されるとともに先端部に導管部221bが形成されたものであってもよい。ピストン部材222をシリンダ部材221内に押し込むことにより、シリンジ内の薬液が導管部221bを介して外部に押し出される。 The syringe 200 has a hollow cylindrical cylinder member 221 and a piston member 222 that is slidably inserted into the cylinder member 221. The cylinder member 221 may have a cylinder flange 221a formed at the base end portion thereof and a conduit portion 221b formed at the tip end portion thereof. By pushing the piston member 222 into the cylinder member 221, the chemical solution in the syringe is pushed out through the conduit portion 221b.
 各シリンジ200の導管部221bには、延長チューブ230が連結される。延長チューブ230は、いわゆるT字管またはY字管であってもよく、一方のシリンジ200Cの導管部221bから分岐部まで延びるチューブ231aと、他方のシリンジ200Pの導管部221bから分岐部まで延びるチューブ231bと、分岐部から患者に向けて延びるチューブ231cとを有するものであってもよい。チューブ231cの先端側(不図示)には例えば注入針が接続される。この注入針を患者の血管に穿刺して、シリンジ200Cおよび/またはシリンジ200P内の薬液を押し出すことで血管内に薬液が注入される。なお、シリンジは予め薬液が充填されたプレフィルドタイプであってもよいし、空のシリンジに薬液を吸引して使用する吸引式のものであってもよい。 The extension tube 230 is connected to the conduit portion 221b of each syringe 200. The extension tube 230 may be a so-called T-shaped tube or Y-shaped tube. The tube 231a extends from the conduit portion 221b of one syringe 200C to the branch portion, and the tube extends from the conduit portion 221b of the other syringe 200P to the branch portion. It may have 231b and the tube 231c extended toward a patient from a branch part. For example, an injection needle is connected to the distal end side (not shown) of the tube 231c. This injection needle is punctured into a patient's blood vessel, and the chemical solution is injected into the blood vessel by pushing out the chemical solution in the syringe 200C and / or the syringe 200P. The syringe may be a prefilled type that is pre-filled with a chemical solution, or may be a suction type that sucks and uses a chemical solution in an empty syringe.
 シリンダ部材221の一部にICタグ225が付されていてもよい。このICタグ225には下記の情報の少なくとも1つが記憶されていてもよい:
-シリンジに関する情報(シリンジの識別情報、シリンジの耐圧、シリンダ部材の内径、およびピストン部材のストローク等のうち1つまたは複数)、
-該シリンジに充填された薬液の情報(名称(例えば製品名)、ヨード量などの成分情報、消費期限、および薬液容量等のうち1つまたは複数)。
An IC tag 225 may be attached to a part of the cylinder member 221. The IC tag 225 may store at least one of the following information:
-Information about the syringe (one or more of syringe identification information, syringe pressure resistance, cylinder member inner diameter, piston member stroke, etc.),
-Information (one or more of name (for example, product name), component information such as iodine amount, expiry date, chemical volume, etc.) of the chemical filled in the syringe.
 ICタグは、そのタグに固有のユニークIDを有していてもよい。ICタグは、シリンジサイズ、シリンジの製造番号、および薬剤標準化コードから選ばれる少なくとも1つの情報を有していてもよい。なお、ICタグ225としては、例えば、RFID(Radio frequency identification)タグを利用することができる。ICタグ225を貼り付ける位置としては、一例で、シリンダ部材221の外周面であってもよく、具体的には、外周面のうちシリンダフランジの付近であってもよい。 IC tag may have a unique ID unique to the tag. The IC tag may have at least one information selected from a syringe size, a syringe serial number, and a drug standardization code. As the IC tag 225, for example, an RFID (Radio frequency identification) tag can be used. The position where the IC tag 225 is attached may be, for example, the outer peripheral surface of the cylinder member 221. Specifically, the IC tag 225 may be near the cylinder flange on the outer peripheral surface.
〔A2.注入ヘッド〕
 注入ヘッド110は、一例として前後方向に長く延びるような筐体を有しており、この筐体の上面先端側に、それぞれシリンジ200C、200Pが載せられる2つの凹部が形成されたものであってもよい。凹部はシリンジ保持部として機能する部分である。凹部に対しては、シリンジ200が直接装着されてもよいし、または、所定のシリンジアダプタを介して装着されてもよい。
[A2. Injection head)
As an example, the injection head 110 has a casing that extends long in the front-rear direction, and two recesses on which the syringes 200C and 200P are respectively placed are formed on the top end side of the casing. Also good. A recessed part is a part which functions as a syringe holding part. The syringe 200 may be directly attached to the recess, or may be attached via a predetermined syringe adapter.
 注入ヘッド110は、また、シリンジ200のピストン部材222を押し込む機能を少なくとも有するピストン駆動機構130を有している。ピストン駆動機構130は二系統設けられており、各機構130は独立して動作する。ピストン駆動機構130は、例えばシリンジ内への薬液吸引のために、ピストン部材222を後退させる機能を有するものであってもよい。2つのピストン駆動機構130は同時に駆動されてもよいし、別々のタイミングで駆動されてもよい。 The injection head 110 also has a piston drive mechanism 130 having at least a function of pushing the piston member 222 of the syringe 200. Two systems of piston drive mechanisms 130 are provided, and each mechanism 130 operates independently. The piston drive mechanism 130 may have a function of retracting the piston member 222, for example, for sucking a chemical solution into the syringe. The two piston drive mechanisms 130 may be driven simultaneously, or may be driven at different timings.
 ピストン駆動機構130は、詳細な図示は省略するが、駆動モータ(不図示)と、その駆動モータの回転出力を直線運動に変換する運動変換機構(不図示)と、その運動変換機構に連結され、ピストン部材222を前進および/または後退させるシリンジプレッサー(ラム部材)とを有するものであってもよい。このようなピストン駆動機構としては、薬液注入装置で一般に用いられる公知の機構を用いることができる。なお、モータ以外のアクチュエータを駆動源としてもよい。 Although not shown in detail, the piston drive mechanism 130 is connected to a drive motor (not shown), a motion conversion mechanism (not shown) that converts the rotational output of the drive motor into a linear motion, and the motion conversion mechanism. It may have a syringe presser (ram member) for moving the piston member 222 forward and / or backward. As such a piston drive mechanism, a known mechanism generally used in a chemical liquid injector can be used. An actuator other than the motor may be used as the drive source.
 典型的なピストン駆動機構の動作としては、次のようなものが挙げられる:薬液注入(ラム部材の前進)および薬液吸引(ラム部材の後退)。「薬液注入」では、所定のモータ制御信号にしたがってモータを動作させラム部材を前進させることにより、設定された注入プロトコル(注入条件)に従った薬液注入を行う。「薬液吸引」では、所定の制御信号にしたがってモータを動作させピストン部材を後退させることにより、シリンジ内に薬液を吸引する。なお、プレフィルドシリンジの場合には、薬液吸引は実施しなくてよい。 Typical operation of the piston drive mechanism includes the following: chemical injection (ram member advance) and chemical suction (ram member reverse). In “chemical solution injection”, a chemical solution is injected in accordance with a set injection protocol (injection condition) by operating the motor in accordance with a predetermined motor control signal and moving the ram member forward. In “chemical solution suction”, a chemical solution is sucked into a syringe by operating a motor in accordance with a predetermined control signal to retract a piston member. In the case of a prefilled syringe, the chemical liquid suction need not be performed.
 ピストン駆動機構130は、シリンジプレッサーがピストン部材220を押圧する力を検出するためのロードセル(不図示)を有していてもよい。ロードセルの検出結果を利用して、例えば、薬液を注入しているときの薬液の圧力の推定値を求めることができる。この推定値の算出は、針のサイズ、薬液の濃度、注入条件なども考慮して行われる。他にも、ロードセル(不図示)を用いるのではなく、駆動モータ(不図示)のモータ電流に基づいて圧力の算出を行うものであってもよい。 The piston drive mechanism 130 may have a load cell (not shown) for detecting the force with which the syringe press presses the piston member 220. For example, the estimated value of the pressure of the chemical solution when the chemical solution is being injected can be obtained using the detection result of the load cell. The calculation of the estimated value is performed in consideration of the needle size, the concentration of the drug solution, the injection conditions, and the like. In addition, instead of using a load cell (not shown), the pressure may be calculated based on a motor current of a drive motor (not shown).
 シリンジにICタグ225が付されている場合には、注入ヘッド110は、図3に示すように、同ICタグ225の情報を読み取るおよび/または同ICタグ225に情報を書き込むリーダ/ライタ145を有していてもよい。このリーダ/ライタ145は、シリンジ200が装着される凹部120aに設けられていてもよい。なお、リーダ/ライタ145は、ICタグ225の情報を読み取る機能のみを有するものであってもよい。 When the IC tag 225 is attached to the syringe, the injection head 110 includes a reader / writer 145 that reads information from the IC tag 225 and / or writes information to the IC tag 225, as shown in FIG. You may have. The reader / writer 145 may be provided in the recess 120a in which the syringe 200 is mounted. Note that the reader / writer 145 may have only a function of reading information from the IC tag 225.
 注入ヘッド110は、図3に示すように、ピストン駆動機構130やリーダ/ライタ145の動作を制御するための制御部144を有していてもよい。また、例えば、ICタグ225から読み取られた情報を一時的に記憶する記憶部146を有していてもよい。 As shown in FIG. 3, the injection head 110 may have a control unit 144 for controlling operations of the piston drive mechanism 130 and the reader / writer 145. In addition, for example, a storage unit 146 that temporarily stores information read from the IC tag 225 may be included.
 注入ヘッド110の筐体の上面および側面には、注入ヘッド110に各種動作を行わせるための複数の物理ボタンも設けられている。これらの物理ボタンの一部は、例えば、所定の情報を術者に知らせるために発光するように構成されていてもよい。 A plurality of physical buttons for causing the injection head 110 to perform various operations are also provided on the top and side surfaces of the casing of the injection head 110. For example, some of these physical buttons may be configured to emit light in order to notify the operator of predetermined information.
〔A3.スタンド等のヘッド保持機構〕
 注入ヘッド110を保持するための可動式のスタンドや、天井懸垂型の保持アームについては、他の図面を参照して後述する。
[A3. (Head holding mechanism such as a stand)
A movable stand for holding the injection head 110 and a ceiling-suspended holding arm will be described later with reference to other drawings.
〔A4.コンソール〕
 コンソール150は、検査室に隣接した操作室内に置かれて使用されるものであってもよい。コンソール150は、所定の画像を表示する表示ユニット151と、その筐体前面に設けられた操作パネル159と、筐体内に配置された制御回路(詳細下記)等を有している。操作パネル159は、1つまたは複数の物理ボタンが配置された部分であり、ユーザによって操作される。
[A4. console〕
The console 150 may be used by being placed in an operation room adjacent to the examination room. The console 150 includes a display unit 151 that displays a predetermined image, an operation panel 159 provided on the front surface of the casing, a control circuit (detailed below) arranged in the casing, and the like. The operation panel 159 is a portion where one or a plurality of physical buttons are arranged, and is operated by the user.
 表示ユニット151は、タッチパネル式ディスプレイであってもよいし、単なるディスプレイであってもよい。コンソール150は、音および/または音声を出力するためのスピーカ等(不図示)を有していてもよい。 The display unit 151 may be a touch panel display or a simple display. The console 150 may include a speaker or the like (not shown) for outputting sound and / or sound.
 コンソール150は、図1のブロック図では、接続されている各部の動作を制御する制御部153と、種々のデータが記憶される記憶部154とを有するものとして描かれている。コンソール150は、注入ヘッド110との接続のためのインターフェースと、撮像装置との接続のためのインターフェース(不図示)とを有していてもよい。コンソール150は、コンソールに有線または無線で接続されユーザの手元で操作されるハンドユニット157(図1では入力装置157)を有していてもよい。図1では図示していないが、コンソール150は情報記憶媒体が接続されるインターフェースを有していてもよく、具体的には、コンソール150の筐体前面、側面、または背面に配置されたスロット等を有していてもよい。 In the block diagram of FIG. 1, the console 150 is depicted as having a control unit 153 that controls the operation of each connected unit and a storage unit 154 that stores various data. The console 150 may have an interface for connection to the injection head 110 and an interface (not shown) for connection to the imaging apparatus. The console 150 may have a hand unit 157 (input device 157 in FIG. 1) that is connected to the console by wire or wirelessly and is operated by the user. Although not shown in FIG. 1, the console 150 may have an interface to which an information storage medium is connected. Specifically, the console 150 has a slot disposed on the front surface, side surface, or rear surface of the housing. You may have.
(コンソールの制御部構成)
 制御部153は、メモリやプロセッサ等を有し、コンピュータプログラムにしたがって種々の処理を行うものであってもよい。このようなコンピュータプログラムはコンソールが有する所定の記憶領域に予め記憶されたものであってもよいし、ネットワーク等を通じて外部からダウンロードされ所定の記憶領域に記憶されるものであってもよいし、あるいは、スロットに挿入された情報記憶媒体から読み取られるものであってもよい。
(Console control unit configuration)
The control unit 153 may include a memory, a processor, and the like, and may perform various processes according to a computer program. Such a computer program may be stored in advance in a predetermined storage area of the console, downloaded from the outside through a network or the like, and stored in the predetermined storage area, or The information may be read from an information storage medium inserted in the slot.
 制御部153は、一例として、図5に示すように、設定画面表示部153a、注入プロトコル作成部153b、注入制御部153c、履歴生成部153d、および履歴出力部153eを含んでいてもよい。 As an example, the control unit 153 may include a setting screen display unit 153a, an injection protocol creation unit 153b, an injection control unit 153c, a history generation unit 153d, and a history output unit 153e, as shown in FIG.
 設定画面表示部153aは、注入プロトコルを設定するための画面、具体的には、後述するような設定用初期画面360(図4A参照)を表示させる機能に相当するものであってもよい。設定画面表示部153aは、詳細は後述するが、表示ユニット151に、複数の注入プロトコル設定モードの中から1つを選択するためのモード選択用表示部363を少なくとも含む設定用初期画面360を表示させる機能に相当するものであってもよい。設定用初期画面360等に関するデータは、薬液注入装置、撮像装置、病院システムまたはその他のコンピュータの記憶装置内に格納されていてもよい。 The setting screen display unit 153a may correspond to a function for displaying a screen for setting an injection protocol, specifically, an initial setting screen 360 (see FIG. 4A) as described later. Although the details will be described later, the setting screen display unit 153a displays an initial setting screen 360 including at least a mode selection display unit 363 for selecting one of a plurality of injection protocol setting modes on the display unit 151. It may correspond to the function to be performed. Data relating to the setting initial screen 360 and the like may be stored in a storage device of a chemical liquid injector, an imaging device, a hospital system, or other computers.
 プロトコル作成部153bは、例えば、ユーザによる表示ユニット151のタッチパネル等への入力操作を受け付け、その内容が反映された注入プロトコルを作成する機能に相当するものであってもよい。このようにユーザによって入力される条件としては、例えば、薬液の種類、薬液の注入速度、薬液の注入量、患者の身体情報、撮像を行う患者の身体区分、および撮像部位などから選ばれる少なくとも1つであってもよい。 The protocol creation unit 153b may correspond to, for example, a function of accepting an input operation on the touch panel of the display unit 151 by the user and creating an injection protocol reflecting the contents. The conditions input by the user in this way are, for example, at least one selected from the type of the chemical solution, the injection rate of the chemical solution, the injection amount of the chemical solution, the patient's physical information, the body classification of the patient to be imaged, the imaging region, and the like. It may be one.
 具体的には、プロトコル作成部153bは、後述するように、
-所定の注入プロトコル設定モードが選択された後、縦軸および横軸の一方が注入速度で他方が注入時間であり少なくとも1つのフェーズを含む注入グラフ361への操作者からの注入パターンの入力を受け付ける注入パターン入力受付部と、
-注入グラフ361上に入力された注入パターンに基づいて薬液の注入プロトコルを作成する注入プロトコル生成部と、
-画面上にポップアップ画面371を表示させるポップアップ画面表示部と、
-プロトコルの変更を受け付けてその内容を反映させるプロトコル変更処理部、等を有するものであってもよい。
Specifically, the protocol creation unit 153b, as will be described later,
-After a predetermined injection protocol setting mode has been selected, one of the vertical axis and the horizontal axis is the injection rate and the other is the injection time, and the input of the injection pattern from the operator to the injection graph 361 including at least one phase. An injection pattern input receiving unit for receiving;
An injection protocol generation unit for creating a chemical liquid injection protocol based on an injection pattern input on the injection graph 361;
A pop-up screen display for displaying a pop-up screen 371 on the screen;
It may have a protocol change processing unit that accepts protocol changes and reflects the contents thereof.
 換言すれば、コンソールのコンピュータシステムは、
-所定の注入プロトコル設定モードの選択を受け付け、
-縦軸および横軸の一方が注入速度で他方が注入時間であり少なくとも1つのフェーズを含む注入グラフを表示させ、
-その注入グラフへと操作者からの注入パターンの入力を受け付け、
-注入グラフ上に入力された注入パターンに基づいて薬液の注入プロトコルを作成し、
-画面上にポップアップ画面(詳細下記)を表示させ、
-プロトコルの変更を受け付けてその内容を反映させる、
 ようにプログラミングされており、かつ、それに必要なグラフィカル・ユーザ・インターフェースのデータを有しているかまたは外部から取得するように構成されている。
In other words, the console computer system
-Accept selection of a predetermined injection protocol setting mode,
-Displaying an injection graph including at least one phase, one of the vertical and horizontal axes being the injection rate and the other being the injection time;
-Accepting the injection pattern input from the operator to the injection graph,
-Create a chemical injection protocol based on the injection pattern entered on the injection graph,
-Display a pop-up screen (details below) on the screen,
-Accept protocol changes and reflect their contents.
And have the graphical user interface data required for it or configured to obtain it externally.
 注入制御部153cは、作成された注入プロトコルにしたがってピストン駆動機構130の動作を制御する機能に相当するものであってもよい。注入制御部153bは、ピストン駆動機構130の一方のみを動作させること、および、両方を同時に動作させることを行うものであってもよい。 The injection control unit 153c may correspond to a function of controlling the operation of the piston drive mechanism 130 according to the created injection protocol. The injection control unit 153b may operate only one of the piston drive mechanisms 130 and operate both at the same time.
 履歴生成部153dは、注入履歴データを生成する機能に相当するものであってもよい。「注入履歴データ」としては、例えば、注入作業ごとに固有の識別情報である注入作業ID、注入開始および終了の日時、薬液注入装置の識別情報、前述の注入条件である薬液や撮像部位の識別情報などであってもよい。これらはテキストデータであってもよい。また、横軸と縦軸との一方が経過時間で他方が注入速度の経時グラフの画像データなどであってもよい。 The history generation unit 153d may correspond to a function for generating injection history data. The “injection history data” includes, for example, an injection operation ID that is unique identification information for each injection operation, injection start and end dates and times, identification information of the chemical injection device, and identification of the chemical solution and the imaging region that are the injection conditions described above. It may be information. These may be text data. Further, image data of a time-dependent graph in which one of the horizontal axis and the vertical axis is the elapsed time and the other is the injection rate may be used.
 履歴出力部153eは、注入履歴データを外部に送信する機能に相当するものであってもよい。具体的には、外部の所定の機器および/またはネットワークにデータを送信するものであってもよい。シリンジのICタグから取得した、または操作者によって手動で入力された、または外部ネットワーク等から入力された薬液の情報やシリンジの情報が、薬液注入装置から病院内の医療情報システムに送信され、例えば会計処理機能を備えるシステムが、その情報に基づいて会計処理を行うようなシステム構成も可能である。 The history output unit 153e may correspond to a function of transmitting injection history data to the outside. Specifically, data may be transmitted to a predetermined external device and / or network. Information on the liquid medicine obtained from the IC tag of the syringe or manually input by the operator or input from an external network or the like is transmitted from the liquid injector to the medical information system in the hospital. A system configuration in which a system having an accounting processing function performs accounting processing based on the information is also possible.
 記憶部154には、例えば、表示ユニット151に表示される画像のデータなどが記憶されていてもよい。また、注入条件を設定するための計算式などを含むアルゴリズムや、注入プロトコルのデータが記憶されていてもよい。注入速度は、一定であってもよいし、時間とともに変化するものであってもよい。造影剤と生理食塩水とを注入する場合、それらの薬液をどのような順序で注入するかといった情報も、注入プロトコルに含まれる。 The storage unit 154 may store, for example, image data displayed on the display unit 151. Further, an algorithm including a calculation formula for setting injection conditions, and data of injection protocol may be stored. The injection rate may be constant or may change with time. In the case of injecting contrast medium and physiological saline, information on the order of injecting these drug solutions is also included in the injection protocol.
 なお、このような注入プロトコルに関する情報は、インターフェース端子(不図示)を介して接続された外部機器から入力されてもよい。また、コンソール150がスロット(不図示)を有し、そこに差し込まれ情報部記憶媒体をから入力されてもよい。 Note that information regarding such an injection protocol may be input from an external device connected via an interface terminal (not shown). Further, the console 150 may have a slot (not shown), and the console 150 may be inserted into and input from the information storage medium.
〔A5.撮像装置〕
 撮像装置300は、例えばX線CTスキャナ、MRI装置、またはアンギオグラフィ装置、PET装置、超音波診断装置などであり、図3に示すように、患者の透視画像を撮像する撮像部303bと、患者を載せるベッド304と、それらの動作を制御する制御部303aとを有するものであってもよい。
[A5. Imaging device]
The imaging apparatus 300 is, for example, an X-ray CT scanner, an MRI apparatus, an angiography apparatus, a PET apparatus, an ultrasonic diagnostic apparatus, or the like. As shown in FIG. 3, an imaging unit 303b that captures a fluoroscopic image of a patient, And a bed 304 on which the robot is placed and a control unit 303a that controls the operation of the bed 304 may be provided.
 注入ヘッドおよびコンソール等の構成に関し、下記のような変更がなされてもよい:
(a1)注入ヘッド110とコンソール150とは、ケーブルで接続されてもよいが、前述のとおり、無線方式の通信ユニット等を介して接続されていてもよい。この場合、通信ユニットは、注入ヘッド110に外付けされてもよいし、内蔵されてもよい。同様に、通信ユニットは、コンソール150に外付けされてもよいし、内蔵されてもよい。
(a2)上記では2つのシリンジが装着される注入ヘッドを示したが、1つの注入ヘッドのみが装着される注入ヘッドとしてもよい。
(a3)薬液注入装置100は、CT検査用に限らず、MR検査用、アンギオグラフィ検査用、PET検査用、超音波診断用等のものであってもよい。
(a4)造影剤の注入パターンとしては、注入速度を直線的に低下させ以後は注入速度を一定に維持する可変パターン、および/または、注入速度を直線的に低下させ以後は再び注入速度を直線的に増加させる可変パターンを使用することもできる。さらに、それらの第2フェーズを省略したものを使用してもよい。
(a5)上記では、例えば図1に示すように、注入ヘッドとコンソールとが別体に構成された薬液注入装置を示した。しかしながら、下記のような薬液注入装置としてもよい:
-注入ヘッドとコンソールとが一体となったような薬液注入装置、換言すれば、1つの装置で、注入プロトコルの設定、薬液注入中の各種状態の表示、およびピストン駆動機構の動作制御等を行うことができるような薬液注入装置。
-注入ヘッドとコンソールとが1つの筐体として一体となったような上記薬液注入装置において、さらに、別体のバッテリーユニットを備える薬液注入装置。このようなバッテリーユニットはAC電源であってもよく、また、検査室の任意の個所に据え置かれてもよいし、可動式スタンドの一部に保持されるものでもよい。
-例えば有線または無線のリモートコントローラを用いて、検査室の外部から薬液注入装置の所定の動作をコントロール可能な薬液注入装置。この場合、無線の方式としては、赤外線を用いる方式であってもよいし、無線LAN、Wi-Fi(登録商標)、Bluetooth(登録商標)、ZigBee(登録商標)等を用いるものであってもよい。
-コントロールされる動作としては、例えば、装置の電源オン/電源オフ等をはじめとしてどのようなものであっても構わない。他の例としては、注入ヘッドの任意の動作の開始および/または停止がリモートコントローラでコントロールされてもよい。
-注入ヘッドとコンソールとが別体であるが、注入ヘッドにサブディスプレイが設けられた薬液注入装置。
-コンソールを小型化したようなコントロールユニット(例えば1つまたは複数のボタンおよび/またはディスプレイを有するようなものであってもよい)が、注入ヘッドの近傍に配置された薬液注入装置。例えばこのようなコントロールユニットは、注入ヘッドと一緒に可動式スタンド上に保持される。または、例えばこのようなコントロールユニットは、注入ヘッドと一緒に天井懸垂式のアームに保持される。または、注入ヘッドにと一体化される。
(a6)薬液注入装置は、注入ヘッドの制御部144が図2の各部153a、153b、153cの機能のうち少なくとも1つを有するものであってもよい。すなわち、本発明における、画面表示機能および注入プロトコル作成機能を担う「制御部」は、その配置位置はとくに限定されるものではなく、注入ヘッド内の制御部であってもよいし、コンソール内の制御部であってもよいし、またはそれらの組合せであってもよい。
(b1-1)注入プロトコルを設定するための設定画面(グラフィカル・ユーザ・インターフェース)がコンソールのディスプレイに表示される構成に加え、次のような構成も採用できる。
-注入ヘッドがサブディスプレイを有し、そこにプロトコルを設定するための上記のような設定画面(グラフィカル・ユーザ・インターフェース)が表示される。この場合、制御部153に相当するものを注入ヘッド110が内蔵していてもよい。換言すれば、本発明における「薬液注入装置」には、コンソール150の機能の少なくとも一部が注入ヘッド110に組み込まれたようなものも含まれる。
(b1-2)あるいは、撮像装置が有するディスプレイに、プロトコルを設定するための上記のような設定画面が表示されてもよい。すなわち、この場合、撮像装置が、グラフィカル・ユーザ・インターフェースを提供することとなり、操作者はこのインターフェース経由で条件の設定を行うことができる。そして、このようにして撮像装置側で設定された条件のデータが、薬液注入装置に対して有線または無線でデータ送信され、撮像装置側から設定が行われるようになっていることも好ましい。
(b1-3)上記のような構成を実現するためにシステム内の任意の機器(例えば、薬液注入装置、撮像装置、データベースサーバ、またはその他のコンピュータシステム)にプロトコルを設定するための上記のような設定画面(グラフィカル・ユーザ・インターフェース)のデータを保有することができる。
The following changes may be made to the configuration of the injection head, console, etc .:
(A1) The injection head 110 and the console 150 may be connected by a cable, but as described above, they may be connected via a wireless communication unit or the like. In this case, the communication unit may be externally attached to the injection head 110 or may be built therein. Similarly, the communication unit may be externally attached to the console 150 or may be built therein.
(A2) In the above description, an injection head to which two syringes are attached is shown, but an injection head to which only one injection head is attached may be used.
(A3) The chemical injection device 100 is not limited to the CT examination, but may be an apparatus for MR examination, angiography examination, PET examination, ultrasonic diagnosis, or the like.
(A4) As a contrast agent injection pattern, a variable pattern in which the injection speed is linearly reduced and thereafter the injection speed is kept constant, and / or the injection speed is linearly reduced and thereafter the injection speed is linearized again. It is also possible to use variable patterns that increase in number. Furthermore, you may use what abbreviate | omitted those 2nd phases.
(A5) In the above description, for example, as shown in FIG. 1, the chemical injection device in which the injection head and the console are configured separately is shown. However, a chemical injection device such as the following may be used:
-A chemical injection device in which the injection head and the console are integrated, in other words, a single device is used to set the injection protocol, display various states during chemical injection, and control the operation of the piston drive mechanism. Such as a chemical injection device.
-The above-mentioned chemical solution injection apparatus in which the injection head and the console are integrated as one casing, and further comprising a separate battery unit. Such a battery unit may be an AC power source, may be installed at any location in the examination room, or may be held in a part of a movable stand.
A chemical injection device capable of controlling a predetermined operation of the chemical injection device from the outside of the examination room using, for example, a wired or wireless remote controller. In this case, the wireless system may be a system using infrared rays, or a wireless LAN, Wi-Fi (registered trademark), Bluetooth (registered trademark), ZigBee (registered trademark), or the like. Good.
-The controlled operation may be any operation including, for example, power on / off of the apparatus. As another example, the start and / or stop of any operation of the injection head may be controlled with a remote controller.
A chemical injection device in which the injection head and the console are separate, but the injection head is provided with a sub-display.
A chemical injection device in which a control unit, such as a miniaturized console (e.g. having one or more buttons and / or a display), is arranged in the vicinity of the injection head. For example, such a control unit is held on a movable stand together with an injection head. Or, for example, such a control unit is held on a ceiling-suspended arm together with an injection head. Alternatively, it is integrated with the injection head.
(A6) In the chemical liquid injector, the controller 144 of the injection head may have at least one of the functions of the units 153a, 153b, and 153c in FIG. That is, in the present invention, the “control unit” responsible for the screen display function and the injection protocol creation function is not particularly limited, and may be a control unit in the injection head or in the console. It may be a control unit or a combination thereof.
(B1-1) In addition to the configuration in which the setting screen (graphical user interface) for setting the injection protocol is displayed on the console display, the following configuration can also be adopted.
-The injection head has a sub-display on which a setting screen (graphical user interface) as described above for setting the protocol is displayed. In this case, the injection head 110 may include a component corresponding to the control unit 153. In other words, the “chemical injection device” in the present invention includes a device in which at least a part of the function of the console 150 is incorporated in the injection head 110.
(B1-2) Alternatively, the setting screen as described above for setting the protocol may be displayed on the display of the imaging apparatus. That is, in this case, the imaging apparatus provides a graphical user interface, and the operator can set conditions via this interface. And it is also preferable that the data of the conditions set on the imaging device side in this way is transmitted to the chemical injection device by wire or wireless, and the setting is performed from the imaging device side.
(B1-3) As described above for setting a protocol in any device (for example, a chemical injection device, an imaging device, a database server, or other computer system) in the system in order to realize the configuration as described above Data for various setting screens (graphical user interface).
〔A6.注入動作の一例〕
 本実施形態の薬液注入装置は、一例として次のように動作するものであってもよい:
[A6. Example of injection operation)
The chemical injection device of this embodiment may operate as follows as an example:
 まず、薬液注入装置100の電源がオンの状態で、ユーザは、注入ヘッド110にシリンジ200P、200Cを装着する。シリンジ200P、200Cの装着後、ユーザは、一例で、延長チューブ230を介してシリンジ200P、200Cに延長チューブを接続し、延長チューブの先端に設けられている注入針(不図示)を患者に穿刺する。 First, the user installs the syringes 200 </ b> P and 200 </ b> C on the injection head 110 with the power supply of the chemical injection device 100 turned on. After mounting the syringes 200P and 200C, for example, the user connects the extension tube to the syringes 200P and 200C via the extension tube 230, and punctures the patient with an injection needle (not shown) provided at the distal end of the extension tube. To do.
 その後、一例として、ユーザがコンソール150の所定のボタンを操作すると、表示ユニット151に注入プロトコル設定用の1つまたは複数の画面が表示される。この画面では、次のようなパラメータの少なくとも1つが入力、選択、または変更されるようになっていてもよい:
-撮像の対象である身体区分
-撮像の対象である部位(撮像部位という)
-患者の体重などの情報
-注入する薬液の種類、等
 これらのパラメータを選択するための画像は順次あるいは一括して表示されてもよい。上記のようなパラメータの入力、選択、または変更は、装置の機能によって自動的になされるものであってもよいし、ユーザの操作によりなされるものであってもよい。
Thereafter, as an example, when the user operates a predetermined button of the console 150, one or a plurality of screens for setting the injection protocol are displayed on the display unit 151. In this screen, at least one of the following parameters may be entered, selected or changed:
-Body segment to be imaged-Region to be imaged (referred to as imaging region)
-Information such as patient weight-Type of medicinal solution to be injected, etc. Images for selecting these parameters may be displayed sequentially or collectively. The input, selection, or change of the parameters as described above may be automatically performed according to the function of the apparatus or may be performed by a user operation.
 パラメータの入力が完了したら、ユーザは画面上の所定のボタン(例えば確認ボタン)を押す。注入プロトコルを作成する場合には、画面に表示された注入プロトコル作成用の画像に従い、例えば、(i)予め用意された幾つかの基本パターンのうち1つを選択し、その内容を確認もしくは必要に応じて変更する、(ii)画面上に表示された注入グラフ内に幾つかの基準点をプロットしていくことにより任意の注入プロトコルを作成する、等の方式によって行うことができる。 When the parameter input is completed, the user presses a predetermined button (for example, a confirmation button) on the screen. When creating an injection protocol, for example, (i) select one of several basic patterns prepared in advance according to the image for creating the injection protocol displayed on the screen, and confirm or need its contents. (Ii) by creating a desired injection protocol by plotting several reference points in the injection graph displayed on the screen.
 なお、(ii)の方式については、他の図面を参照して後述するものとする。注入グラフ上に基準点をプロットしていくための操作としては、グラフ内の任意の位置(または、グラフ内の任意の格子点)に直接タッチして基準点を作成していく方式や、あるいは、所定のポップアップ画面の操作を経て基準点を作成していく方式等を採用しうる。 Note that the method (ii) will be described later with reference to other drawings. To plot the reference point on the injection graph, you can create a reference point by directly touching any position (or any grid point in the graph) in the graph, or A method of creating a reference point through an operation on a predetermined pop-up screen can be adopted.
 薬物動態解析を用いた造影剤の濃度変化推測方法を使って造影剤の濃度の予測を行いつつ、薬液の注入パターンを作成することも可能である。薬物動態解析を行うためには、患者および造影剤の注入条件(例えば、身長、体重、性別、心拍出量、造影剤濃度、注入速度、注入量等の少なくとも一部)を変化させたときの大動脈(右心、左心、動脈、肺循環、全身循環などであってもよい)の時間造影曲線の変化を推測することができるシミュレーションソフトウェア等を利用して実施可能である。また、1mgI/mlのCT値(HU)も設定してもよい。変化させる注入条件としては、体重当りのヨード量や時間当り体重当りのヨード量などであってもよい。
-上記シミュレーションソフトウェアにおける諸条件をPACS、HIS、RIS、撮像装置、ワークステーション等と双方向にデータ通信して入力、出力するようにしてもよい。
-撮像装置が複雑な注入プロトコルを取得したり、撮像装置が注入プロトコルを設定したり、CT値を見ながら速度および/または量を変更してもよい。
It is also possible to create an injection pattern of a drug solution while predicting the concentration of the contrast agent using a method for estimating the concentration change of the contrast agent using pharmacokinetic analysis. To perform pharmacokinetic analysis, when the patient and contrast medium injection conditions (for example, height, weight, sex, cardiac output, contrast medium concentration, injection speed, injection volume, etc.) are changed This can be implemented using simulation software or the like that can estimate changes in the temporal contrast curve of the aorta (which may be the right heart, left heart, artery, pulmonary circulation, systemic circulation, etc.). A CT value (HU) of 1 mgI / ml may also be set. The injection condition to be changed may be the amount of iodine per body weight, the amount of iodine per body weight per time, or the like.
The various conditions in the simulation software may be input / output through two-way data communication with PACS, HIS, RIS, imaging device, workstation, etc.
The imaging device may acquire a complex injection protocol, the imaging device may set the injection protocol, or change the speed and / or amount while viewing the CT value.
 機器どうしの接続やネットワークへの接続、情報送信などに関し、次のような規格のいずれかまたは複数を利用してもよい:
-CANopen規格、
-医療情報交換の標準規格であるHL7規格、
-DICOM(Digital Imaging and Communication in Medicine)規格、等。
Any one or more of the following standards may be used for connecting devices, connecting to networks, sending information, etc .:
-CANopen standards,
-HL7 standard, which is the standard for medical information exchange
-DICOM (Digital Imaging and Communication in Medicine) standard, etc.
 注入プロトコルが作成されたら、ユーザにより所定の注入開始操作がなされた後、その注入プロトコルに基づいてピストン駆動機構130が動作制御され、患者への薬液注入が行われる。 When the injection protocol is created, after a predetermined injection start operation is performed by the user, the operation of the piston drive mechanism 130 is controlled based on the injection protocol, and the drug solution is injected into the patient.
〔B1:注入プロトコルの設定〕
 次に、本実施形態の薬液注入装置100での注入プロトコルの設定の一例について、図3および図4A~図4Hを参照しながら説明する。図3は、注入プロトコルの設定手順等の一例を示すフローチャートである。図4A~図4Hは、コンソール150の表示ユニット151に表示される画面の一例である。
[B1: Setting of injection protocol]
Next, an example of setting the injection protocol in the chemical solution injection device 100 of the present embodiment will be described with reference to FIG. 3 and FIGS. 4A to 4H. FIG. 3 is a flowchart showing an example of an injection protocol setting procedure and the like. 4A to 4H are examples of screens displayed on the display unit 151 of the console 150. FIG.
 まず、例えば、操作者がコンソール150に対して所定の入力操作を行うことにより、図4Aに示すような画面360が表示ユニット151に表示される(ステップS1)。この画面360は、基本的には、複数の注入プロトコル設定モードの中から1つを選択するためのものであり以下の説明では設定用初期画面360ともいう。このステップでは、コンソールが不図示の記憶装置から設定用初期画面360のデータを読み出し、その画像をディスプレイに表示させる。 First, for example, when the operator performs a predetermined input operation on the console 150, a screen 360 as shown in FIG. 4A is displayed on the display unit 151 (step S1). This screen 360 is basically for selecting one of a plurality of injection protocol setting modes, and is also referred to as a setting initial screen 360 in the following description. In this step, the console reads the data of the initial setting screen 360 from a storage device (not shown) and displays the image on the display.
 なお、図4Aの画面では既に注入グラフ361(詳細下記)が表示されているが、この注入グラフ361は例えばモード選択用アイコン363(詳細下記)を選択した後に出現するようになっていてもよい。 In addition, although the injection graph 361 (detailed below) is already displayed on the screen of FIG. 4A, this injection graph 361 may appear after selecting the mode selection icon 363 (detailed below), for example. .
 ここで、図4Aの設定用初期画面360の各表示について説明する。この画面では、プロトコル作成用の注入グラフ361が表示されている。注入グラフ361は、横軸が経過時間で縦軸が注入速度である。この例では、縦軸に関しては、速度が5.0ml/secまで表示されており(一例で、1.0ml/secごと)、また、横軸に関しては、5つのフェーズが含まれるような態様が示されている。 Here, each display of the setting initial screen 360 of FIG. 4A will be described. On this screen, an injection graph 361 for creating a protocol is displayed. In the injection graph 361, the horizontal axis represents elapsed time and the vertical axis represents injection speed. In this example, the vertical axis displays the speed up to 5.0 ml / sec (in the example, every 1.0 ml / sec), and the horizontal axis includes five phases. It is shown.
 なお、当然ながら、表示されるフェーズ数は5つに限らず、1つ、2つ、3つ、4つ、または、6つ以上であってもよい。縦軸の速度に関する目盛りおよび横軸のフェーズの表示態様は適宜変更しても構わない。なお、この例では、縦軸が速度で横軸が時間であるが、縦軸が時間で横軸が速度のような表示としてもよい。 Of course, the number of phases to be displayed is not limited to five, and may be one, two, three, four, or six or more. The scale concerning the speed on the vertical axis and the display mode of the phase on the horizontal axis may be appropriately changed. In this example, the vertical axis is speed and the horizontal axis is time, but the vertical axis may be time and the horizontal axis may be speed.
 図4Aの画面において、注入グラフ361の上方(一例)に、種々のアイコン361a、361b、362a、362b、363~366が表示されている。なお、画面に表示される全てまたは一部のアイコンは、それぞれの表示箇所をタッチペンあるいは操作者の指等でタッチすることで、または、画面上のカーソル等で、選択可能である。 In the screen of FIG. 4A, various icons 361a, 361b, 362a, 362b, and 363 to 366 are displayed above the injection graph 361 (an example). All or some of the icons displayed on the screen can be selected by touching each display location with a touch pen or an operator's finger or the like, or with a cursor on the screen.
 図面に例示されたアイコンまたはその他の表示要素は全てが必須ではなく、適宜省略可能である。 * All icons and other display elements illustrated in the drawings are not essential and may be omitted as appropriate.
 アイコン361a、361bは、それぞれ造影剤、生理食塩水を示しており、一例で、造影剤が「A」で表され、生理食塩水が「B」で表されている。アイコン361a(造影剤)を選択している状態では、注入グラフ361内で、造影剤の注入パターンを作成可能となる。アイコン361b(生理食塩水)を選択している状態では、注入グラフ361内で、生理食塩水の注入パターンを作成可能となる。言い換えれば、これらのアイコン361a、361bは、造影剤と生理食塩水のうちいずれについての作業を行うかを選択するためのものである。 Icons 361a and 361b respectively indicate a contrast medium and physiological saline. In one example, the contrast medium is represented by “A”, and the physiological saline is represented by “B”. When the icon 361a (contrast agent) is selected, a contrast agent injection pattern can be created in the injection graph 361. When the icon 361b (saline) is selected, a saline injection pattern can be created in the injection graph 361. In other words, these icons 361a and 361b are for selecting which of the contrast medium and the physiological saline is to be performed.
 アイコン362a、362bは、所定の注入プロトコルの基本パターンを表示するためのものである。このような、注入プロトコルの基本パターンを表示するためのアイコンの数は、選択可能な注入プロトコルの数に合わせて適宜変更可能であり、3つ以上のこの種のアイコンが表示されるようになっていてもよい。また、このアイコンに、どのような注入プロトコルであるかを視覚的に容易に認識できるようにするための画像(例えば当該プロトコルの形状を簡略化したような画像)を表示するようにしてもよい。また、1つのアイコンをタッチすることで、2つまたは3つ以上の注入プロトコルの候補が順次表示されるようになっていてもよい。 Icons 362a and 362b are for displaying a basic pattern of a predetermined injection protocol. The number of icons for displaying the basic pattern of the injection protocol can be appropriately changed according to the number of selectable injection protocols, and three or more such icons can be displayed. It may be. In addition, an image (for example, an image obtained by simplifying the shape of the protocol) may be displayed on the icon so that the injection protocol can be easily recognized visually. . Further, by touching one icon, two or three or more injection protocol candidates may be sequentially displayed.
 なお、注入プロトコルの基本パターンを表示させるための操作としては、上記のようなアイコンをタッチするのではなく、例えば所定の文字情報を入力したり、マウス等を操作してカーソルで所定の対象画像を選択したりするものであってもよい。 As an operation for displaying the basic pattern of the injection protocol, instead of touching the icon as described above, for example, predetermined character information is input or a predetermined target image is operated with a cursor by operating a mouse or the like. Or may be selected.
 モード選択用アイコン363は、基本的には、操作者が手動で任意の注入パターン(注入プロファイル)を作成するためのものである。その場合の、注入プロトコル設定モードを選択するためのものがこのアイコン363である。注入プロトコルの設定モードとしては、(i)フローレートモード、(ii)標準・体重入力モード、(iii)心臓・体重入力モードなどが挙げられる。それぞれの詳細については後述するものとする。モード選択用アイコン363を押すと、これらのうちの少なくとも2つ、好ましくは3つが順次切り換わるようになっていてもよい。 The mode selection icon 363 is basically for an operator to manually create an arbitrary injection pattern (injection profile). In this case, this icon 363 is used to select the injection protocol setting mode. Examples of setting modes for the injection protocol include (i) flow rate mode, (ii) standard / weight input mode, (iii) heart / weight input mode, and the like. Details of each will be described later. When the mode selection icon 363 is pressed, at least two, preferably three of them may be switched sequentially.
 アイコン364は、患者の体重を表示しており、ここでは一例として「60」Kgとなっている。限定されるものではないが、アイコン364を押すと所定のポップアップ画面(不図示)またはプルダウン画面(不図示)が表示され、その画面内のテンキーもしくは増減用ボタンを押すことで、体重を変更できるようになっていてもよい。 The icon 364 displays the weight of the patient, and is “60” Kg as an example here. Although not limited, when the icon 364 is pressed, a predetermined pop-up screen (not shown) or pull-down screen (not shown) is displayed, and the weight can be changed by pressing the numeric keypad or the increase / decrease button in the screen. It may be like this.
 アイコン365は、患者の体重当りのヨード量を表示しており、ここでは一例として「450」mgI/Kgとなっている。この450mgI/Kgという数値は、標準・体重入力モードにおけるヨード量の一例である。心臓・体重入力モードの場合には例えば24.5mgI/Kg/sec等の表示がされてもよい。 The icon 365 displays the amount of iodine per patient's body weight, and here is “450” mgI / Kg as an example. The numerical value of 450 mg I / Kg is an example of the amount of iodine in the standard / weight input mode. In the case of the heart / weight input mode, for example, 24.5 mg I / Kg / sec may be displayed.
 限定されるものではないが、上記同様、アイコン365を押すと所定のポップアップ画面(不図示)またはプルダウン画面(不図示)が表示され、その画面内のテンキーもしくは増減用ボタンを押すことで、この数値を変更できるようになっていてもよい。 Although not limited thereto, when the icon 365 is pressed, a predetermined pop-up screen (not shown) or pull-down screen (not shown) is displayed as described above. By pressing a numeric keypad or an increase / decrease button in the screen, this is displayed. The numerical value may be changeable.
 アイコン366は、圧力リミット値を表示するものであってもよく、一例として「10.0」Kg/cmなどと表示されていてもよい。限定されるものではないが、上記同様、アイコン365を押すと所定のポップアップ画面(不図示)またはプルダウン画面(不図示)が表示され、その画面内のテンキーもしくは増減用ボタンを押すことで、この数値を変更できるようになっていてもよい。 The icon 366 may display a pressure limit value, and may be displayed as “10.0” Kg / cm 2 or the like as an example. Although not limited thereto, when the icon 365 is pressed, a predetermined pop-up screen (not shown) or pull-down screen (not shown) is displayed as described above. By pressing a numeric keypad or an increase / decrease button in the screen, this is displayed. The numerical value may be changeable.
 画面には、上記アイコンの他にも、被験者のID、体重以外の等の患者情報や、撮像部位といった情報を表示させることもできる。また、所定の削除ボタンが表示され、この削除ボタンを押すことでグラフ361に表示されている注入プロトコルの一部または全部を削除できるようになっていてもよい。 In addition to the above icons, the screen can also display information such as patient information other than the subject's ID and weight, and information such as the imaging site. Further, a predetermined delete button may be displayed, and a part or all of the injection protocol displayed in the graph 361 may be deleted by pressing this delete button.
 再び図3のフローチャートを参照する。ステップS2-1、S2-2においては、それぞれ、患者の体重入力およびヨード量の入力が行われる。ステップS2-1とステップS2-2の順序はいずれが先であってもよいし、または、同時であってもよい。さらに、図3のフローチャートでは設定用初期画面360が表示された後にこのような入力が行われているが、当然ながら、設定用初期画面360が表示される前にこのような入力が行われてもよい。あるいは、ステップS2-1およびステップS2-2のうちの一方がステップS1よりも前に行われ、他方がステップS1よりも後に行われてもよい。 Refer again to the flowchart of FIG. In steps S2-1 and S2-2, the patient's weight and iodine amount are input, respectively. Any of the order of step S2-1 and step S2-2 may be first or may be simultaneous. Further, in the flowchart of FIG. 3, such an input is performed after the initial setting screen 360 is displayed. Of course, such an input is performed before the initial setting screen 360 is displayed. Also good. Alternatively, one of step S2-1 and step S2-2 may be performed before step S1, and the other may be performed after step S1.
 患者の体重入力やヨード量の入力の他にも、身体区分および/または撮像部位の入力等が行われてもよいが、これについては後述するものとする。 In addition to patient weight input and iodine amount input, body classification and / or imaging region input may be performed, which will be described later.
 患者体重(例えば60Kg)の入力は、例えば、従来より実施されている方式などで行うことができる。一例では、操作者が表示ユニット151(ここでは入力装置も兼ねるタッチパネル)を通じて所定の入力(下記参照)することで体重の入力が行われてもよい:
-テンキー入力、
-画面に2つ、3つ、またはそれ以上の体重区分のアイコンが表示され、操作者がその内の1つを選択する、
-予め設定されたデフォルト値またはデフォルトの体重区分が表示され、必要に応じて、操作者が値または区分の変更を行う、等。
The input of the patient weight (for example, 60 kg) can be performed by, for example, a conventionally implemented method. In one example, the operator may input the weight through a predetermined input (see below) through the display unit 151 (here, a touch panel that also serves as an input device):
-Numeric keypad input,
-Two, three or more weight category icons are displayed on the screen, and the operator selects one of them,
-A preset default value or default weight category is displayed, and the operator changes the value or category as necessary, etc.
 なお、外部のネットワーク経由でコンソール150に自動的に患者の体重データが入力されてもよい。具体的は、LAN(Local Area Network)やインターネット等を介して接続されたデータベースサーバ(例えば病院情報システム、HIS、Hospital Information System)から、少なくとも体重のデータを含む患者情報を入手するようにしてもよい。この場合、薬液注入装置は、一例で、図12のような、PACS(Picture Archiving and Communication Systems)、HIS(Hospital Information System)、RIS(Radiology Information System)、ワークステーション、画像読影装置、プリンタなどのうち一部または全部が接続されたネットワークに有線または無線で接続されるものであってもよい。 Note that patient weight data may be automatically input to the console 150 via an external network. Specifically, patient information including at least body weight data may be obtained from a database server (for example, hospital information system, HIS, Hospital Information System) connected via a LAN (Local Area Network) or the Internet. Good. In this case, the chemical injection device is an example, as shown in FIG. 12, such as PACS (Picture Archiving and Communication Systems), HIS (Hospital Information System), RIS (Radiologic Information System, image printer, workstation image, etc.). It may be wired or wirelessly connected to a network to which some or all of them are connected.
 また、薬液注入装置に電子体重計(図示せず)をオンライン接続しておき、その電子体重計で患者の体重を計測して、その結果を薬液注入装置にデータ入力することも可能である。また、撮像装置には寝台(ベッド)が存在するので、例えば、その寝台で被験者の体重を測定して薬液注入装置にデータ提供することも可能である。 It is also possible to connect an electronic weight scale (not shown) to the chemical injection device online, measure the patient's weight with the electronic weight scale, and input the result to the chemical injection device. In addition, since there is a bed (bed) in the imaging apparatus, for example, it is possible to measure the weight of the subject on the bed and provide data to the drug solution injector.
 ヨード量の入力としては、造影剤のヨード含有量(具体的な一例として、例えば300mg/ml)および体重当りに必要なヨード量(具体的な一例として、例えば450mgI/Kg)が挙げられる。造影剤のヨード含有量についても、操作者がコンソール150の表示ユニット151(例えばタッチパネル)を通じて所定の入力をすることで入力されてもよいし、または、シリンジのICタグから自動的に読み取られて入力されてもよい。体重当りに必要なヨード量に関しても、操作者が表示ユニット151(例えばタッチパネル)を通じてテンキー入力等をすることで入力されてもよい。あるいは、身体区分の選択や撮像部位の選択が行われる場合には、選択された身体区分ないし撮像部位に応じて予め設定された値が自動的に設定されるようになっていてもよい。 Examples of the input of the iodine amount include the iodine content (for example, 300 mg / ml) of the contrast agent and the iodine amount required per body weight (for example, 450 mg I / Kg). The iodine content of the contrast agent may also be input by the operator making a predetermined input through the display unit 151 (for example, a touch panel) of the console 150, or may be automatically read from the IC tag of the syringe. It may be entered. The amount of iodine required per body weight may also be input by the operator performing numeric keypad input or the like through the display unit 151 (for example, a touch panel). Alternatively, when a body segment or an imaging region is selected, a value set in advance according to the selected body segment or imaging region may be automatically set.
 なお、図4Aの画面では、画面上部(一例)に「300」と表示されたアイコン373aが現れているが、これは、造影剤のヨード含有量が300mg/mlであることを示している。限定されるものではないが、このアイコン373を押すと、他のヨード含有量の候補(例えば240、330、350、370等)が例えばプルダウンメニューとして現れ、その1つを選択することでヨード含有量を変更できるように構成されていてもよい。 In the screen of FIG. 4A, an icon 373a displayed as “300” appears in the upper part of the screen (an example), which indicates that the iodine content of the contrast medium is 300 mg / ml. Although not limited, when this icon 373 is pressed, other iodine content candidates (for example, 240, 330, 350, 370, etc.) appear as, for example, a pull-down menu. You may be comprised so that quantity can be changed.
「タイミング」と表示されたアイコンに関し、このアイコンを押すと造影剤または造影剤から生食で薬液の到達時間を事前確認するために少量注入するような構成であってもよい。その際、プロット本注入に必要な残量に影響がないか残量を確認してもよい。
「ルートボタン」と表示されたアイコンに関し、このアイコンを押すと生食または造影剤で血管確保がきちんとされているか確認するために少量注入するような構成であってもよい。その際、プロット本注入に必要な残量に影響がないか残量を確認してもよい。
With respect to the icon displayed as “timing”, a configuration may be adopted in which when this icon is pressed, a small amount is injected in order to confirm in advance the arrival time of the drug solution from the contrast medium or the contrast medium by saline. At that time, the remaining amount may be checked to determine whether the remaining amount necessary for the main plot injection is affected.
Regarding the icon displayed as “root button”, when this icon is pressed, a configuration may be used in which a small amount is injected in order to confirm whether the blood vessel is properly secured with a raw diet or a contrast medium. At that time, the remaining amount may be checked to determine whether the remaining amount necessary for the main plot injection is affected.
 患者の体重入力およびヨード量の入力が完了したら、次いで、ステップS3において、その患者に注入すべき造影剤の注入量(ml)および初速度(ml/sec)の一方または両方を計算する。この計算は、一例で、コンピュータプログラムの命令に基づきコンソール150の制御部153が行う。他の例としては、撮像装置側のコンピュータシステムや、または、その他のコンピュータシステムによって計算が行われてもよい。つまり、本発明の一態様では、注入プロトコルを設定するための所定の計算や所定の設定画面の表示されるものであれば、それによる作用効果が奏される。したがって、そのような観点で言えば、どのコンピュータシステムが計算を行うか、あるいは、どのディスプレイモニタに画面を表示させるかといったことは任意に変更してもよい。 When the input of the patient's weight and iodine amount is completed, in step S3, one or both of the injection amount (ml) and the initial velocity (ml / sec) of the contrast medium to be injected into the patient are calculated. This calculation is an example, and is performed by the control unit 153 of the console 150 based on a command of the computer program. As another example, the calculation may be performed by a computer system on the imaging apparatus side or another computer system. In other words, according to one aspect of the present invention, if a predetermined calculation for setting an injection protocol or a predetermined setting screen is displayed, the operation effect thereof is exhibited. Therefore, from such a viewpoint, which computer system performs the calculation or which display monitor displays the screen may be arbitrarily changed.
 ここで、造影剤の注入量(ml)および初速度(ml/sec)の計算と、それぞれのプロトコル設定モードについて説明する。 Here, calculation of the injection amount (ml) and initial velocity (ml / sec) of the contrast agent and respective protocol setting modes will be described.
(I.標準・体重入力モード)
「標準・体重入力モード」とは、体重とヨード量に基づいて、注入すべき造影剤の注入量を予め算出しておく方式であって、操作者が注入グラフ上の1つまたは複数のフェーズに注入パターンを入力することで全体として1つの注入パターンを作成する設定方式である。この場合、注入量の計算には次の式を用いることができる:
  V=I/ICM×W
      V:注入量(ml)
      I:単位時間当りに必要とされるヨード量(mgI/Kg)
      ICM:造影剤のヨード含有量(mgI/ml)
      W:体重(Kg)
(I. Standard / weight input mode)
The “standard / weight input mode” is a method in which the injection amount of the contrast medium to be injected is calculated in advance based on the body weight and the iodine amount, and the operator can select one or more phases on the injection graph. This is a setting method in which one injection pattern is created as a whole by inputting an injection pattern. In this case, the following formula can be used to calculate the dose:
V = I H / I CM × W
V: Injection volume (ml)
I H : Amount of iodine required per unit time (mgI / Kg)
I CM : Iodine content of contrast agent (mgI / ml)
W: Weight (Kg)
(II.心臓・体重入力モード)
「心臓・体重入力モード」とは、心臓造影等の場合に使用されるモードであって、操作者が注入グラフ上の1つまたは複数のフェーズに注入パターンを入力することで全体として1つの注入パターンを作成する設定方式である。この場合、初速度の計算には次の式を用いることができる:
  f=I/ICM×W
      V:注入量(ml)
      I:毎秒単位時間当りに必要とされるヨード量
      (mgI/Kg/sec)
      ICM:造影剤のヨード含有量(mgI/ml)
      W:体重(Kg)
(II. Heart / weight input mode)
The “heart / weight input mode” is a mode used in the case of cardiography or the like, and the operator inputs an injection pattern in one or a plurality of phases on the injection graph as a whole. This is a setting method for creating a pattern. In this case, the following equation can be used to calculate the initial velocity:
f 1 = I A / I CM × W
V: Injection volume (ml)
I A: iodine amount required per second unit time (mgI / Kg / sec)
I CM : Iodine content of contrast agent (mgI / ml)
W: Weight (Kg)
「毎秒単位時間当りに必要とされるヨード量」も、上述した「体重当りに必要なヨード量」と同様、例えば操作者が表示ユニット151(例えばタッチパネル)を通じてテンキー入力をすることで入力されてもよい。あるいは、シリンジのICタグから自動的に読み込まれるものであってもよい。身体区分の選択や撮像部位の選択が行われる場合には、選択された区分ないし部位に応じた予め設定された値が自動的に設定されるようになっていてもよい。 The “iodine amount required per unit time per second” is also input, for example, by an operator inputting a numeric keypad through the display unit 151 (for example, a touch panel), in the same manner as the “iodine amount required per unit weight” described above. Also good. Alternatively, it may be automatically read from the IC tag of the syringe. When selecting a body segment or an imaging region, a preset value corresponding to the selected segment or region may be automatically set.
(III.フローレートモード)
「フローレートモード」とは、造影剤の注入量や初速度を決めずに、操作者が注入グラフ上の1つまたは複数のフェーズに注入パターンを入力していくことで全体として1つの注入パターンを作成するモードである。
(III. Flow rate mode)
In the “flow rate mode”, the operator inputs an injection pattern in one or a plurality of phases on the injection graph without deciding the injection amount or initial speed of the contrast medium, so that one injection pattern as a whole. It is a mode to create.
 再び図3のフローチャートを参照する。ステップS4では、操作者は設定モード選択アイコン363を押して注入プロトコルの設定モードを選択する。 Refer again to the flowchart of FIG. In step S4, the operator presses the setting mode selection icon 363 to select the setting mode of the injection protocol.
 以下、注入プロトコル作成の一例について説明する(ステップS5)。 Hereinafter, an example of creating an injection protocol will be described (step S5).
(B2-1:標準・体重入力モード)
 「標準・体重入力モード」を選択するために、操作者は画面上のモード選択用アイコン363を操作する。標準・体重入力モードが選択された状態では、上述のような計算式に基づいて少なくとも患者に注入すべき造影剤の注入量V(具体的な一例として、90ml、100ml、150ml等)が計算されている。
(B2-1: Standard / weight input mode)
In order to select the “standard / weight input mode”, the operator operates the mode selection icon 363 on the screen. When the standard / weight input mode is selected, at least the injection amount V of the contrast medium to be injected into the patient (as a specific example, 90 ml, 100 ml, 150 ml, etc.) is calculated based on the above formula. ing.
 この時点では、薬液の注入速度は決定されていないので、基本的には、注入グラフ361上に注入パターンは現れない。そこで、操作者は注入グラフ361上に各フェーズ(フェーズが1つの場合には単一のフェーズ)の注入パターンを作成していく。具体的には、図4Bに示すように、操作者が注入グラフ361内の第1フェーズのエリア374にタッチすると、ポップアップ画面371が現れる。なお、エリア374にタッチするのではなく、例えば、画面上の所定のアイコン(不図示)を選択することにより、ポップ画面371が現れるようになっていてもよい。 At this time, since the injection speed of the chemical solution has not been determined, basically, no injection pattern appears on the injection graph 361. Therefore, the operator creates an injection pattern for each phase (a single phase when there is one phase) on the injection graph 361. Specifically, as shown in FIG. 4B, when the operator touches the first phase area 374 in the injection graph 361, a pop-up screen 371 appears. Instead of touching the area 374, for example, a pop screen 371 may appear by selecting a predetermined icon (not shown) on the screen.
 ポップアップ画面371内には、可変定数の表示部371aおよび注入時間の表示部371b等が表示されている。また、フラッシュボタン372a、希釈ボタン372b、終速固定パターンボタン372cなどが表示されている。また、入力内容を確定するOKボタンと、入力内容を破棄するキャンセルボタンも表示されている。 In the pop-up screen 371, a variable constant display unit 371a, an injection time display unit 371b, and the like are displayed. Further, a flash button 372a, a dilution button 372b, a final speed fixed pattern button 372c, and the like are displayed. An OK button for confirming the input content and a cancel button for discarding the input content are also displayed.
 可変定数の表示部371aは、この例では、可変定数の数値を示す文字表示部と、その値を増減させるための調整ボタンとを含んでいる。調整ボタンは、一例で、可変定数の数値を増やすための画像ボタン(upボタン)と、可変定数の数値を減らすための画像ボタン(downボタン)とを有するものであってもよい。 In this example, the variable constant display unit 371a includes a character display unit that indicates a numerical value of the variable constant and an adjustment button for increasing or decreasing the value. For example, the adjustment button may include an image button (up button) for increasing the numerical value of the variable constant and an image button (down button) for decreasing the numerical value of the variable constant.
 「可変定数」とは、造影剤の注入パターンの傾きに係わるパラメータであって、そのフェーズにおける終速度と初速度の比のことをいう。可変定数Cは、C=f/fで表わされる(ここで、fは終速度で、fは初速度)。 The “variable constant” is a parameter related to the gradient of the contrast agent injection pattern, and refers to the ratio between the final velocity and the initial velocity in the phase. The variable constant C is represented by C = f 2 / f 1 (where f 2 is the final speed and f 1 is the initial speed).
 注入時間を示す表示部371bは、この例では、そのフェーズの注入時間の数値を示す文字表示部と、その値を増減させるための調整ボタンとを含んでいる。調整ボタンについては、可変定数の表示部371aのものと同様の構成であってもよい。調整ボタンを操作することで、現在の注入時間(一例で「10」sec)を、例えば「20」secあるいは「5」secのように変更することができる。 In this example, the display unit 371b indicating the injection time includes a character display unit indicating a numerical value of the injection time of the phase and an adjustment button for increasing or decreasing the value. The adjustment button may have the same configuration as that of the variable constant display unit 371a. By operating the adjustment button, the current injection time (“10” sec in one example) can be changed to, for example, “20” sec or “5” sec.
 フラッシュボタン372aは、当該フェーズの次のフェーズに生理食塩水の一定速度注入を作成するためのボタンである。この場合の生理食塩水の注入速度は、一例で、当該フェーズの造影剤の初速度であってもよい。また、図4D(詳細下記)のような造影剤と生理食塩水の同時注入の場合には、造影剤の注入速度と生理食塩水の注入速度との和と同一の速度であってもよい。さらに、フラッシュ注入の効果が得られる注入速度である限り、たとえば上記のような基準速度(造影剤の初速度や、2つの薬液の合計速度)に対して±20%、好ましくは±10%の範囲内の速度であってもよい。 The flush button 372a is a button for creating a constant rate injection of physiological saline in the next phase of the phase. In this case, the physiological saline injection speed may be an initial speed of the contrast medium in the phase. In the case of simultaneous injection of the contrast medium and physiological saline as shown in FIG. 4D (details below), the same speed as the sum of the contrast medium injection speed and the physiological saline injection speed may be used. Furthermore, as long as the injection speed at which the effect of flash injection can be obtained, for example, ± 20%, preferably ± 10% of the reference speed (the initial speed of the contrast medium or the total speed of the two drug solutions) as described above. The speed may be within a range.
 希釈ボタン372bは、当該フェーズにおいて造影剤と同時注入される生理食塩水の注入パターンを作成するためのボタンである。希釈ボタン372bを押すと、次のような注入パターンが作成されるようになっていてもよい:
(i)造影剤の注入速度が一定の場合、一定速度の生理食塩水の注入パターンが表示される、
(ii)造影剤の注入速度が減少するパターン、具体的には一例で図4Dに例示するような、注入速度が時間とともに減少するパターンのであって終速度がゼロおよび実質的にゼロではないパターンの場合、造影剤の注入パターンとクロスするような、具体的には、造影剤の注入速度と生理食塩水の注入速度との和がそのフェーズにおいて一定または実質的に一定となるように、所定の基準線(一例で注入パターンの線分の略中心を通過する垂直または水平の基準線)を基準として造影剤の注入パターンと線対称形となる生理食塩水の注入パターンが表示される、
(iii)造影剤の注入速度が減少するパターン、具体的には一例で図4Gに例示するような、注入速度が時間とともにパターンであって終速度がゼロまたは実質的にゼロではなのバターンの場合、この場合にも、上記(ii)と同様に、造影剤の注入パターンに対して線対称形にクロスするような生理食塩水の注入パターンが表示される。
The dilution button 372b is a button for creating an injection pattern of physiological saline injected simultaneously with the contrast agent in the phase. When the dilution button 372b is pressed, the following injection pattern may be created:
(I) When the injection speed of the contrast agent is constant, a constant-rate saline injection pattern is displayed.
(Ii) A pattern in which the contrast agent injection rate decreases, specifically, a pattern in which the injection rate decreases with time as illustrated in FIG. 4D as an example, and the final rate is zero and not substantially zero. In the case of crossing the contrast agent injection pattern, specifically, the sum of the contrast agent injection rate and the saline injection rate is constant or substantially constant in the phase. The reference line (vertical or horizontal reference line that passes through the approximate center of the line segment of the injection pattern in one example) is displayed as a reference and the contrast medium injection pattern and the physiological saline injection pattern are displayed.
(Iii) A pattern in which the injection rate of the contrast agent decreases, specifically, in a pattern where the injection rate is a pattern with time and the final rate is zero or substantially zero, as exemplified in FIG. 4G. In this case as well, a physiological saline injection pattern that crosses the contrast agent injection pattern in a line symmetrical manner is displayed, as in (ii) above.
 終速固定パターンボタン372cは、当該フェーズにおいて、所定の初速度からゼロもしくは実質的ゼロの終速度へと変化するような形状の注入パターンを作成するためのボタンである。なお、注入速度がゼロということは、基本的には、ピストン駆動機構の130のモータ(不図示)を動作させないことを意味する。このような速度設定をしてもよい。しかしながら、例えば注入速度を0.01ml/sec~0.5ml/secの範囲、または0.05ml/sec~0.2ml/secの範囲などのように実質的にゼロとし、モータの動作を継続しつつ薬液注入は実質的には行わないという制御をしてもよい。 The final speed fixed pattern button 372c is a button for creating an injection pattern having a shape that changes from a predetermined initial speed to a zero or substantially zero final speed in the phase. Note that the injection speed being zero basically means that the motor (not shown) of the piston drive mechanism 130 is not operated. Such speed setting may be performed. However, the operation of the motor is continued by setting the injection rate to substantially zero, for example, in the range of 0.01 ml / sec to 0.5 ml / sec, or in the range of 0.05 ml / sec to 0.2 ml / sec. However, it may be controlled that the chemical liquid injection is not substantially performed.
 図4Cの例は、可変定数が1.0でかつフラッシュボタン372aが選択された状態で、ポップアップ画面371のOKボタンが押されて表示される注入パターンの一例を示している。この例では、第1フェーズに、一定速度の造影剤の注入パターン(線分)368aが表示され、第2のフェーズに、一定速度の生理食塩水の注入パターン(線分)368bが表示されている。注入速度はいずれも一例で4.0ml/secで同速である。 The example of FIG. 4C shows an example of an injection pattern that is displayed when the OK button on the pop-up screen 371 is pressed while the variable constant is 1.0 and the flash button 372a is selected. In this example, a constant rate contrast agent injection pattern (line segment) 368a is displayed in the first phase, and a constant rate saline injection pattern (line segment) 368b is displayed in the second phase. Yes. The injection rate is 4.0 ml / sec, which is the same as an example.
 標準・体重入力モードでは、既に患者に注入すべき造影剤の注入量が計算されている(具体的な一例として80ml)。ここで、例えば、ポップアップ画面371で設定された注入時間が20secの場合は、注入速度は、注入量を注入時間で除することにより、4.0ml/secのように計算されることとなる。このような設定方式の場合、注入速度が自動的に計算されるので、操作者が注入量を計算しそれを入力するという作業が不要となる。 In the standard / weight input mode, the amount of contrast medium to be injected into the patient has already been calculated (as a specific example, 80 ml). Here, for example, when the injection time set on the pop-up screen 371 is 20 seconds, the injection speed is calculated as 4.0 ml / sec by dividing the injection amount by the injection time. In the case of such a setting method, since the injection speed is automatically calculated, it is not necessary for the operator to calculate the injection amount and input it.
 フラッシュ注入の条件が、前のフェーズの注入速度と同速となるように設定されている場合においては、図4Cの例のように、第2のフェーズの生理食塩水の速度も4.0ml/secとなる。 In the case where the conditions for flush injection are set to be the same as the injection speed of the previous phase, the rate of the physiological saline in the second phase is also 4.0 ml / second as in the example of FIG. 4C. sec.
 図4Dの例は、可変定数が0.5でかつ希釈ボタン372bが選択されて作成される注入パターンの一例を示している。この例では、第1フェーズに、速度が4.0ml/secから2.0ml/secに減少する造影剤の注入パターン368aと、速度が2.0ml/secから4.0ml/secに増加する生理食塩水の注入パターン(線分)368bが表示されている。すなわち、このフェーズでは、造影剤の注入速度および生理食塩水の注入速度はそれぞれ一定ではないものの、両方の合計速度は4.0ml/secで一定となっている。 The example of FIG. 4D shows an example of an injection pattern created when the variable constant is 0.5 and the dilution button 372b is selected. In this example, in the first phase, the contrast agent injection pattern 368a in which the speed decreases from 4.0 ml / sec to 2.0 ml / sec, and the physiology in which the speed increases from 2.0 ml / sec to 4.0 ml / sec. A saline injection pattern (line segment) 368b is displayed. That is, in this phase, the contrast agent injection rate and the physiological saline injection rate are not constant, but the total rate of both is constant at 4.0 ml / sec.
 なお、当然ながら、このような第1フェーズの注入パターンに、第2のフェーズの生理食塩水によるフラッシュ注入を組み合わせてもよい。その際の、第2のフェーズの生理食塩水の注入速度は、第1フェーズの造影剤の初速度と同じになるように設定されていてもよい。 Of course, the first phase injection pattern may be combined with the second phase flush injection with physiological saline. In that case, the injection speed of the physiological saline of the second phase may be set to be the same as the initial speed of the contrast agent of the first phase.
 図4Eの例は、ポップアップ画面371において、可変定数が1.0の場合に希釈ボタン372bを選択した状態の一例を示している。このように、可変定数が1.0の場合に希釈ボタン372bを選択したときに、混和比率を示す表示部371cが現れるようになっていてもよい。この例では、比率の数値を示す文字表示部と、その値を増減させるための調整ボタンとが表示されている。調整ボタンについては、可変定数の表示部371aのものと同様の構成であってもよい。混和比率を変更することで、造影剤と生理食塩水の比率を50:50から例えば60:40、70:30のように変更することも可能である。これに対応して造影剤および生理食塩水の注入パターンの表示位置が自動的に変更されてもよい。 The example of FIG. 4E shows an example of a state in which the dilution button 372b is selected on the pop-up screen 371 when the variable constant is 1.0. In this way, when the dilution constant 372b is selected when the variable constant is 1.0, the display unit 371c indicating the mixing ratio may appear. In this example, a character display portion indicating the numerical value of the ratio and an adjustment button for increasing or decreasing the value are displayed. The adjustment button may have the same configuration as that of the variable constant display unit 371a. By changing the mixing ratio, it is also possible to change the ratio of contrast medium and physiological saline from 50:50 to, for example, 60:40, 70:30. Correspondingly, the display position of the injection pattern of the contrast medium and physiological saline may be automatically changed.
 図4Fの例は、第1フェーズで、造影剤および生理食塩水を50:50で一定速度で注入する例を示している。なお、この画面表示の例では、造影剤と生理食塩水との合計注入速度が4.0ml/secであることを示している。もっとも、このような表示態様に限らず、造影剤の注入パターンと生理食塩水の注入パターンの各々を2.0ml/secの高さに表示するようにしてもよい。 The example of FIG. 4F shows an example in which a contrast medium and physiological saline are injected at a constant rate of 50:50 in the first phase. In the example of this screen display, it is indicated that the total injection rate of the contrast medium and the physiological saline is 4.0 ml / sec. However, the present invention is not limited to such a display mode, and each of the contrast agent injection pattern and the physiological saline injection pattern may be displayed at a height of 2.0 ml / sec.
 図4Gの例は、終速固定パターンボタン372cが選択されて作成される注入パターンの一例を示している。この例では、第1フェーズに、速度が4.0ml/secから0.1ml/sec(実質的にゼロ)に減少する造影剤の注入パターン368aが表示されている。 The example of FIG. 4G shows an example of an injection pattern created by selecting the final speed fixed pattern button 372c. In this example, a contrast agent injection pattern 368a in which the speed is reduced from 4.0 ml / sec to 0.1 ml / sec (substantially zero) is displayed in the first phase.
 終速固定パターンボタン372cの他の機能としては次のようなものであってもよい:すなわち、図4Fのような、造影剤と生理食塩水との混和注入の場合に終速固定パターンボタン372cを選択すると、所定の初速度(ここでは一例で4.0ml/sec)から実質的にゼロの終速度に変化する造影剤の注入パターンと、その注入パターンに対してクロスするように、実質的にゼロの初速度から所定の終速度(ここでは一例で4.0ml/sec)に変化する生理食塩水の注入パターンとが現れる。 Other functions of the end speed fixing pattern button 372c may be as follows: That is, in the case of mixed injection of contrast medium and physiological saline as shown in FIG. 4F, the end speed fixing pattern button 372c. Is selected so that the contrast agent injection pattern changes from a predetermined initial velocity (here, 4.0 ml / sec in the example) to a substantially zero final velocity so that it crosses the injection pattern. In addition, a physiological saline injection pattern that changes from an initial velocity of zero to a predetermined final velocity (here, 4.0 ml / sec as an example) appears.
 例えば図4Dに示すような注入パターンの場合に終速固定パターンボタン372cを選択すると、上記同様、所定の初速度(ここでは一例で4.0ml/sec)から実質的にゼロの終速度に変化する造影剤の注入パターンと、その注入パターンに対してクロスするように、実質的にゼロの初速度から所定の終速度(ここでは一例で4.0ml/sec)に変化する生理食塩水の注入パターンとが現れるように構成されていてもよい。
-また、可変定数が1.0未満の状態で終速固定パターンボタン372cを選択した場合にも、上記同様、造影剤の注入パターンに関し、所定の初速度から実質的にゼロの終速度に変化するパターンが現れるようになっていてもよい。
For example, in the case of an injection pattern as shown in FIG. 4D, when the final speed fixed pattern button 372c is selected, the predetermined initial speed (here, 4.0 ml / sec in this example) is changed to a substantially zero final speed as described above. An injection pattern of contrast medium to be injected, and an injection of physiological saline that changes from a substantially zero initial speed to a predetermined final speed (in this example, 4.0 ml / sec) so as to cross the injection pattern A pattern may appear.
-Also, when the fixed speed fixed pattern button 372c is selected when the variable constant is less than 1.0, the contrast medium injection pattern changes from a predetermined initial speed to a substantially zero final speed as described above. A pattern to be displayed may appear.
 なお、注入グラフ361の表示に関しては、図4A~図4Gに例示したようなものに限らず、種々変更可能である。例えば、図4Hの画面のように、フェーズの始点またはフェーズの終点のところに中断アイコン369aが表示され、このアイコンを操作する(一例として当該アイコンを長押しする)と所定の時間間隔の薬液中断フェーズが挿入されるようになっていてもよい。 The display of the injection graph 361 is not limited to the one illustrated in FIGS. 4A to 4G, and various changes can be made. For example, as shown in the screen of FIG. 4H, an interruption icon 369a is displayed at the start point of the phase or at the end point of the phase, and when this icon is operated (for example, long pressing the icon), the chemical solution is interrupted at a predetermined time interval. A phase may be inserted.
 また、各フェーズの注入時間を示す時間表示部369bが表示されてもよい。この表示部369bは単なる文字表示であってもよいし、選択可能なアイコンであってもよい。また、注入パターンの端部の速度を示す速度表示部369(ここでは、一例として、初速度の「4.0」のみを示す)が表示されてもよい。また、各フェーズの造影剤および薬液のそれぞれの注入量を示す注入量表示部369dが表示されていてもよい。 Further, a time display unit 369b indicating the injection time of each phase may be displayed. The display unit 369b may be a simple character display or a selectable icon. Further, a speed display portion 369 indicating the speed of the end portion of the injection pattern (here, only the initial speed “4.0” is shown as an example) may be displayed. Moreover, the injection amount display part 369d which shows each injection amount of the contrast agent and chemical | medical solution of each phase may be displayed.
 上述したようなポップアップ画面371を通じて、操作者が1つまたは複数のフェーズの注入パターンを設定していくことで全体として1つの注入パターンの入力が完了する(ステップS5)。 The input of one injection pattern is completed as a whole by setting the injection pattern of one or a plurality of phases through the pop-up screen 371 as described above (step S5).
 次いで、操作者による確認および必要に応じたパターン修正(詳細後述)を経て、注入プロトコルが完成する(ステップS6)。 Next, the injection protocol is completed through confirmation by the operator and pattern correction as necessary (details will be described later) (step S6).
 その後、例えば、操作者により所定の注入開始ボタンが操作された後、その注入プロトコルに基づいてピストン駆動機構130が動作制御され、患者への薬液注入が行われる(ステップS7)。 Then, for example, after a predetermined injection start button is operated by the operator, the piston drive mechanism 130 is controlled based on the injection protocol, and the medical solution is injected into the patient (step S7).
 なお、アイコン362a、362bなどに予め登録されている注入プロトコル(例えば2フェーズからなるようなもの)に対して、ポップアップ画面371の操作を介して第3フェーズを付加するようなことも可能である。また、登録されている注入プロトコルの基本パターンをポップアップ画面371の操作を介して適宜修正するようなことを行なっても良い。 It is also possible to add a third phase to the injection protocol (for example, consisting of two phases) registered in advance in the icons 362a, 362b, etc. via the operation of the pop-up screen 371. . In addition, the basic pattern of the registered injection protocol may be appropriately corrected through the operation of the pop-up screen 371.
(B2-2:心臓・体重入力モード)
 「心臓・体重入力モード」を選択するために、操作者は画面上の設定モード選択アイコン363を操作する。この設定モードが選択された状態では、前述したような計算式に基づいて少なくとも患者に注入すべき造影剤の初速度(具体的な一例として、3.0ml/sec、4.0ml/sec、5.0ml/sec等)が計算されている。
(B2-2: Heart / weight input mode)
In order to select the “heart / weight input mode”, the operator operates the setting mode selection icon 363 on the screen. In a state in which this setting mode is selected, at least the initial velocity of the contrast medium to be injected into the patient based on the above-described calculation formula (as a specific example, 3.0 ml / sec, 4.0 ml / sec, 5 ml .0 ml / sec) is calculated.
 この設定モードにおいても、基本的には、操作者は上記標準・体重入力モードと同じように、注入グラフ361上のポップアップ画面371を操作して任意の注入パターンを作成することができる。ただし、心臓・体重入力モードでは予め造影剤の初速度が求められているので、第1フェーズの注入パターン(線分)の起点が自動的に決定されることとなり、操作者が初速度を入力する必要がない。注入パターンを作成するその他の手順については、上述した標準・体重入力モードのものと同様とすることができる。 Also in this setting mode, basically, the operator can create an arbitrary injection pattern by operating the pop-up screen 371 on the injection graph 361 as in the standard / weight input mode. However, since the initial velocity of the contrast medium is determined in advance in the heart / weight input mode, the starting point of the first phase injection pattern (segment) is automatically determined, and the operator inputs the initial velocity. There is no need to do. Other procedures for creating the injection pattern can be the same as those in the standard / weight input mode described above.
(B2-3:フローレート入力モード)
 「フローレート入力モード」を選択するために、操作者は画面上の設定モード選択アイコン363を操作する。この設定モードでは、上述の2つの設定モードのように造影剤の注入量や初速度は算出されておらず、操作者が任意の注入パターンを入力していくことで、全体として1つの注入パターンを作成することができる。このモードに関しても、注入パターンを作成するその他の手順については、上述した標準・体重入力モードのものと同様とすることができる。
(B2-3: Flow rate input mode)
In order to select the “flow rate input mode”, the operator operates the setting mode selection icon 363 on the screen. In this setting mode, the contrast agent injection amount and the initial velocity are not calculated as in the above two setting modes, and the operator inputs an arbitrary injection pattern, so that one injection pattern as a whole is input. Can be created. Regarding this mode, other procedures for creating the injection pattern can be the same as those in the standard / weight input mode described above.
 なお、フローレート入力モードでは造影剤の注入量や初速度は算出されていないことから、アイコン363でフローレート入力モードが選択された場合には、画面上(図4A)のアイコン364、365が消えるように構成されていてもよい。他の入力方式が画面上に表示されそれらを適宜選択できるようになっていてもよいことについては、後述するものとする。 In the flow rate input mode, the contrast medium injection amount and the initial velocity are not calculated. Therefore, when the flow rate input mode is selected with the icon 363, the icons 364 and 365 on the screen (FIG. 4A) are displayed. It may be configured to disappear. It will be described later that other input methods may be displayed on the screen and appropriately selected.
(B3:注入パターン修正)
 注入条件の各パラメータが変更された場合の注入パターンの修正の基本的な考え方について、以下、図5A~図5Dを参照して説明する。以下では、注入時間がtで、注入量がVであり、速度がfからfに減少する注入パターン(いわゆる可変パターン)に対して、その各パラメータを変更した場合について説明する。
(B3: Injection pattern correction)
The basic concept of correcting the injection pattern when each parameter of the injection condition is changed will be described below with reference to FIGS. 5A to 5D. In the following, a case will be described in which each parameter is changed for an injection pattern (so-called variable pattern) in which the injection time is t, the injection amount is V, and the speed is reduced from f 1 to f 2 .
(体重またはヨード量を変更)
 図5Aは、注入量をVからV′に変更する場合を示している。ここでは、注入時間tは変更されず、初速度fと終速度fが変更される。初速度f′および終速度f′は下記の式で求めることができる:
   f′=2/t(1+C)×V′
   f′=f′・C
(Change weight or iodine amount)
FIG. 5A shows a case where the injection amount is changed from V to V ′. Here, the injection time t is not changed, and the initial speed f 1 and the final speed f 2 are changed. The initial speed f 1 ′ and the final speed f 2 ′ can be determined by the following equations:
f 1 '= 2 / t ( 1 + C) × V'
f 2 ′ = f 1 ′ · C
 ここで、注入量をVからV′に変更する場合としては、看者の体重がWからW′に変更(増加)された場合や、ヨード量がaからa′に変更(増加)された場合が挙げられる。図4Aの画面との関連で言えば、アイコン364を押して体重が変更された場合や、アイコン365を押してヨード量が変更された場合がこれに相当する。 Here, when the injection amount is changed from V to V ′, the weight of the observer is changed (increased) from W to W ′, or the iodine amount is changed (increased) from a to a ′. There are cases. In relation to the screen of FIG. 4A, this corresponds to the case where the weight is changed by pressing the icon 364, or the case where the iodine amount is changed by pressing the icon 365.
 このようなパラメータが変更された場合、例えば図6の例のように、表示されている注入パターンが自動的に変更されるようになっていてもよい。すなわち、注入時間および可変定数は維持したまま、造影剤の初速度が自動的に一例として4.0ml/secから2.0ml/secに変更され、終速度が2.0ml/secから1.0ml/secに変更される(注入パターン368a、368a′参照)。また、これに対応して生理食塩水の注入パターン368bも自動的に注入パターン368b′のように変更される。 When such parameters are changed, for example, as shown in the example of FIG. 6, the displayed injection pattern may be automatically changed. That is, the initial speed of the contrast agent is automatically changed from 4.0 ml / sec to 2.0 ml / sec, for example, while maintaining the injection time and variable constant, and the final speed is 2.0 ml / sec to 1.0 ml. / Sec (see injection patterns 368a and 368a '). Correspondingly, the saline injection pattern 368b is automatically changed to the injection pattern 368b '.
(可変定数を変更)
 図5Bは、可変定数をCからC′に変更する場合を示している。ここでは、注入時間tは変更されず、終速度fと注入量Vが変更される。すなわち、変更後の終速度f と注入量V′は下記の式で求めることができる:
   f′=f′・C′
   V′=f(1+C′)/2×t
(Change variable constant)
FIG. 5B shows a case where the variable constant is changed from C to C ′. Here, the injection time t is not changed, the injection amount V is changed at a final rate f 2. That is, the changed final velocity f 2 and the injection amount V ′ can be obtained by the following equations:
f 2 ′ = f 1 ′ · C ′
V ′ = f 1 (1 + C ′) / 2 × t
 図4Bのポップアップ画面371内の可変定数の数値が変更された場合に、それに対応して、注入グラフに表示されていた造影剤の注入パターンが上記に例示したような態様で自動的に変更されてもよい。また、生理食塩水の注入パターンもこれに対応して自動的に変更されるようになっていてもよい。 When the numerical value of the variable constant in the pop-up screen 371 in FIG. 4B is changed, the contrast agent injection pattern displayed in the injection graph is automatically changed in the manner exemplified above correspondingly. May be. Further, the physiological saline injection pattern may be automatically changed correspondingly.
(注入時間を変更)
 図5Cは、注入時間をtからt′に変更する場合を示している。ここでは、初速度、終速度、および可変定数は変更されず、注入量Vが変更される。すなわち、変更後の注入量V′は下記の式で求めることができる:
   V′=f(1+C)/2×t′
(Change injection time)
FIG. 5C shows a case where the injection time is changed from t to t ′. Here, the initial velocity, the final velocity, and the variable constant are not changed, and the injection amount V is changed. That is, the changed injection amount V ′ can be obtained by the following formula:
V ′ = f 1 (1 + C) / 2 × t ′
 上記同様、注入グラフ361上で注入時間が変更された場合、それに対応して、注入グラフに表示されていた造影剤の注入パターンが上記に例示したような態様で自動的に変更されてもよい。また、生理食塩水の注入パターンもこれに対応して自動的に変更されるようになっていてもよい。 As described above, when the injection time is changed on the injection graph 361, the injection pattern of the contrast agent displayed on the injection graph may be automatically changed in the manner illustrated above correspondingly. . Further, the physiological saline injection pattern may be automatically changed correspondingly.
(初速度を変更)
 図5Dは、初速度をfからf′に変更する場合を示している。ここでは、可変定数は変更されず、終速度fおよび注入量Vが変更される。すなわち、変更後の終速度f および注入量V′は下記の式で求めることができる:
   f′=f′・C
   V′=f+f/2×t
(Change the initial speed)
Figure 5D illustrates the case of changing the f 1 'of the initial velocity from the f 1. Here, the variable constant is not changed, the terminal velocity f 2 and an injection amount V is changed. That is, the changed final speed f 2 and the injection amount V ′ can be obtained by the following equations:
f 2 ′ = f 1 ′ · C
V '= f 1 + f 2 /2 × t
 上記同様、注入グラフ361上で造影剤の初速度が変更された場合、それに対応して、注入グラフに表示されていた造影剤の注入パターンが上記のような態様で自動的に変更されてもよい。また、生理食塩水の注入パターンもこれに対応して自動的に変更されるようになっていてもよい Similarly to the above, when the initial velocity of the contrast agent is changed on the injection graph 361, the contrast agent injection pattern displayed on the injection graph is automatically changed in the above manner in response to the change. Good. Further, the physiological saline injection pattern may be automatically changed correspondingly.
(表示されている注入グラフの変更)
 なお、注入グラフ361上に表示されている注入パターン(線分)の形状を変更するための操作としては特に限定されるものではなく、どのような入力方式であっても構わない。例えば、GUI(Graphical User Interface)機能により、注入パターンの一方または両方の端部が選択可能となっており、選択した端部を上下方向および/または左右方向に移動させることで、注入パターンの端部の位置が変更され、それに応じて注入速度および注入時間の少なくとも一方が自動的に変更されるようになっていてもよい。あるいは、注入パターン(線分)を任意方向(上下方向および左右方向の少なくとも一方)に動かし、それに応じて自動的に条件の変更がなされるようになっていてもよい。
(Change of displayed injection graph)
The operation for changing the shape of the injection pattern (line segment) displayed on the injection graph 361 is not particularly limited, and any input method may be used. For example, one or both ends of the injection pattern can be selected by a GUI (Graphical User Interface) function, and the end of the injection pattern is moved by moving the selected end in the vertical direction and / or the horizontal direction. The position of the part may be changed, and at least one of the injection speed and the injection time may be automatically changed accordingly. Alternatively, the injection pattern (line segment) may be moved in any direction (at least one of the vertical direction and the horizontal direction), and the condition may be automatically changed accordingly.
 一度設定した注入パターン(例えば図4Dのような、造影剤の注入パターンと生理食塩水の注入パターンとが交差するようなパターン)を修正する場合に、一例として、注入パターンどうしの交差部付近にタッチするとポップアップ画面371が表示され、このポップアップ画面371を操作して条件の変更を行うことができる構成としてもよい。 For example, when correcting an injection pattern once set (for example, a pattern in which a contrast agent injection pattern and a physiological saline injection pattern intersect) as shown in FIG. When touched, a pop-up screen 371 is displayed, and the pop-up screen 371 may be operated to change the condition.
 このように、本実施形態の薬液注入装置では、注入グラフ361上で操作者が自由に所望の注入パターンを入力することがでる。 Thus, in the chemical injection device of this embodiment, the operator can freely input a desired injection pattern on the injection graph 361.
 なお、仕上げた注入プロトコルについて、薬液注入装置の制御部がそのデータを所定の記憶部に保存するように構成されていてもよい。この場合、記憶部としては、薬液注入装置(例えばコンソール内)が有する記憶領域であってもよいし、コンソールのスロットに挿入される記憶媒体であってよいし、または、有線または無線で薬液注入装置に接続された外部のネットワークの記憶領域であってもよい。また、薬液注入装置の制御部は、注入プロトコルの内容が事後的に変更・上書きされないようにロックをかけた状態で保存してもよい。当該ロックは、パスワードを入力することによって解除されるものであってもよい。 In addition, about the finished injection | pouring protocol, the control part of a chemical | medical solution injection apparatus may be comprised so that the data may be preserve | saved at a predetermined memory | storage part. In this case, the storage unit may be a storage area of a chemical injection device (for example, in the console), a storage medium inserted into a slot of the console, or a chemical injection by wired or wireless. It may be a storage area of an external network connected to the device. Further, the control unit of the chemical solution injector may be stored in a locked state so that the contents of the injection protocol are not changed or overwritten later. The lock may be released by inputting a password.
 薬液注入装置はそのような注入パターンに基づいて作成された注入プロトコルに従った薬液注入を行う。薬液注入中の注入圧検出動作や、漏出検出動作、あるいは薬液注入後の注入履歴データの作成、記憶、外部への送信等に関しては、従来公知の態様をはじめとして種々の態様をとることができる。 The chemical injection device performs chemical injection in accordance with an injection protocol created based on such an injection pattern. With respect to the injection pressure detection operation during the liquid injection, the leak detection operation, or the creation, storage, transmission to the outside of the injection history data after the liquid injection, etc., various modes including a conventionally known mode can be taken. .
〔C:薬液注入装置の各部の具体的構成〕
(薬液注入装置)
 薬液注入装置100は、具体的には、図7のような構成であってもよい。この薬液注入装置100は、可動式スタンド111の上部に回動自在に保持された二筒式の注入ヘッド110を備えている。この注入ヘッド110は、各凹部120aに対して、一例として、シリンジのシリンダフランジおよびその近傍を保持するシリンジアダプタS121、S122を介してシリンジが装着される。
[C: Specific configuration of each part of chemical injection device]
(Chemical injection device)
Specifically, the chemical injection device 100 may have a configuration as shown in FIG. The chemical injection device 100 includes a two-tube injection head 110 that is rotatably held on an upper portion of a movable stand 111. In this injection head 110, as an example, a syringe is attached to each recess 120 a via syringe adapters S 121 and S 122 that hold the cylinder flange of the syringe and the vicinity thereof.
 コンソール150は、一例で、ケーブル102により注入ヘッド110に接続されている。表示ユニット151はタッチパネル式ディスプレイである。操作パネル159としては複数の物理ボタンが配置されていている。例えば、コンソール正面にホームボタン(物理ボタン)が設けられており、このホームボタンを押すと、画面上に、複数のアイコンが配列されたホーム画面が表示されるように構成されていてもよい。このようなアイコンとして「PLOT」アイコンが表示され、このアイコンを選択することで、図4Aに示したような設定用初期画面360が表示される構成としてもよい。ハンドユニット157は、コンソール150に有線接続され、作業テーブル上などで使用される。 The console 150 is connected to the injection head 110 by a cable 102 as an example. The display unit 151 is a touch panel display. A plurality of physical buttons are arranged as the operation panel 159. For example, a home button (physical button) may be provided on the front of the console, and when the home button is pressed, a home screen on which a plurality of icons are arranged may be displayed on the screen. A “PLOT” icon may be displayed as such an icon, and by selecting this icon, an initial setting screen 360 as shown in FIG. 4A may be displayed. The hand unit 157 is wired to the console 150 and used on a work table.
(シリンジ)
 なお、シリンジとしては具体的には図8A(a)、(b)に示すようなものであってもよく、このシリンジは例えば100ml用のものである。このシリンジは、シリンダ部材501とピストン部材502とを備え、シリンダ部材501のシリンダフランジ501aはIカット形状の輪郭形状を有し、同フランジ501aの外周部には2つの切欠き部505(一方のみを示す)が形成されている。シリンダ部材501の先端の導管部501bは、同軸状に配置された内側および外側の2つの筒状部を有するルアーロック接続用のものであってもよい。図8A(b)に示すように、シリンダフランジ501aの後面には、リング状の突起部501cが形成されていてもよい。
(Syringe)
In addition, as a syringe, what is specifically shown to FIG. 8A (a), (b) may be sufficient, and this syringe is for 100 ml, for example. This syringe includes a cylinder member 501 and a piston member 502. A cylinder flange 501a of the cylinder member 501 has an I-cut contour shape, and two notches 505 (only one of them is provided on the outer peripheral portion of the flange 501a. Is formed). The conduit portion 501b at the tip of the cylinder member 501 may be for luer lock connection having two inner and outer cylindrical portions arranged coaxially. As shown in FIG. 8A (b), a ring-shaped protrusion 501c may be formed on the rear surface of the cylinder flange 501a.
 2本のシリンジのうちの他方としては、図8B(a)、(b)に示すようなシリンジであってもよく、このシリンジは例えば200ml用のものである。このシリンジも、上記シリンジと同様、シリンダ部材501とピストン部材502とを備え、シリンダ部材501のシリンダフランジ501aはIカット形状の輪郭形状を有するものであってもよい。シリンダフランジ501aの外周部には2つの切欠き部505(一方のみを示す)が形成されている。シリンダ部材501の先端の導管部501bは、同軸状に配置された内側および外側の2つの筒状部を有するルアーロック接続用のものであってもよい。図8B(b)に示すように、シリンダフランジ501aの後面には、リング状の突起部501cと、その突起部501cから外側に向かって延びる複数のリブ501dが形成されていてもよい。 The other of the two syringes may be a syringe as shown in FIGS. 8B (a) and (b), and this syringe is for, for example, 200 ml. Similarly to the above syringe, this syringe also includes a cylinder member 501 and a piston member 502, and the cylinder flange 501a of the cylinder member 501 may have an I-cut contour. Two notches 505 (only one is shown) are formed on the outer periphery of the cylinder flange 501a. The conduit portion 501b at the tip of the cylinder member 501 may be for luer lock connection having two inner and outer cylindrical portions arranged coaxially. As shown in FIG. 8B (b), a ring-shaped protrusion 501c and a plurality of ribs 501d extending outward from the protrusion 501c may be formed on the rear surface of the cylinder flange 501a.
 なお、図8Bではシリンダフランジ501aに切欠き部505とリブ501dの両方が形成されたものが描かれているが、いずれか一方のみが形成されたもの(例えば、切欠き部S505が形成されていないもの)であってもよい。また、リブS501dに関し、図示上下方向に並んだ複数のリブのうち上部と下部の2つのリブのみを残し、他のリブを省略したような形状としてもよい。このようなリブ群が、フランジ部の左右両側のいずれか一方のみに形成されたシリンジとしてもよい。あるいは、上側両端の2つのリブもしくは下側両端の2つのリブとしてもよい。 In FIG. 8B, the cylinder flange 501a is formed with both the notch 505 and the rib 501d, but only one of them is formed (for example, the notch S505 is formed). May not be). Further, the rib S501d may have a shape in which only two upper and lower ribs are left out of the plurality of ribs arranged in the vertical direction in the figure, and the other ribs are omitted. Such a rib group may be a syringe formed on only one of the left and right sides of the flange portion. Alternatively, two ribs at both upper ends or two ribs at both lower ends may be used.
 延長チューブ508の一例としては、図8Cに示すようなものであってもよい。この延長チューブ508は、T字コネクタを介して接続された3本のチューブを有している。各シリンジに接続されるチューブの端部には接続コネクタ509、509が取り付けられており、患者側に向かうチューブの端部には別の形態の接続コネクタ510が取り付けられている。各接続コネクタ509は、先端にネジ部509bが形成された円筒部509aを有し、ルアーロック方式でシリンジの導管部501bに接続されるものであってもよい。また、この接続コネクタ509は、一方弁としての機能を有するもの、特には、WO2012/060365に公開されているようなものであってもよい。接続コネクタ510は、例えば不図示のカテーテルや留置針に接続されるものであってもよい。 An example of the extension tube 508 may be as shown in FIG. 8C. The extension tube 508 has three tubes connected via a T-shaped connector. Connection connectors 509 and 509 are attached to the end of the tube connected to each syringe, and another form of connection connector 510 is attached to the end of the tube toward the patient. Each connection connector 509 may have a cylindrical portion 509a having a screw portion 509b formed at the tip, and may be connected to the syringe conduit portion 501b by a luer lock method. Further, the connection connector 509 may have a function as a one-way valve, in particular, as disclosed in WO2012 / 060365. For example, the connection connector 510 may be connected to a catheter or an indwelling needle (not shown).
(天井懸垂型の保持アーム)
 天井懸垂型の保持アーム111′としては、図9Aに示すような、水平回転および上下移動の組合せを可能とするようなものであってもよい。この例では、天井に取り付けられるベース部と、そこから延び出した多関節のアーム部とを有しており、注入ヘッド110は、アーム部の末端側の支持バー(一例で鉛直方向に延びる棒状部材)に保持されている。
(Ceiling suspension type holding arm)
The ceiling-suspended holding arm 111 ′ may be a combination of horizontal rotation and vertical movement as shown in FIG. 9A. In this example, it has a base part attached to the ceiling and an articulated arm part extending from the base part, and the injection head 110 has a support bar (in one example, a bar shape extending in the vertical direction) on the terminal side of the arm part. Member).
(サブディスプレイ)
 図9Bのように、保持アーム111′の一部、具体的には注入ヘッド110を保持する部分の近傍に、サブディスプレイ149を取り付けた薬液注入装置としてもよい。このサブディスプレイ149は、注入ヘッド110に電気的に接続され、または、コンソール150に電気的に接続され、薬液注入に関する様々な情報を表示できるように構成されていてもよい。サブディスプレイ149は、タッチパネル式ディスプレイであってもよいし、タッチパネルの機能の無い単なるディスプレイであってもよい。
(Sub display)
As shown in FIG. 9B, a chemical liquid injection device in which a sub-display 149 is attached to a part of the holding arm 111 ′, specifically, in the vicinity of a part holding the injection head 110 may be used. The sub-display 149 may be electrically connected to the injection head 110 or electrically connected to the console 150, and may be configured to be able to display various information related to the chemical solution injection. The sub display 149 may be a touch panel display, or may be a simple display without a touch panel function.
 なお、このようなサブディスプレイ149が注入ヘッド110の一部に直接設けられていてもよい。例えば、注入ヘッド110の筐体の側方または後方にそのようなサブディスプレイ149を設けてもよい。または、サブディスプレイ149が可動式スタンド111の一部に取り付けられてもよい。なお、可動式スタンド111上に、注入ヘッド110とは別体に制御ユニット(不図示)が搭載されていてもよい。 Note that such a sub-display 149 may be provided directly on a part of the injection head 110. For example, such a sub display 149 may be provided on the side or rear of the casing of the injection head 110. Alternatively, the sub display 149 may be attached to a part of the movable stand 111. Note that a control unit (not shown) may be mounted on the movable stand 111 separately from the injection head 110.
 サブディスプレイ149に関連して、薬液注入装置の制御部は次のように構成されていてもよい:
(s1)サブディスプレイ149に、図4A~図4Hに例示したような注入グラフ361を表示表示させる、
(s2)その注入グラフ361における操作者からの注入パターンの入力を受け付ける、
(s3)その注入グラフ361において、一端作成された注入パターンを修正するための操作者からの入力を受け付ける、
(s4)修正内容を反映して新たな注入パターンを表示する。
 なお、上記s2とs3については、いずれか一方のみ行うものであってもよい。すなわち、コンソール側で作成された注入パターンを、サブディスプレイ側で修正のみ行うような構成としてもよい。
In connection with the sub-display 149, the control unit of the chemical injection device may be configured as follows:
(S1) The injection graph 361 as illustrated in FIGS. 4A to 4H is displayed on the sub-display 149.
(S2) Accepting an injection pattern input from the operator in the injection graph 361;
(S3) In the injection graph 361, an input from an operator for correcting the injection pattern created once is received.
(S4) A new injection pattern is displayed reflecting the correction contents.
Note that only one of s2 and s3 may be performed. That is, the injection pattern created on the console side may be modified only on the sub display side.
 以上説明したような本実施形態の薬液注入装置100によれば、図4Aに示したような設定用初期画面360において、モード選択用アイコン363が表示されており、操作者はこのアイコン363を操作して自分が使用するプロトコル設定モードを選択することができる。したがって、例えば、撮像目的などに応じて設定すべき注入プロトコルの内容が変わったような場合においても、プロトコル設定モードを適宜変更し、その検査に適したプロトコル設定モードで条件設定を行うことができる。 According to the chemical injection device 100 of the present embodiment as described above, the mode selection icon 363 is displayed on the initial setting screen 360 as shown in FIG. 4A, and the operator operates the icon 363. Then, you can select the protocol setting mode that you use. Therefore, for example, even when the content of the injection protocol to be set changes according to the imaging purpose or the like, the protocol setting mode can be changed as appropriate, and the conditions can be set in the protocol setting mode suitable for the inspection. .
 このような設定モードの変更が仮に可能であったとしても、例えば画面上で複雑な操作を要するなど、簡単に変更が出来ない場合には、現場の医師が当該機能を使用しない可能性もある。しかしながら、本実施形態の構成によれば画面上に表示された表示部(ここではモード選択用アイコン363)を押すだけでモードの変更を行うことができるので、複雑な作業を必要とせず、しかも画面上で直感的に行うことができる。 Even if such a setting mode can be changed, the doctor on site may not use the function if it cannot be changed easily, for example, if a complicated operation is required on the screen. . However, according to the configuration of the present embodiment, the mode can be changed by simply pressing the display unit (mode selection icon 363 here) displayed on the screen. Can be done intuitively on the screen.
 以上、本発明について幾つかの形態を参照して説明したが当然ながら、上述した各種の形態はその内容が相反しないかぎり適宜組み合わせることができる。また、本発明は上記内容に限定されるものではなく、種々変更可能である。 As mentioned above, although this invention was demonstrated with reference to some forms, naturally, as long as the content does not conflict, the various forms mentioned above can be combined suitably. Further, the present invention is not limited to the above contents, and various modifications can be made.
(b1)上記では、標準・体重入力モードと、心臓・体重入力モードと、フローレートモードとの2つまたは3つが選択できる構成について説明した。しかしながら、本発明の薬液注入装置としては、2種以上の異なるプロトコル設定モードを選択できるものであれば、その具体的な設定方式の内容、および、選択可能なプロトコル設定モードの数はどのようなものであっても構わない。
(b2)例えば、標準・体重入力モードや心臓・体重入力モード等に加え、例えば、
-除脂肪体重に基づく条件設定方式、
-体表面積に基づく条件設定方式、および、
-血液量に基づく条件設定方式、
 から選ばれる少なくとも1つの入力モードが選択できるように構成されていてもよい。これは、薬液注入装置の制御部がこのような機能を有することにより実現可能である。
(B1) In the above description, the configuration in which two or three of the standard / weight input mode, the heart / weight input mode, and the flow rate mode can be selected has been described. However, as long as two or more different protocol setting modes can be selected as the chemical solution injection device of the present invention, what is the specific setting method content and the number of selectable protocol setting modes? It doesn't matter.
(B2) For example, in addition to the standard / weight input mode and the heart / weight input mode, for example,
-Condition setting method based on lean body mass,
-Condition setting method based on body surface area, and
-Condition setting method based on blood volume,
It may be configured such that at least one input mode selected from can be selected. This is realizable when the control part of a chemical injection device has such a function.
(b3-1)例えば、「スリップ注入プロトコル」(SLIP、Stable Line Imaging Protocol)と呼ばれるプロトコルを設定するための表示部が画面上に表示されてもよい。この注入プロトコルは、一例として、心臓から延びる血管といった広い範囲を造影するのに好適に利用可能である。スリップ注入プロトコルにおいては、造影剤および生理食塩水は次のような条件で注入される:
(i)第1フェーズ、時間tから時間tまで:
-造影剤の注入速度が速度Vcから速度Vcまで単調に減少する。
-希釈剤の注入速度が速度Vpから速度Vpまで単調に増加する。
-速度Vcと速度Vpとは実質的に同一である。
(ii)第2フェーズ、時間t1以降:
-希釈剤の注入速度がVpより速い速度Vpとなる。
-造影剤の注入速度は0ml/secである。
「単調に増加/減少する」とは、注入速度が直線的に増加/減少する態様に加え、曲線状もしくは階段状であるが実質的には直線的に増加/減少する態様をも含むことを意図している。「実質的に同一」とは、2つの速度が同一の場合に加え、一方の速度と他方の速度との差が例えば10%以内であるような場合をも含むことを意図している。
(b3-2)第1フェーズの時間は、基本的には撮影速度や撮像時間に依存するが、一例として、撮像時間(スキャンタイム)と同様またはそれよりやや短い程度であってもよい。第2のフェーズの時間は、生理食塩水の注入量と注入速度から算出されるものであってもよい。例えば、注入量が30mlで速度が一例で5.0ml/secの場合には6.0secということになる。
(b3-3)一例のスリップ注入プロトコルにおいて、造影剤の速度は速度Vcから速度Vcまで直線的に減少するようになっている。速度Vcは、一例で、2ml/sec以上、または3ml/sec以上、または4ml/sec以上であってもよい。具体的には、速度Vcは4.8ml/sec等としてもよい。血管造影において、注入速度が速すぎると血管に損傷を与える可能性がある。そのような観点からは、上限速度は、例えば6.0ml/secなどであってもよい。速度Vcから速度Vcまでの速度変化を表す可変定数(Vc/Vc)は、一例で、0.6~0.4の範囲内であってもよい。例えば、速度Vcは4.8ml/secで可変定数が0.5の場合、Vcは2.4ml/secとなる。
(b3-4)生理食塩水の速度Vpに関しては、速度Vpから速度Vpまで直線的に増加するようになっている。速度Vpは、一例で0ml/secであってもよい。速度Vpから速度Vpまでの生理食塩水の速度Vpは、造影剤の注入速度の減少に対応して徐々に増加するものであってもよい。具体的には、速度Vpは、時間t0から時間t1のまでの間、速度Vc+速度Vp=一定(速度Vttl)となるように設定されていてもよい。一例のスリップ注入プロトコルにおいて、時間t以降の生理食塩水の速度Vpは、一例で、造影剤の時間tにおける速度Vcと同一であってもよい。または、この値に対して+/-20%の範囲内、または+/-10%の範囲内であってもよい。
(B3-1) For example, a display unit for setting a protocol called “slip injection protocol” (SLIP, Stable Line Imaging Protocol) may be displayed on the screen. This injection protocol can be suitably used for imaging a wide range, for example, a blood vessel extending from the heart. In the slip injection protocol, contrast agent and saline are injected under the following conditions:
(I) First phase, from time t 0 to time t 1 :
The contrast agent injection rate decreases monotonically from velocity Vc 0 to velocity Vc 1
The diluent injection rate increases monotonically from rate Vp 0 to rate Vp 1
The speed Vc 1 and the speed Vp 1 are substantially the same.
(Ii) Second phase, after time t1:
-The diluent injection rate is Vp 2 faster than Vp 1 .
The injection rate of the contrast agent is 0 ml / sec.
“Monotonically increasing / decreasing” includes not only a mode in which the injection rate increases / decreases linearly but also a mode in which the injection rate is curved or stepped but increases / decreases substantially linearly. Intended. “Substantially the same” is intended to include not only the case where two speeds are the same, but also the case where the difference between one speed and the other speed is within 10%, for example.
(B3-2) The time of the first phase basically depends on the imaging speed and the imaging time, but as an example, it may be the same as or slightly shorter than the imaging time (scan time). The time of the second phase may be calculated from the amount of saline injected and the rate of injection. For example, when the injection volume is 30 ml and the speed is 5.0 ml / sec as an example, it is 6.0 sec.
(B3-3) In an example slip injection protocol, the contrast agent velocity decreases linearly from velocity Vc 0 to velocity Vc 1 . The speed Vc 0 may be 2 ml / sec or more, 3 ml / sec or more, or 4 ml / sec or more, for example. Specifically, the speed Vc 0 may be 4.8 ml / sec. In angiography, if the injection rate is too high, the blood vessels may be damaged. From such a viewpoint, the upper limit speed may be, for example, 6.0 ml / sec. The variable constant (Vc 1 / Vc 0 ) representing the speed change from the speed Vc 0 to the speed Vc 1 is an example, and may be in the range of 0.6 to 0.4. For example, when the speed Vc 0 is 4.8 ml / sec and the variable constant is 0.5, Vc 1 is 2.4 ml / sec.
(B3-4) with respect to the speed Vp of saline, so as to linearly increase from the speed Vp 0 to the speed Vp 1. The speed Vp 0 may be 0 ml / sec as an example. The physiological saline velocity Vp from velocity Vp 0 to velocity Vp 1 may gradually increase in response to a decrease in the contrast agent injection rate. Specifically, the speed Vp is during the time t0 to the time t1, the speed Vc + speed Vp = may be set to be constant (rate V ttl). In an example slip injection protocol, the saline velocity Vp 2 after time t 1 may be the same as the velocity Vc 0 at time t 0 of the contrast agent in one example. Alternatively, it may be within the range of +/− 20% or +/− 10% with respect to this value.
(b4)注入グラフ361の表示内容に関して、各フェーズの注入時間(時間の短長)に対応して、表示するフェーズの幅を変更してもよいし、または、各フェーズの注入時間がどのようなものであってもフェーズの幅は一定に表示される構成としてもよい。
(b5)プロトコル設定モードを変更するための画面上の表示部としては、1つのアイコン363で切り替える態様に限らず、例えばモードの候補ごとにアイコンが用意され、そのうちの1つのアイコンを選択するような態様としてもよい。
(b6)上記では、ポップアップ画面371への入力を通じてそれぞれのフェーズの注入パターンを作成していく例について説明した。しかしながら、例えば、注入グラフ内の任意の点(または格子点)を選択していくことで、自由に注入パターン(一例で注入パターン368aのようなもの)を順次作成していくことができる構成としてもよい。
(b7)上記で説明したポップアップ画面371内の表示部371a~371c、372a~372cの1つまたは複数は、他のポップアップ画面内に表示されてもよいし、あるいは、ポップアップ画面ではない画面上の所定位置に表示されてもよい。ポップアップ画面371内には、必ずしも、表示部371a~371c、372a~372cの全てが表示されている必要はなく、いずれか1つのみあるいは一部のみが表示されていてもよい。
(b8)入力された注入パターンの数値(例えば注入速度、注入時間など)が予め設定された基準値を超えている、または、同基準値を下回っているような場合に、画面上に警告のためのメッセージ表示が現れるように構成してもよい。
(b9)ところで、フェーズの境界でグラフの傾きが大きく異なると、その境界で薬液の注入速度が大きく変化し、ピストン駆動機構が注入プロトコルに追随できなくなる場合もあり得る。そこで、画面上に曲線補間ボタン(アイコン)を設け、それが選択されると、制御部は、折れ線で表された注入プロトコルを曲線に変換する演算を行うようにすることもできる。直線から曲線への変換は、制御部の演算機能が、入力された注入パターン形状を解析して、注入速度の変化率が許容される変化率以下となるように、隣り合うフェーズの部分同士を曲線で結ぶようなものであってもよい。この場合、結ぶ曲線の曲率の程度は、少なくともピストン駆動機構が追随できる範囲であればよく、ピストン駆動機構に対する負荷および消費電力を考慮して調整することも好ましい。直線から曲線への変換は、好ましくはスプライン曲線補間で行うことができる。
(B4) Regarding the display content of the injection graph 361, the width of the phase to be displayed may be changed corresponding to the injection time (short time) of each phase, or how the injection time of each phase is Even if it is a thing, it is good also as a structure by which the width of a phase is displayed uniformly.
(B5) The display unit on the screen for changing the protocol setting mode is not limited to the mode of switching with one icon 363. For example, an icon is prepared for each mode candidate, and one of the icons is selected. It is good also as an aspect.
(B6) In the above, the example in which the injection pattern of each phase is created through the input to the pop-up screen 371 has been described. However, for example, by selecting an arbitrary point (or lattice point) in the injection graph, an injection pattern (such as an injection pattern 368a as an example) can be created sequentially in sequence. Also good.
(B7) One or more of the display units 371a to 371c and 372a to 372c in the pop-up screen 371 described above may be displayed in another pop-up screen or on a screen that is not a pop-up screen It may be displayed at a predetermined position. In the pop-up screen 371, it is not always necessary to display all of the display portions 371a to 371c and 372a to 372c, and only one or only a part of them may be displayed.
(B8) When a numerical value of the input injection pattern (for example, injection speed, injection time, etc.) exceeds a preset reference value or falls below the reference value, a warning is displayed on the screen. A message display may be displayed.
(B9) By the way, if the slope of the graph is greatly different at the boundary of the phase, the injection speed of the chemical solution changes greatly at the boundary, and the piston drive mechanism may not be able to follow the injection protocol. Therefore, a curve interpolation button (icon) is provided on the screen, and when it is selected, the control unit can perform an operation of converting the injection protocol represented by the broken line into a curve. Conversion from a straight line to a curved line is performed by analyzing the input injection pattern shape by the calculation function of the control unit, so that the change rate of the injection rate is equal to or less than the allowable change rate. It may be connected with a curve. In this case, the degree of curvature of the connecting curve may be at least within a range that can be followed by the piston drive mechanism, and is preferably adjusted in consideration of the load and power consumption on the piston drive mechanism. Conversion from a straight line to a curve can be preferably performed by spline curve interpolation.
(c1)情報記憶媒体であるカード媒体から薬液注入装置に動作条件(例えば薬液注入プロトコル情報)を取得してもよい。情報記憶媒体としては各種製品を使用することが可能である。注入プロトコル情報などは、外部のデータベースサーバに記憶されたものをオンラインでダウンロードすることも可能である。
(c2)注入される造影剤や生理食塩水の圧力は薬液シリンジのピストン部材を押圧する圧力から算出することができるが、例えば、薬液シリンジや延長チューブの内部に感圧素子を設置して造影剤などの注入圧力を直接に検出することも可能である。
(c3)装着される薬液シリンジの造影剤の種類を判定することで造影剤の種類の入力操作を無用とし、作業負担を軽減することが可能である。これを実現するため、例えば、本出願人が特願2002-021762号として出願したように、各種の薬液シリンジが、各々に専用のシリンダアダプタ(図示せず)で注入ヘッドに装着される場合、注入ヘッドがシリンダアダプタ(図示せず)から薬液シリンジおよび造影剤の識別データを取得することが可能である。
(c4)薬液シリンジにバーコードなどで造影剤の種類などをデータ付与しておき(図示せず)、そのバーコードなどを注入ヘッドが読み取ることでも、薬液注入装置が造影剤情報を取得することが可能である。
(c5)造影剤の種類の前回の設定が保存されており、造影剤を変更しない限りは種類の入力操作を無用とすることができる薬液注入装置としてもよい。部位選択機能を有する場合には、例えば、撮像部位の前回の設定を保存することも可能である。薬液注入装置を使用する環境が、例えば、脳外科の場合は脳部しか撮像せず、心臓外科の場合は心臓しか撮像しないことがあるので、このような場合には、撮像部位の前回の設定を保存して変更が必要となるまで入力操作を無用とすることも有用である。
(c6)注入速度を直線的に低下させ以後は注入速度を一定に維持する、または、以後は再び注入速度を直線的に増加させる可変パターンの基本パターン情報が予め記憶されており、画面上の所定のアイコンを選択することで当該基本パターンが表示されてもよい。
(c7)部位選択機能を有する場合、横型または縦型の人体形状として表された複数の身体区分の模式画像が画面上に表示されてもよい。
(c8)部位選択機能を有する場合、撮像部位の選択と体重と造影剤の種類との入力操作が必要な構成であってもよいが、それに限らず、撮像部位の選択のみ実行すれば、体重や造影剤の種類は入力操作せずとも注入速度/総量/時間がデータ設定されることも可能である。このようなことは、造影剤が一種類しかない場合や、各種の造影剤に実質的な差異がない場合や、使用する造影剤が特定されていて事前にデータ登録されている場合や、標準的な体重の被験者のみ撮像する場合、等に有効であり、さらに作業負担を軽減することが可能である。
(C1) You may acquire operation conditions (for example, chemical | medical solution injection | pouring protocol information) from the card | curd medium which is an information storage medium to a chemical | medical solution injection | pouring apparatus. Various products can be used as the information storage medium. The injection protocol information or the like stored in an external database server can be downloaded online.
(C2) The pressure of the injected contrast medium and physiological saline can be calculated from the pressure that presses the piston member of the chemical syringe. For example, a pressure sensitive element is installed inside the chemical syringe or the extension tube to contrast It is also possible to directly detect the injection pressure of an agent or the like.
(C3) By determining the type of contrast medium in the chemical syringe to be mounted, it is possible to eliminate the operation of inputting the type of contrast medium and reduce the work load. In order to realize this, for example, when various kinds of liquid syringes are attached to the injection head with a dedicated cylinder adapter (not shown), as filed by the present applicant as Japanese Patent Application No. 2002-021762, The injection head can acquire the identification data of the chemical syringe and the contrast agent from a cylinder adapter (not shown).
(C4) The medical solution injector acquires the contrast agent information even if data such as the type of contrast medium is given to the liquid syringe with a barcode or the like (not shown) and the injection head reads the barcode or the like. Is possible.
(C5) The previous setting of the type of contrast agent is stored, and a liquid injector that can make the type input operation unnecessary can be used as long as the contrast agent is not changed. In the case of having a part selection function, for example, the previous setting of the imaging part can be stored. For example, in the case of brain surgery, the environment where the drug solution injector is used may only capture the brain, and in cardiac surgery, only the heart may be imaged. It is also useful to eliminate input operations until they need to be saved and changed.
(C6) The basic pattern information of a variable pattern for decreasing the injection rate linearly and maintaining the injection rate constant thereafter, or increasing the injection rate linearly thereafter is stored in advance. The basic pattern may be displayed by selecting a predetermined icon.
(C7) In the case of having a region selection function, a schematic image of a plurality of body sections expressed as a horizontal or vertical human body shape may be displayed on the screen.
(C8) In the case of having a site selection function, the configuration may be such that the selection of the imaging site and the input operation of the body weight and the type of contrast medium are necessary. Alternatively, the injection rate / total amount / time can be set as data without inputting the type of contrast medium. This may be the case when there is only one type of contrast agent, when there is no substantial difference between the various contrast agents, when the contrast agent to be used is specified and registered in advance, This is effective when imaging only a subject having a proper weight, and can further reduce the work load.
 なお、本明細書で云う各種の構成要素(デバイス、装置など)は、個々に独立した存在である必要はなく、複数の構成要素が一個の部材として形成されていること、一つの構成要素が複数の部材で形成されていること、ある構成要素が他の構成要素の一部であること、ある構成要素の一部と他の構成要素の一部とが重複していること、等であってもよい。 It should be noted that the various components (devices, apparatuses, etc.) referred to in this specification do not have to be independent of each other, but a plurality of components are formed as a single member. It is formed of a plurality of members, a certain component is a part of another component, a part of a certain component overlaps a part of another component, etc. May be.
 ここで、構成要素は、その機能を実現するように形成されていればよく、ハードウェアにより実現するものでも、ソフトウェアにより実現されるものでも何れでも構わない。例えば、ある構成要素が、所定の機能を発揮する専用のハードウェア、所定の機能がコンピュータプログラムにより実現された処理装置、これらの組合せ、等として実現することができる。 Here, the components need only be formed so as to realize their functions, and may be realized by hardware or realized by software. For example, a certain component can be realized as dedicated hardware that exhibits a predetermined function, a processing device in which the predetermined function is realized by a computer program, a combination thereof, or the like.
 コンピュータプログラムに対応してプロセッサが動作することにより、薬液注入装置(制御部)の各種機能として各種手段(各部、各ユニット)が論理的に実現されてもよいが各種手段(各部、各ユニット)は、固有のハードウェアとして形成したり、あるいは、ソフトウェアにより実現される部分とハードウェアにより実現される部分との組合せとしてもよい。 Various means (each part, each unit) may be logically realized as various functions of the chemical injection device (control unit) by operating the processor in response to the computer program, but various means (each part, each unit) May be formed as unique hardware, or may be a combination of a part realized by software and a part realized by hardware.
 薬液注入装置およびそれを含むシステム等については、上記内容に限定されるものではなく、更に例えば下記のように種々変更可能である:
(d1-1)シリンジのICタグが、そのシリンジを加温するかどうかの情報を含んでいてもよい。
(d1-2)シリンジのICタグから読み取られた情報の少なくとも一部の項目をプリンタ等を用いて印刷する。または、シリンジのICタグから読み取られた情報の少なくとも一部の項目と薬液の注入履歴データとを少なくとも含むデータを、プリンタ等を用いて印刷する。
(d2)使用後のシリンジが廃棄されたかどうかの情報をシステム内の所定の管理サーバで管理する。
(d3)薬液注入装置の制御部は、注入中の薬液圧力の推定値を、ロードセルとモータ電流との両方を用いて算出してもよい。
The chemical liquid injector and the system including the same are not limited to the above contents, and various modifications can be made as follows, for example:
(D1-1) The IC tag of the syringe may include information on whether or not to heat the syringe.
(D1-2) Print at least some items of information read from the IC tag of the syringe using a printer or the like. Alternatively, data including at least some items of information read from the IC tag of the syringe and chemical injection history data is printed using a printer or the like.
(D2) Information on whether the used syringe has been discarded is managed by a predetermined management server in the system.
(D3) The controller of the chemical liquid injector may calculate the estimated value of the chemical liquid pressure during the injection using both the load cell and the motor current.
(d4)薬液注入装置に注入動作を開始させるため、停止させるため、または終了させるため操作に関して、このような操作としては、
-注入ヘッドの物理ボタンを押す、
-コンソールのディスプレイ(メインディスプレイ)上の画像ボタンを押す、
-コンソールに設けられた物理ボタンを押す、
-サブディスプレイ上の画像ボタンを押す、
-コンソールのハンドスイッチを押す
 から選択される1つまたは複数の組合せが挙げられる。
(D4) With regard to the operation for starting, stopping, or terminating the injection operation of the chemical liquid injection device, as such an operation,
-Press the physical button on the injection head,
-Press the image button on the console display (main display),
-Press the physical button on the console,
-Press the image button on the sub-display,
-One or more combinations selected from pressing the hand switch on the console.
(d5-1)設定用初期画面において、画面上に所定のヘルプボタンが表示され、それを押すと、動作や画面上の表示についてのヘルプテキスト、ペルプ画像、音声としてのヘルプガイダンス、またはこれらの組合せが表示されるように、薬液注入装置の制御部が構成される。
(d5-2)設定用初期画面において表示される各種数値データの単位は適宜変更可能である。例えば、圧力については「Kg/cm」などではなく「psi」であってもよい。
(d5-3)コンソールの画面の一部(例えばアイコン373、図4A参照)に、造影剤名称(製品名など)を表示させる。薬液注入装置の制御部がこのような機能を有する。
(d5-4)コンソールの画面の一部に、そのコンソールが他の機器の接続されているか、または、接続されかつ連動する状態となっているかなどのステーテスを表示する。薬液注入装置の制御部がこのような機能を有する。
(D5-1) On the initial screen for setting, a predetermined help button is displayed on the screen, and when this button is pressed, help text on operation and display on the screen, help image as audio, help guidance as these, or these The controller of the chemical liquid injector is configured so that the combination is displayed.
(D5-2) The units of various numerical data displayed on the initial setting screen can be changed as appropriate. For example, the pressure may be “psi” instead of “Kg / cm 2 ”.
(D5-3) The contrast agent name (product name, etc.) is displayed on a part of the console screen (eg, icon 373, see FIG. 4A). The control unit of the chemical liquid injector has such a function.
(D5-4) A status such as whether the console is connected to another device or connected and linked is displayed on a part of the console screen. The control unit of the chemical liquid injector has such a function.
(d6-1)空のシリンジに薬液を吸引する方式の場合では、薬液注入装置は次のように構成されてもよい:
-シリンジを注入ヘッドにセットして、チューブを薬液ボトル等に接続した状態で、所定のボタンを押すとガスケットが前進してエア抜きを行う。ここで、所定のボタンとしては具体的な一例でオートフィルボタンであってもよい。
-次いで、薬液の吸引を行う。
-このステップとしては、まず、薬液を途中まで吸引する(すなわち、目的量の全量を引くのではなく、一部のみを引く)。
-次いで、再度エア抜きの動作を行う。
-その後、目的量となるまで薬液の吸引を継続する。この吸引は、上記最初の吸引速度と同じであってもよいし、そより速い速度であってもよい。その後、シリンジのピストン部材を少量前進させることで準備が完了する。
(D6-1) In the case of a method in which a chemical solution is sucked into an empty syringe, the chemical solution injection device may be configured as follows:
-With the syringe set in the injection head and the tube connected to a chemical bottle etc., press the predetermined button to advance the gasket and release the air. Here, the predetermined button may be an autofill button as a specific example.
-The chemical solution is then aspirated.
As this step, first, the chemical solution is aspirated halfway (ie, only a part is drawn, not the whole target amount).
-Next, the air bleeding operation is performed again.
-After that, continue sucking the chemical until the target amount is reached. This suction may be the same as the initial suction speed or may be faster. Thereafter, the preparation is completed by advancing the piston member of the syringe by a small amount.
(d6-2)注入ヘッドに傾斜センサが内蔵されている薬液注入装置としてもよい。この場合、制御部は、次の処理の一部または全部を行う:
-注入ヘッドが略垂直となっている状態(言い換えれば、シリンジが搭載されるヘッド前方が鉛直上方を向いた状態)かどうかを判定する。
-注入ヘッドが略垂直となっている状態の場合、オートフィル動作の実施を許容する。そうでない場合にはオートフィル動作は禁止する。
-注入ヘッドが水平姿勢もしくは前方が相対的に低くなった姿勢かどうかを判定する。
-これらの姿勢であって場合、薬液の注入動作を許容する。そうでない場合には、注入動作は禁止する。
(D6-2) A chemical solution injector in which an inclination sensor is built in the injection head may be used. In this case, the control unit performs part or all of the following processing:
-It is determined whether or not the injection head is in a substantially vertical state (in other words, the front of the head on which the syringe is mounted faces vertically upward).
-Allow the autofill operation to be performed if the injection head is in a substantially vertical state. Otherwise, autofill operation is prohibited.
Determine if the injection head is in a horizontal position or a position where the front is relatively low.
-In these postures, the liquid injection operation is allowed. Otherwise, the injection operation is prohibited.
(d7)仕上げた注入プロトコルの書き出しに関し、上書き等を禁止するロックをかける場合、そのロックの解除は、パスワード入力、生体認証、指紋認証、顔認証などから選択される1つまたは組合せを利用することができる。 (D7) When a lock that prohibits overwriting or the like is applied for writing the finished injection protocol, the lock is released using one or a combination selected from password input, biometric authentication, fingerprint authentication, face authentication, etc. be able to.
(d8-1)操作者が所定の入力を行うための装置(入力装置)としては、マウス、トラックボール、卓上コントローラ、キーボード、ペンタブレットなどを利用できる。他にも、これらとの組合せもしくは単独で、入力装置として音声入力やタッチパネルからの入力をも利用可能である。
(d8-2)他の例として、注入ヘッド、コンソール、ヘッドディスプレイ等に設けられた物理的ボタン等でもよい。また、音声入力、タッチセンサなどであってもよい。
(D8-1) As a device (input device) for an operator to perform a predetermined input, a mouse, a trackball, a desktop controller, a keyboard, a pen tablet, or the like can be used. In addition, a voice input or an input from a touch panel can be used as an input device in combination with or alone.
(D8-2) As another example, a physical button or the like provided on an injection head, a console, a head display, or the like may be used. Moreover, voice input, a touch sensor, or the like may be used.
(e1:延長チューブの一態様)
 延長チューブからのエア抜きのための動作としては、Aシリンジ(造影剤)側のピストン駆動機構を動作させ、次いで、Bシリンジ(生理食塩水)側のピストン駆動機構を動作させさせてもよい。あるいは、Aシリンジ(造影剤)側のピストン駆動機構とBシリンジ(生理食塩水)側のピストン駆動機構とを同時に動作させさせてもよい。図8Cの延長チューブのような構成の場合、チューブ末端の接続コネクタ510に液溜まりキャップを設けてもよい。この液溜まりキャップは、チューブからの薬液を受け止め、薬液が床や他の医療機器等の上に垂れることを防止する。薬液が機器の隙間等に浸入した場合、機器の故障や操作者の誤操作の原因となりうるが、このような構成によればそうした不具合の発生を低減させることができる。延長チューブのT管部分として、特開2011-217796に開示されたような部材を備える延長チューブである場合には、薬液注入を行う際の薬液どうしの混合をより効果的に実施でき、優れた造影効果を得ることが可能となる。
(E1: One mode of extension tube)
As an operation for bleeding air from the extension tube, the piston drive mechanism on the A syringe (contrast medium) side may be operated, and then the piston drive mechanism on the B syringe (physiological saline) side may be operated. Alternatively, the piston drive mechanism on the A syringe (contrast medium) side and the piston drive mechanism on the B syringe (physiological saline) side may be operated simultaneously. In the case of a configuration like the extension tube of FIG. 8C, a liquid pool cap may be provided on the connector 510 at the end of the tube. The liquid storage cap receives the chemical solution from the tube and prevents the chemical solution from dripping on the floor or other medical devices. When the chemical liquid enters the gaps between the devices, it may cause a failure of the device or an erroneous operation by the operator. However, according to such a configuration, occurrence of such a problem can be reduced. In the case of an extension tube having a member as disclosed in JP 2011-217796 as a T-tube portion of the extension tube, mixing of the chemicals when performing chemical injection can be performed more effectively, and it is excellent. A contrast effect can be obtained.
(e2:延長チューブの他の態様)
 以下、図10A~図10Cを参照して、2つの薬液が良好に混合されるようにミキシングデバイスを備えた延長チューブの一例について説明する。
(E2: Other embodiment of extension tube)
Hereinafter, with reference to FIGS. 10A to 10C, an example of an extension tube provided with a mixing device so that two chemical solutions are mixed well will be described.
 この延長チューブは、第1の薬液(例えば造影剤)が充填されるシリンジとミキシングデバイス241とを接続する第1のチューブ231aと、第2の薬液(例えば生理食塩水)が充填されるシリンジとミキシングデバイス241とを接続する第2のチューブ231bと、ミキシングデバイス241の液体出口(詳細下記)に接続され患者側へと延びる第3のチューブ231cとを有している。 The extension tube includes a first tube 231a that connects the syringe filled with the first drug solution (for example, contrast medium) and the mixing device 241, and a syringe filled with the second drug solution (for example, physiological saline). It has the 2nd tube 231b which connects the mixing device 241, and the 3rd tube 231c which is connected to the liquid outlet (detailed below) of the mixing device 241 and extends to the patient side.
 特に限定されるものではないが、第1および第2のチューブ231a、231bはそれぞれ接続コネクタ239a、239bを介してシリンジの導管部に接続されるようになっていてもよい。同様に、第3のチューブ231cも、接続コネクタ239cを介してカテーテル等に接続されるようになっていてもよい。 Although not particularly limited, the first and second tubes 231a and 231b may be connected to the conduit portion of the syringe via the connection connectors 239a and 239b, respectively. Similarly, the third tube 231c may be connected to a catheter or the like via the connection connector 239c.
 なお、薬液注入装置による薬液の注入前には、エア抜きを目的としたプライミングが行われる。このプライミングにはいくつかの方法があり、延長チューブ内が生理食塩水、造影剤のいずれかの薬液で満たされる。具体的な一例としては、(a)まず造影剤シリンジから造影剤を押し出し、ミキシングデバイスまでの第1のチューブを造影剤で満たす。次いで、生理食塩水シリンジから生理食塩水を押し出して、第2のチューブ、ミキシングデバイス、第3のチューブ、および、カテーテルまでを生理食塩水で満たす。これにより街路全体が薬液で満たされ、エアが抜かれた状態となる。他にも、(b)まず、造影剤シリンジから造影剤を押し出し、次いで生理食塩水シリンジから生理食塩水を押し出した後に、両シリンジから同時に薬液を押し出す方法や、(c)まず生理食塩水シリンジから生理食塩水を押し出し、次いで造影剤シリンジから造影剤を押し出して薬液の回路全体を薬液で満たす方法などもある。 In addition, priming for the purpose of releasing air is performed before the injection of the chemical solution by the chemical solution injection device. There are several methods for this priming, and the extension tube is filled with either a physiological saline solution or a contrast medium. As a specific example, (a) First, the contrast agent is pushed out from the contrast agent syringe, and the first tube up to the mixing device is filled with the contrast agent. Then, the physiological saline is pushed out from the physiological saline syringe, and the second tube, the mixing device, the third tube, and the catheter are filled with the physiological saline. As a result, the entire street is filled with the chemical solution and the air is removed. In addition, (b) a method of first extruding a contrast medium from a contrast medium syringe, then extruding a physiological saline solution from a physiological saline syringe, and then simultaneously extruding a drug solution from both syringes, or (c) a first physiological saline syringe There is also a method in which the physiological saline is extruded from the contrast medium, and then the contrast medium is extruded from the contrast medium syringe to fill the entire circuit of the chemical liquid with the chemical liquid.
 なお、薬液注入装置には上記のようなプライミング動作を自動的に行わせる機能が備わっていてもよく、また、プライミング動作開始のトリガとなるものは例えば操作者による入力操作であってもよい。 The chemical injection device may have a function for automatically performing the priming operation as described above, and the trigger for starting the priming operation may be an input operation by an operator, for example.
 続いて、ミキシングデバイス241について、詳しく説明する。ミキシングデバイス241は、図10A、図10Bに示すように、旋回流を生成する旋回流生成室242aである第1室と、旋回流を軸方向に集中させる狭窄室242bである第2室と有する本体部242を備えている。この例では、旋回流生成室242aは円柱状の内部空間を有し、狭窄室242bは旋回流生成室242aと共軸の円錐状の内部空間を有する。なお、旋回流生成室の短手方向の断面形状は、円、楕円、その他の曲線から形成される種々の形状が考えられる。また、旋回流生成室は、狭窄室に近づくにつれて先が狭まる狭窄形状を有するように構成することもできる。 Subsequently, the mixing device 241 will be described in detail. As shown in FIGS. 10A and 10B, the mixing device 241 includes a first chamber that is a swirl flow generation chamber 242a that generates a swirl flow, and a second chamber that is a constriction chamber 242b that concentrates the swirl flow in the axial direction. A main body 242 is provided. In this example, the swirl flow generation chamber 242a has a cylindrical inner space, and the constriction chamber 242b has a conical inner space coaxial with the swirl flow generation chamber 242a. The cross-sectional shape in the short direction of the swirl flow generating chamber may be various shapes formed from a circle, an ellipse, or other curves. In addition, the swirl flow generation chamber can be configured to have a narrowed shape that narrows as it approaches the narrowed chamber.
 ミキシングデバイス241の本体部242の流れ上流側には第1のチューブ231aが接続される導管部243aが設けられ、下流側には第3のチューブ231cが接続される導管部243cが設けられている。第2のチューブ231bが接続される導管部243bは、旋回流生成室242aの中央から上流側の位置に配置されている(詳細下記)。 A conduit portion 243a to which the first tube 231a is connected is provided on the upstream side of the main body portion 242 of the mixing device 241, and a conduit portion 243c to which the third tube 231c is connected is provided on the downstream side. . The conduit portion 243b to which the second tube 231b is connected is disposed at a position upstream from the center of the swirl flow generation chamber 242a (details below).
 この例では、導管部243aから造影剤が流入するとともに導管部243bから生理食塩水が流入し、ミキシングデバイス内で両薬液が混合される。その後、造影剤及び生理食塩水の混合薬液は、液体出口としての導管部243cから流出する。 In this example, the contrast agent flows from the conduit portion 243a and the physiological saline flows from the conduit portion 243b, and both drug solutions are mixed in the mixing device. Thereafter, the mixed drug solution of the contrast medium and physiological saline flows out from the conduit portion 243c as a liquid outlet.
 比重の大きい薬液が流入する導管部243aは、流れ方向の上流側において、旋回流生成室242a上流側壁面の中央部に設けられている。液体出口である導管部243cは、この導管部243cの中心線と導管部243aの中心線とが一致するように、すなわち両者が共軸となるように設けられている。各部が共軸を有するように配置することにより、ミキシングデバイス内において発生する渦の等方性を高めることができる。つまり、渦を空間内で淀みなく均一に発生させ,混合効率を向上させることができる。 The conduit portion 243a into which a high specific gravity chemical solution flows is provided in the central portion of the upstream side wall surface of the swirl flow generation chamber 242a on the upstream side in the flow direction. The conduit portion 243c serving as the liquid outlet is provided so that the center line of the conduit portion 243c and the center line of the conduit portion 243a coincide, that is, both are coaxial. By arranging each part so as to have a coaxial axis, it is possible to increase the isotropic property of the vortex generated in the mixing device. That is, vortices can be generated uniformly in the space without stagnation, and the mixing efficiency can be improved.
 他方、比重の小さい薬液が流入する導管部243bは、は、旋回流生成室242aの側面に配置けられ、断面円形である旋回流生成室242aの円周の接線方向に延在する。別の言い方をすれば、導管部243bは、旋回流生成室242aが有する円柱状空間の中心軸線からの周縁側にずれた位置に設けられ、これにより、導管部243bから流入した比重の小さい薬液の旋回流が生成されるようになっている。より詳しくは、図10Cに示すように、流路241fbが、旋回流生成室242aの湾曲した内面の円周接線方向に延在するように構成されており、これにより、この流路から流入した薬液が旋回流となる。さらに狭窄室242bは、図面からも明らかなように、流れ方向下流側に向かってすぼまる傾斜した内面を有しているので、発生した旋回流は、渦の中心軸方向に集中することになる。 On the other hand, the conduit portion 243b into which the chemical liquid having a small specific gravity flows is disposed on the side surface of the swirl flow generation chamber 242a and extends in the tangential direction of the circumference of the swirl flow generation chamber 242a having a circular cross section. In other words, the conduit portion 243b is provided at a position shifted to the peripheral side from the central axis of the cylindrical space included in the swirl flow generation chamber 242a, and thereby, the chemical liquid having a small specific gravity flowing from the conduit portion 243b. The swirl flow is generated. More specifically, as shown in FIG. 10C, the flow path 241fb is configured to extend in the circumferential tangential direction of the curved inner surface of the swirl flow generation chamber 242a, and thereby flows from this flow path. The chemical becomes a swirl flow. Further, as is clear from the drawing, the constriction chamber 242b has an inclined inner surface that swells toward the downstream side in the flow direction, so that the generated swirling flow is concentrated in the direction of the central axis of the vortex. Become.
 また、造影剤が流入する導管部243aは、流路241faを介して旋回流生成室242aと連通している。これにより、比重の大きい薬液を、比重の小さい薬液の旋回流の中心軸と平行な方向で旋回流生成室に導入することができる。つまり、比重の大きい薬液は、旋回流生成室が有する円柱状空間の中心軸線と平行な方向に導入される。また、生理食塩水が流入する導管部は、流路241fbを介して旋回流生成室と連通している。一例で、流路241fbの内径は、造影剤(一例)が流入する流路241faの内径よりも小さく形成されていてもよい。こうした構成によれば、所定の圧力で薬液を注入する場合、断面積が相対的に小さい流路241fbから流入する比重の小さい薬液の流速が、比重の大きい薬液の流速よりも速くなる。したがって、比重の小さい薬液の流速が遅い場合に生じうる、旋回流の慣性力の減衰やそれに伴う旋回強度の不足に起因する、薬液どうしの混合効率の低下を回避することができる。 Also, the conduit portion 243a into which the contrast agent flows is in communication with the swirling flow generation chamber 242a through the flow path 241fa. Thereby, the chemical liquid having a large specific gravity can be introduced into the swirling flow generating chamber in a direction parallel to the central axis of the swirling flow of the chemical liquid having a small specific gravity. That is, the chemical liquid having a large specific gravity is introduced in a direction parallel to the central axis of the cylindrical space included in the swirl flow generation chamber. Further, the conduit part into which the physiological saline flows is in communication with the swirl flow generation chamber via the flow path 241fb. For example, the inner diameter of the flow path 241fb may be smaller than the inner diameter of the flow path 241fa into which the contrast agent (one example) flows. According to such a configuration, when a chemical solution is injected at a predetermined pressure, the flow rate of the chemical solution having a small specific gravity flowing from the flow path 241fb having a relatively small cross-sectional area becomes faster than the flow rate of the chemical solution having a large specific gravity. Therefore, it is possible to avoid a decrease in the mixing efficiency between the chemical solutions due to the attenuation of the inertial force of the swirling flow and the accompanying lack of swirling strength, which can occur when the flow rate of the chemical solution having a small specific gravity is low.
 上記のように構成されたミキシングデバイス241では、例えば造影剤および生理食塩水を同デバイス内に流入させると、流路faから旋回流生成室に流入した造影剤は軸方向下流側に向かう流れとなる。一方、流路241fbから旋回流生成室に流入した生理食塩水は、同室内の湾曲した内面に沿って旋回する旋回流となり、そして、生理食塩水の旋回流は、狭窄室に導かれて旋回流の中心軸方向に集中する。このような渦はランキン渦として知られ、旋回流のもつ慣性力を渦の回転軸の近傍に集中させることができる。 In the mixing device 241 configured as described above, for example, when a contrast agent and physiological saline are flowed into the device, the contrast agent that has flowed into the swirl flow generation chamber from the flow channel fa flows toward the downstream side in the axial direction. Become. On the other hand, the physiological saline flowing into the swirl flow generation chamber from the flow path 241fb becomes a swirl flow swirling along the curved inner surface of the same chamber, and the swirl flow of the physiological saline is guided to the stenosis chamber and swirls. Concentrate in the direction of the central axis of the flow. Such a vortex is known as a Rankine vortex, and the inertial force of the swirling flow can be concentrated in the vicinity of the rotation axis of the vortex.
 そしてこのようなミキシングデバイス241を有する延長チューブで2つの薬液の同時注入を行う場合、両薬液が良好に混合されることとなる。すなわち、この例では、造影剤と生理食塩水とが良好に混合された希釈造影剤を得ることができ、その結果、造影剤の濃度のムラ等が無くなるので一般的な分岐チューブの場合と比較して優れた造影効果が期待できる。 And when performing the simultaneous injection of two chemicals with an extension tube having such a mixing device 241, both chemicals will be mixed well. That is, in this example, it is possible to obtain a diluted contrast agent in which the contrast agent and physiological saline are well mixed, and as a result, there is no unevenness in the concentration of the contrast agent. Therefore, an excellent contrast effect can be expected.
 さらに、このような延長チューブを用い、生理食塩水の後押し注入(すなわち薬液の同時注入ではなく生理食塩水のみの注入)を行う場合、生理食塩水の旋回流を生じさせることができ、その結果、一般的な分岐チューブで生理食塩水の後押し注入を行う場合と比較して造影効果をより向上させる(具体的にはより高いHU値を得る)ことができると考えられる。 In addition, when such an extension tube is used for boost injection of physiological saline (that is, injection of only physiological saline rather than simultaneous injection of chemical solutions), a swirling flow of physiological saline can be generated. It is considered that the contrast effect can be further improved (specifically, a higher HU value can be obtained) as compared with the case where physiological saline is boosted and injected with a general branch tube.
(ディスプレイに表示される画像例)
 上記実施形態では、身体区分や撮像部位といった撮像対象を特定する情報を入力または選択し、それに基いて(当然ながら、この情報だけでなく、例えば患者体重等の他の情報にも基いてよい)、システムが注入条件を決定することについて触れたが、このような部位選択が行われる場合、図11のような設定確認画面(グラフィカル・ユーザ・インターフェース)が表示されるようになっていてもよい。
(Image example displayed on the display)
In the above-described embodiment, information specifying an imaging target such as a body classification and an imaging part is input or selected, and based on the information (of course, it may be based not only on this information but also on other information such as patient weight). As mentioned above, the system determines the injection conditions. When such a site selection is performed, a setting confirmation screen (graphical user interface) as shown in FIG. 11 may be displayed. .
 図11の画面では、画面上部にステータスバー721-1が表示され、その下にもう1つのステータスバー721-2が表示され、その下に設定した注入パターンのグラフが表示されている。 In the screen of FIG. 11, a status bar 721-1 is displayed at the top of the screen, another status bar 721-2 is displayed below it, and a graph of the injection pattern set below it is displayed.
 ステータスバー721-1内には、例えば、タイミングテスト画面に移行するためのアイコン722aや、ルート確認画面に移行するためのアイコン722bが表示されていてもよい。ステータスバー721-2内には、患者の体重情報、単位体重あたり必要とされる造影剤ヨード量の情報、注入時間の情報のうちの1つまたは複数が表示される。 In the status bar 721-1, for example, an icon 722a for shifting to the timing test screen and an icon 722b for shifting to the route confirmation screen may be displayed. In the status bar 721-2, one or more of patient weight information, information on the contrast medium iodine amount required per unit weight, and information on injection time are displayed.
 この例では、特に、部位選択で選択された患者の部位が視覚的に分かるように画像化された人体型の部位表示アイコン723が表示されている。なお、図では部位表示アイコン723が下段のステータスバー721-2内に表示されている例が示されているが、このアイコン723は画面内の任意の位置に表示可能である。 In this example, in particular, a human body-shaped part display icon 723 is displayed so that the part of the patient selected by the part selection can be visually recognized. In the figure, an example in which the part display icon 723 is displayed in the lower status bar 721-2 is shown, but this icon 723 can be displayed at an arbitrary position on the screen.
 部位表示アイコン723を押すと、撮像部位を選択するための画面に戻るようになっており、したがって、操作者は、図11のような確認画面で撮像部位を変更したいと思った場合にはこのアイコン723を押して部位の再選択を行うことができる。また、部位選択アイコン723は、現在選択されている部位が例えば反転表示されるなどして分かるようになっているので、操作者が図11の画面を見た際に、選択された部位の確認を行いやすい。 When the region display icon 723 is pressed, the screen returns to the screen for selecting the imaging region. Therefore, when the operator wants to change the imaging region on the confirmation screen as shown in FIG. A part can be reselected by pressing the icon 723. Further, the part selection icon 723 can be recognized by highlighting the currently selected part, for example, so that the operator can confirm the selected part when viewing the screen of FIG. Easy to do.
(注入パターンの画面上での修正例)
 注入グラフ上に表示されている注入パターン(線分)368は、図13Aおよび図13Bのような方式で変更可能となっていてもよい。
(Example of correction on the injection pattern screen)
The injection pattern (line segment) 368 displayed on the injection graph may be changeable by a method as shown in FIGS. 13A and 13B.
 図13A(a)では、一例で、第1フェーズにおいて可変定数が1.0、注入速度が3.0ml/secの注入パターン368が示されている。ここで、例えば、終端速度を変えたい場合、操作者は注入パターンの端部368qをタッチする。なお、当然ながら、タッチパネルではない場合には画面上のカーソルにより端部368qを選択してもよい。 FIG. 13A (a) shows an injection pattern 368 with a variable constant of 1.0 and an injection speed of 3.0 ml / sec in the first phase as an example. Here, for example, when it is desired to change the terminal speed, the operator touches the end 368q of the injection pattern. Of course, if the touch panel is not a touch panel, the end 368q may be selected by a cursor on the screen.
 すると、図13A(b)に示すように、端部368qの位置が変更可能な状態となる(例えば端部368qを囲むようなマーカ表示が表れてもよい)。そして、図13A(c)に示すように、この状態で操作者が例えば2.0ml/secの格子点付近をタッチすると、端部368qの位置が変わり、注入パターン(線分)368の終端速度が変更されることとなる。なお、注入パターンの始端速度を変更する場合にもこれと同様の変更方式で行うことができる。 Then, as shown in FIG. 13A (b), the position of the end 368q can be changed (for example, a marker display surrounding the end 368q may appear). Then, as shown in FIG. 13A (c), when the operator touches, for example, the vicinity of a lattice point of 2.0 ml / sec in this state, the position of the end portion 368q is changed, and the terminal velocity of the injection pattern (line segment) 368 is changed. Will be changed. Note that the same change method can be used to change the starting speed of the implantation pattern.
 本実施形態のシステムがこのようなグラフィカル・ユーザ・インターフェースを提供するものである場合、操作者は注入グラフ上で直感的に注入速度を修正することができる。 When the system of this embodiment provides such a graphical user interface, the operator can intuitively correct the injection speed on the injection graph.
 また、この他にも、例えば図13B(a)の状態で注入パターン368の端部368qを選択すると、より具体的には、図13Aの場合と異なる方式(例えば、長押しする(一定時間タッチし続ける)または2回ないし複数回タッチする等)端部368qを選択すると、図13B(b)のようなポップアップウィンドウ377が表示されるようになっていてもよい。 In addition to this, for example, when the end portion 368q of the implantation pattern 368 is selected in the state of FIG. 13B (a), more specifically, a method different from the case of FIG. If the end portion 368q is selected), a pop-up window 377 as shown in FIG. 13B (b) may be displayed.
 このポップアップウィンドウ377は、数値を直接入力する数値入力部377aと、増加ボタンおよび減少ボタン377bとの少なくとも一方を有している。図13B(b)では、今、注入速度は「3.0」であるが、これを「4.0」に変えたい場合には、図示するように数値入力部377aを選択して4.0と入力する。この入力は、例えば画面上のテンキー等を介して行うことができる。そして、リターンキー(決定キー)をタッチすることで、注入速度は「3.0」から「4.0」に変わり、図示は省略するが、注入パターン(線分)368の表示位置が変更される。なお、このような数値入力ではなく、増加ボタンおよび減少ボタン377bで所定の速度に変更し、リターンキー(決定キー)をタッチすることで速度の変更を行ってもよい。 The pop-up window 377 has at least one of a numerical value input unit 377a for directly inputting a numerical value and an increase button and a decrease button 377b. In FIG. 13B (b), the injection rate is “3.0”, but when it is desired to change it to “4.0”, the numerical value input unit 377a is selected as shown in the drawing to 4.0. Enter. This input can be performed via, for example, a numeric keypad on the screen. By touching the return key (decision key), the injection speed is changed from “3.0” to “4.0”, and although not shown, the display position of the injection pattern (line segment) 368 is changed. The Instead of such numerical input, the speed may be changed by changing to a predetermined speed with the increase button and the decrease button 377b and touching a return key (decision key).
(ディスプレイコントロールユニットでの表示制御)
 図14は、本発明の一形態のコンピュータシステムのブロック図である。このコンピュータシステム1500は、一例で薬液注入装置のコンソールを構成するが、それに限定されるものではない。
(Display control with display control unit)
FIG. 14 is a block diagram of a computer system according to one embodiment of this invention. The computer system 1500 constitutes a console of the chemical liquid injector by way of example, but is not limited thereto.
 コンピュータシステム1500は、具体的には以下のような構成要素の一部または全部を備えるものであってもよい:全体的な制御を行うメインコントローラ1510と、ディスプレイコントロールユニット(画面表示回路)1530と、記憶装置1520と、ディスプレイモニタ(不図示)等にデータを出力するための出力インターフェース1512aと、操作者からの種々の入力を可能とする入力手段1513と、コンピュータ可読媒体からデータを読み込むスロット1515と、外部機器との通信等を行う入力インターフェース1512b等。 Specifically, the computer system 1500 may include some or all of the following components: a main controller 1510 that performs overall control, a display control unit (screen display circuit) 1530, and the like. , A storage device 1520, an output interface 1512a for outputting data to a display monitor (not shown), an input means 1513 enabling various inputs from an operator, and a slot 1515 for reading data from a computer readable medium And an input interface 1512b for performing communication with an external device.
 メインコントローラ1510は、一例で、CPUやメモリ、コンピュータプログラム等を有するプロセッサユニットであってもよく、図面では1つのものとして描かれているが、複数のコントローラによって構成されるものであってもよい。 For example, the main controller 1510 may be a processor unit having a CPU, a memory, a computer program, and the like, and is illustrated as one in the drawing, but may be configured by a plurality of controllers. .
 ディスプレイコントロールユニット1530は、例えばソフトウェアの機能として提供されるものであってもよいし、電気回路として提供されるものであってもよいし、それらの組合せであってもよい。入力手段1513を通じた操作者からの所定の入力、または、外部機器からの所定の入力があったときに、メインコントローラ1510がそれをトリガとして、所定の動作信号をディスプレイコントロールユニット1530に与え、ディスプレイコントロールユニット1530に一定の動作を行わせてディスプレイモニタに所定の画面、アイコン、警告メッセージ、グラフィカル・ユーザ・インターフェース等を表示させる。 The display control unit 1530 may be provided as a software function, may be provided as an electric circuit, or may be a combination thereof. When there is a predetermined input from the operator through the input means 1513 or a predetermined input from an external device, the main controller 1510 gives a predetermined operation signal to the display control unit 1530 as a trigger, The control unit 1530 performs a certain operation to display a predetermined screen, icon, warning message, graphical user interface, etc. on the display monitor.
 ディスプレイモニタとしては、情報を表示できるものであればどのようなものであっても構わないが、例えば液晶ディスプレイ(LCD:Liquid Crystal Display)や有機ELディスプレイ等であってもよい。モニタの数は特に限定されるものではなく、1つまたは複数であってもよい。1つまたは複数のモニタが、コンピュータシステムとは別個に(離隔した位置に)、任意の位置に配置されてもよい。この場合、コンピュータシステムとそれらモニタとの間の接続は、例えば有線接続であってもよいし無線接続であってもよい。 The display monitor may be any display monitor as long as it can display information. For example, a liquid crystal display (LCD) or an organic EL display may be used. The number of monitors is not particularly limited, and may be one or more. One or more monitors may be located at any location, separate from the computer system (at a distance). In this case, the connection between the computer system and these monitors may be, for example, a wired connection or a wireless connection.
 入力手段1513は、キーボード、マウス、トラックボール、音声入力、グラフィカル・ユーザ・インターフェース等から選ばれる1つまたは2つ以上であってもよい。入力手段1513を通じて医師等からの指令が入力されうる。 The input means 1513 may be one or two or more selected from a keyboard, mouse, trackball, voice input, graphical user interface, and the like. A command from a doctor or the like can be input through the input unit 1513.
 スロット1515は、別の言い方をすれば媒体読取部ということもできる。すなわち、コンピュータ可能媒体から接触式または非接触式でデータを読み取ることができるユニットであってもよい。このコンソールC150は、撮像装置C300と注入ヘッドC110の両方の動作を制御する共通コンソールとして構成することもできる。 In other words, the slot 1515 can be called a medium reading unit. That is, it may be a unit that can read data from a computer-readable medium in a contact type or a non-contact type. The console C150 can also be configured as a common console that controls the operations of both the imaging device C300 and the injection head C110.
 記憶装置1520には、グラフィカル・ユーザ・インターフェースのデータや、注入プロトコルを設定する際に使用されるデータテーブルや数式等の種々のデータが記憶されていてもよい。 The storage device 1520 may store various data such as graphical user interface data and data tables and mathematical formulas used when setting the injection protocol.
 このようなコンピュータシステム1500であっても、すなわち、上記実施形態のような薬液注入装置のコンソールではないコンピュータシステムであっても、注入プロトコルの設定画面(グラフィカル・ユーザ・インターフェース)を提供できるものである限り、上述した本発明の一形態のものと同様の作用効果を奏することができる。 Even in such a computer system 1500, that is, a computer system that is not a console of the chemical solution injection apparatus as in the above embodiment, an injection protocol setting screen (graphical user interface) can be provided. As long as there is a certain effect, the same effects as those of the above-described embodiment of the present invention can be obtained.
 コンピュータシステムとしては、前述の説明からも明らかなように、撮像装置内に組み込まれたもの、あるいは、撮像装置のコンソールとして機能するものとして構成することができる。 As is apparent from the above description, the computer system can be configured to be incorporated in the imaging apparatus or to function as a console of the imaging apparatus.
(撮像装置コンソール)
 図15では、ガントリC303とベッドC304を備える撮像装置C300と、その動作制御を行う撮像装置コンソールC150と、薬液注入装置の注入ヘッドC110が描かれている。コンピュータシステムは、この例では、撮像装置コンソールC150であってもよい。撮像装置コンソールC150において設定された注入プロトコルを撮像装置コンソールC150から注入ヘッドC110に転送し、注入ヘッドC110がそれにしたがって動作してもよい。
 
(Imaging device console)
In FIG. 15, an imaging device C300 including a gantry C303 and a bed C304, an imaging device console C150 that controls the operation of the imaging device C300, and an injection head C110 of a chemical injection device are illustrated. In this example, the computer system may be an imaging device console C150. The injection protocol set at the imaging device console C150 may be transferred from the imaging device console C150 to the injection head C110, and the injection head C110 may operate accordingly.
(付記1)
 本出願は下記の発明を開示する:
1.シリンジのピストン部材を動作させるピストン駆動機構(130)と、
 そのピストン駆動機構の動作を制御する制御部(144、153)と、
 所定の情報を表示するための表示ユニット(151)と、
 操作者からの入力を受け付ける入力装置(151、157)と、
 を備える薬液注入装置(100)であって、
 前記制御部(144、153)は、
a:前記表示ユニットに、複数の注入プロトコル設定モードの中から1つを選択するためのモード選択用表示部(363)を少なくとも含む設定用初期画面(360)を表示させ、
b:所定の注入プロトコル設定モードが選択された後、縦軸および横軸の一方が注入速度で他方が注入時間であり少なくとも1つのフェーズを含む注入グラフ(361)への操作者からの注入パターンの入力を受け付け、
c:前記注入グラフ(361)上に入力された注入パターンに基づいて薬液の注入プロトコルを作成し、
d:作成された前記注入プロトコルに従って前記ピストン駆動機構(130)を動作させ、薬液を注入する、
 薬液注入装置(100)。
(Appendix 1)
This application discloses the following inventions:
1. A piston drive mechanism (130) for operating the piston member of the syringe;
Control units (144, 153) for controlling the operation of the piston drive mechanism;
A display unit (151) for displaying predetermined information;
Input devices (151 and 157) for receiving input from the operator;
A chemical injection device (100) comprising:
The control units (144, 153)
a: causing the display unit to display a setting initial screen (360) including at least a mode selection display unit (363) for selecting one of a plurality of injection protocol setting modes;
b: After a predetermined injection protocol setting mode is selected, an injection pattern from the operator to the injection graph (361) including one at the vertical axis and the horizontal axis at the injection speed and the other as the injection time and including at least one phase. Is accepted,
c: Create a chemical injection protocol based on the injection pattern entered on the injection graph (361),
d: operating the piston drive mechanism (130) in accordance with the created injection protocol to inject a chemical solution;
Chemical injection device (100).
2.前記複数の注入プロトコル設定モードとして、
(i)前記注入グラフ上の1つのフェーズまたは複数のフェーズに注入パターンを入力することで全体として1つの注入パターンが作成される、フローレートモードと、
(ii)少なくとも患者の体重に基づいて薬液の造影量が予め決定され、次いで、前記注入グラフ上の1つのフェーズまたは複数のフェーズに注入パターンを入力することで全体として1つの注入パターンが作成される第1の体重入力モードと、
(iii)少なくとも患者の体重に基づいて薬液の初速度が予め決定され、次いで、前記注入グラフ上の1つのフェーズまたは複数のフェーズに注入パターンを入力することで全体として1つの注入パターンが作成される第2の体重入力モードと、
 のうち少なくとも2つが選択可能である、上記記載の薬液注入装置。
2. As the plurality of injection protocol setting modes,
(I) a flow rate mode in which an injection pattern is created as a whole by inputting an injection pattern in one phase or a plurality of phases on the injection graph;
(Ii) The contrast amount of the drug solution is determined in advance based on at least the weight of the patient, and then an injection pattern is created as a whole by inputting the injection pattern in one phase or a plurality of phases on the injection graph. A first weight input mode,
(Iii) The initial velocity of the drug solution is determined in advance based on at least the patient's weight, and then an injection pattern is created as a whole by inputting the injection pattern in one phase or a plurality of phases on the injection graph. A second weight input mode,
The said chemical | medical solution injection | pouring apparatus of the said description whose at least 2 can be selected.
3.独立して動作する2つの前記ピストン駆動機構(130)を備え、前記薬液として造影剤と生理食塩水とを注入するように構成され、
 前記制御部(144、153)は、操作者が前記注入グラフの1フェーズにおいて注入パターンを作成するためのポップアップ画面(371)を表示し、
 前記ポップアップ画面(371)は、
-当該フェーズにおける注入パターンの傾きに係わるパラメータを入力するための表示部(371a)、
-当該フェーズの注入時間を入力するための表示部(371b)、および、
-当該フェーズの注入速度を入力するための表示部、
 のうち少なくとも1つを含む、上記記載の薬液注入装置。
3. Two piston drive mechanisms (130) that operate independently, and configured to inject a contrast medium and physiological saline as the drug solution;
The control unit (144, 153) displays a pop-up screen (371) for an operator to create an injection pattern in one phase of the injection graph,
The pop-up screen (371)
A display unit (371a) for inputting parameters relating to the inclination of the implantation pattern in the phase;
-A display (371b) for inputting the injection time of the phase, and
-A display for entering the injection rate of the phase,
The said chemical | medical solution injection device containing at least 1 among these.
4.注入パターンの傾きに係わる前記パラメータが、注入速度の終速度と初速度との比として表わされる可変定数である、上記記載の薬液注入装置。 4). The said chemical | medical solution injection | pouring apparatus of the said description whose said parameter regarding the inclination of an injection | pouring pattern is a variable constant represented as ratio of the final velocity of an injection | pouring speed | rate and an initial velocity.
5.独立して動作する2つの前記ピストン駆動機構(130)を備え、前記薬液として造影剤と生理食塩水とを注入するように構成され、
 前記制御部(144、153)は、操作者が前記注入グラフの1フェーズにおいて注入パターンを作成するためのポップアップ画面(371)を表示し、
 前記ポップアップ画面(371)は、
-前記生理食塩水の注入パターンを作成するための表示部(372a)であって、造影剤の注入速度が一定速度の場合に当該表示部(372a)を選択すると、希釈注入を行うために、当該フェーズ内に一定速度の生理食塩水の注入パターンが表示される、希釈注入表示部(372b)を含む、
 上記記載の薬液注入装置。
5. Two piston drive mechanisms (130) that operate independently, and configured to inject a contrast medium and physiological saline as the drug solution;
The control unit (144, 153) displays a pop-up screen (371) for an operator to create an injection pattern in one phase of the injection graph,
The pop-up screen (371)
A display unit (372a) for creating the physiological saline injection pattern, and when the display unit (372a) is selected when the injection rate of the contrast medium is constant, Including a dilution injection display (372b) in which a constant rate saline injection pattern is displayed within the phase;
The above-mentioned chemical injection device.
6.さらに、
 所定のフェーズ内で一定速度の造影剤の注入パターンと一定速度の生理食塩水の注入パターンとが表示されている場合に、前記希釈注入表示部(372b)を選択すると、造影剤と生理食塩水との混和比率を示す表示部(371c)が表示される、
 上記記載の薬液注入装置。
6). further,
When a contrast medium injection pattern and a constant saline injection pattern are displayed within a predetermined phase, when the dilution injection display unit (372b) is selected, the contrast medium and the saline are selected. A display part (371c) showing the mixing ratio with is displayed.
The above-mentioned chemical injection device.
7.さらに、
 造影剤の注入パターンが傾斜したパターンである場合に、前記希釈注入表示部(372b)を選択すると、造影剤の注入速度と生理食塩水の注入速度との和が当該フェーズにおいて実質的に一定となるように、所定の基準線を基準として前記造影剤の注入パターンと線対称形となる生理食塩水の注入パターン(368b)が表示される、
 上記記載の薬液注入装置。
7). further,
If the injection pattern of the contrast medium is an inclined pattern and the dilution injection display section (372b) is selected, the sum of the contrast medium injection speed and the physiological saline injection speed is substantially constant in the phase. As shown, a saline injection pattern (368b) that is symmetrical with the contrast agent injection pattern with respect to a predetermined reference line is displayed.
The above-mentioned chemical injection device.
8.独立して動作する2つの前記ピストン駆動機構(130)を備え、前記薬液として造影剤と生理食塩水とを注入するように構成され、
 前記制御部(144、153)は、操作者が前記注入グラフの1フェーズにおいて注入パターンを作成するためのポップアップ画面(371)を表示し、
 前記ポップアップ画面(371)は、
-当該フェーズの次のフェーズ内に、生理食塩水によるフラッシュ注入のための注入パターンを追加するためのフラッシュ注入表示部(372a)を含む、
 上記記載の薬液注入装置。
8). Two piston drive mechanisms (130) that operate independently, and configured to inject a contrast medium and physiological saline as the drug solution;
The control unit (144, 153) displays a pop-up screen (371) for an operator to create an injection pattern in one phase of the injection graph,
The pop-up screen (371)
-Including a flash infusion display (372a) for adding an infusion pattern for flush infusion with saline within the next phase of the phase;
The above-mentioned chemical injection device.
9.独立して動作する2つの前記ピストン駆動機構(130)を備え、前記薬液として造影剤と生理食塩水とを注入するように構成され、
 前記制御部(144、153)は、操作者が前記注入グラフの1フェーズにおいて注入パターンを作成するためのポップアップ画面(371)を表示し、
 前記ポップアップ画面(371)は、
 造影剤の注入パターンを作成するための表示部(372c)であって、当該表示部を選択すると、速度が所定の初速度からゼロもしくは実質的ゼロの終速度へと変化するような形状の注入パターンが表示される、傾斜パターン表示部(372c)を含む、
 上記記載の薬液注入装置。
9. Two piston drive mechanisms (130) that operate independently, and configured to inject a contrast medium and physiological saline as the drug solution;
The control unit (144, 153) displays a pop-up screen (371) for an operator to create an injection pattern in one phase of the injection graph,
The pop-up screen (371)
A display unit (372c) for creating an injection pattern of a contrast agent, and when the display unit is selected, injection is performed such that the speed changes from a predetermined initial speed to a zero or substantially zero final speed. Including an inclined pattern display part (372c) on which a pattern is displayed;
The above-mentioned chemical injection device.
10.前記制御部(144、153)が、さらに、
 検査対象となる患者の身体区分および撮像区分の少なくとも一方の情報の入力を受け付け、
 入力された身体区分または撮像区分の情報に少なくとも基づいて、患者に注入すべき注入量の計算を行う、
 上記記載の薬液注入装置。
10. The control unit (144, 153) further includes
Accepts input of information on at least one of the body category and imaging category of the patient to be examined,
Calculate the infusion volume to be infused into the patient based at least on the input body segment or imaging segment information;
The above-mentioned chemical injection device.
11.前記制御部(144、153)が、さらに、
 患者の身体情報のうち少なくとも患者の体重の情報の入力を受け付け、
 入力された前記体重の情報に少なくとも基づいて、患者に注入すべき注入量の計算を行う、
 上記記載の薬液注入装置。
11. The control unit (144, 153) further includes
Accept at least patient weight input from patient physical information,
Calculating an infusion volume to be infused into the patient based at least on the inputted weight information;
The above-mentioned chemical injection device.
12.前記制御部(144、153)が、さらに、
 造影剤のヨード量の情報の入力を受け付け、
 入力された前記ヨード量の情報に少なくとも基づいて、患者に注入すべき注入量の計算を行う、
 上記記載の薬液注入装置。
12 The control unit (144, 153) further includes
Accept the input of the contrast medium iodine amount,
Calculating an infusion volume to be infused into the patient based at least on the input iodine amount information;
The above-mentioned chemical injection device.
13.前記制御部(144、153)が、さらに、
 患者の身体情報のうち少なくとも患者の体重の情報と、造影剤のヨード量の情報との入力を受け付け、
 入力されたそれらの情報に少なくとも基づいて造影剤の初速度の計算を行う、
 上記記載の薬液注入装置。
13. The control unit (144, 153) further includes
Accept at least the patient's body weight information and the contrast medium iodine amount information of the patient's physical information,
Calculate the initial velocity of the contrast agent based at least on those information entered,
The above-mentioned chemical injection device.
14.シリンジが取外し可能に装着される注入ヘッド(110)と、
 その注入ヘッド(110)に接続されたコンソール(150)と、を備え、
 前記注入ヘッドが前記ピストン駆動機構を有し、前記コンソールが前記制御部を有する、上記記載の薬液注入装置。
14 An injection head (110) to which a syringe is detachably mounted;
A console (150) connected to the injection head (110),
The chemical injection device according to the above, wherein the injection head includes the piston drive mechanism, and the console includes the control unit.
15.前記コンソールが、前記入力装置としての機能も有する前記表示ユニットとして、タッチパネル式ディスプレイ(151)を有する、上記記載の薬液注入装置。 15. The chemical injection device according to the above, wherein the console has a touch panel display (151) as the display unit that also has a function as the input device.
16.前記シリンジが、シリンジ内に予め造影剤が充填されたプレフィルドタイプのシリンジである、上記記載の薬液注入装置。 16. The liquid medicine injection device as described above, wherein the syringe is a prefilled type syringe in which a contrast medium is filled in advance.
17.前記シリンジがICタグ付きのシリンジである、上記記載の薬液注入装置。 17. The chemical injection device according to the above, wherein the syringe is a syringe with an IC tag.
18.記シリンジが、
 中空のシリンダ部材とそれにスライド自在に挿入されたピストン部材を有するものであり、
 前記シリンダ部材の端部のシリンダフランジに少なくとも1つの切欠き部が形成されている、上記記載の薬液注入装置。
18. The syringe is
It has a hollow cylinder member and a piston member slidably inserted in it,
The chemical injection device according to the above, wherein at least one notch is formed in a cylinder flange at an end of the cylinder member.
A1.制御部と、
 所定の情報を表示するための表示ユニットと、
 操作者からの入力を受け付ける入力装置と、
 を備えるコンピュータ装置であって、
 前記制御部は、
a:前記表示ユニットに、複数の注入プロトコル設定モードの中から1つを選択するためのモード選択用表示部(363)を少なくとも含む設定用初期画面(360)を表示させ、
b:所定の注入プロトコル設定モードが選択された後、縦軸および横軸の一方が注入速度で他方が注入時間であり少なくとも1つのフェーズを含む注入グラフ(361)への操作者からの注入パターンの入力を受け付け、
c:前記注入グラフ(361)上に入力された注入パターンに基づいて薬液の注入プロトコルを作成し、
d:作成された前記注入プロトコルに従って前記ピストン駆動機構(130)を動作させ、薬液を注入する、コンピュータ装置。
A1. A control unit;
A display unit for displaying predetermined information;
An input device that receives input from the operator;
A computer device comprising:
The controller is
a: causing the display unit to display a setting initial screen (360) including at least a mode selection display unit (363) for selecting one of a plurality of injection protocol setting modes;
b: After a predetermined injection protocol setting mode is selected, an injection pattern from the operator to the injection graph (361) including one at the vertical axis and the horizontal axis at the injection speed and the other as the injection time and including at least one phase. Is accepted,
c: Create a chemical injection protocol based on the injection pattern entered on the injection graph (361),
d: A computer device that operates the piston drive mechanism (130) according to the created injection protocol and injects a chemical solution.
 すなわち、本発明においては、図面を参照して例示したようなプロトコルの設定を行えるものであれば、薬液注入装置に限定されるものではなく、注入機能を有しないコンピュータ装置などにも応用可能である。このことは、上記A1.で規定される技術的事項だけではなく、本明細書で開示する他の技術的事項と組み合せ得るものである。 That is, the present invention is not limited to a chemical solution injection device as long as it can set a protocol as exemplified with reference to the drawings, and can be applied to a computer device having no injection function. is there. This means that the above A1. The present invention can be combined with other technical matters disclosed in the present specification as well as the technical matters defined in the above.
(付記2)
 さらに、本明細書は次の発明をも開示する:
B1.注入プロトコルを設定するためのグラフィカル・ユーザ・インターフェースを有するシステムであって、
 上記グラフィカル・ユーザ・インターフェースは、
a:複数の注入プロトコル設定モードの中から1つを選択するためのモード選択用表示(例えばアイコン)を少なくとも含む設定用初期画面と、
b:所定の注入プロトコル設定モードが選択された後、縦軸および横軸の一方が注入速度で他方が注入時間であり少なくとも1つのフェーズを含む注入グラフへの操作者からの注入パターンの入力を受け付ける入力画面と、
 を含み、
c:(操作者による確認の入力または変更の入力を受け付け、)上記注入グラフ上に入力された注入パターンに基づいて薬液の注入プロトコルを作成する、システム。
(Appendix 2)
In addition, the specification also discloses the following invention:
B1. A system having a graphical user interface for configuring an infusion protocol,
The graphical user interface is
a: an initial setting screen including at least a mode selection display (for example, an icon) for selecting one of a plurality of injection protocol setting modes;
b: After a predetermined injection protocol setting mode is selected, one of the vertical axis and the horizontal axis is the injection speed, the other is the injection time, and the input of the injection pattern from the operator to the injection graph including at least one phase. An input screen to accept,
Including
c: System that accepts confirmation input or change input by the operator, and creates a chemical injection protocol based on the injection pattern input on the injection graph.
B2.前記複数の注入プロトコル設定モードとして、
(i)前記注入グラフ上の1つのフェーズまたは複数のフェーズに注入パターンを入力することで全体として1つの注入パターンが作成される、フローレートモードと、
(ii)少なくとも患者の体重に基づいて薬液の造影量が予め決定され、次いで、前記注入グラフ上の1つのフェーズまたは複数のフェーズに注入パターンを入力することで全体として1つの注入パターンが作成される第1の体重入力モードと、
(iii)少なくとも患者の体重に基づいて薬液の初速度が予め決定され、次いで、前記注入グラフ上の1つのフェーズまたは複数のフェーズに注入パターンを入力することで全体として1つの注入パターンが作成される第2の体重入力モードと、
 のうち少なくとも2つが選択可能である、システム。
B2. As the plurality of injection protocol setting modes,
(I) a flow rate mode in which an injection pattern is created as a whole by inputting an injection pattern in one phase or a plurality of phases on the injection graph;
(Ii) The contrast amount of the drug solution is determined in advance based on at least the weight of the patient, and then an injection pattern is created as a whole by inputting the injection pattern in one phase or a plurality of phases on the injection graph. A first weight input mode,
(Iii) The initial velocity of the drug solution is determined in advance based on at least the patient's weight, and then an injection pattern is created as a whole by inputting the injection pattern in one phase or a plurality of phases on the injection graph. A second weight input mode,
At least two of which are selectable.
C1-1.注入プロトコルの設定方法であって、
a:表示ユニットに、複数の注入プロトコル設定モードの中から1つを選択するためのモード選択用表示部を少なくとも含む設定用初期画面を表示させるステップと、
b:所定の注入プロトコル設定モードが選択された後、縦軸および横軸の一方が注入速度で他方が注入時間であり少なくとも1つのフェーズを含む注入グラフへの操作者からの注入パターンの入力を受け付けるステップと、
c:前記注入グラフ上に入力された注入パターンに基づいて薬液の注入プロトコルを作成するステップと、
 を有する、方法。
C1-1. An injection protocol setting method,
a: causing the display unit to display a setting initial screen including at least a mode selection display unit for selecting one of a plurality of injection protocol setting modes;
b: After a predetermined injection protocol setting mode is selected, one of the vertical axis and the horizontal axis is the injection speed, the other is the injection time, and the input of the injection pattern from the operator to the injection graph including at least one phase. Accepting steps,
c: creating an infusion protocol for the medicinal solution based on the infusion pattern input on the infusion graph;
Having a method.
C1-2.さらに、
 d:作成された前記注入プロトコルに従ってピストン駆動機構を動作させ、薬液を注入するステップを有する、方法。
C1-2. further,
d: operating the piston drive mechanism according to the created injection protocol and injecting the chemical solution.
C2.複数の注入プロトコル設定モードとして、
(i)前記注入グラフ上の1つのフェーズまたは複数のフェーズに注入パターンを入力することで全体として1つの注入パターンが作成される、フローレートモードと、
(ii)少なくとも患者の体重に基づいて薬液の造影量が予め決定され、次いで、前記注入グラフ上の1つのフェーズまたは複数のフェーズに注入パターンを入力することで全体として1つの注入パターンが作成される第1の体重入力モードと、
(iii)少なくとも患者の体重に基づいて薬液の初速度が予め決定され、次いで、前記注入グラフ上の1つのフェーズまたは複数のフェーズに注入パターンを入力することで全体として1つの注入パターンが作成される第2の体重入力モードと、
 のうち少なくとも2つが選択可能である、上記記載の方法。
C2. As multiple injection protocol setting modes,
(I) a flow rate mode in which an injection pattern is created as a whole by inputting an injection pattern in one phase or a plurality of phases on the injection graph;
(Ii) The contrast amount of the drug solution is determined in advance based on at least the weight of the patient, and then an injection pattern is created as a whole by inputting the injection pattern in one phase or a plurality of phases on the injection graph. A first weight input mode,
(Iii) The initial velocity of the drug solution is determined in advance based on at least the patient's weight, and then an injection pattern is created as a whole by inputting the injection pattern in one phase or a plurality of phases on the injection graph. A second weight input mode,
The method as described above, wherein at least two of the options are selectable.
C3.さらに、
e:操作者が前記注入グラフの1フェーズにおいて注入パターンを作成するためのポップアップ画面を表示するステップを有し、
 前記ポップアップ画面は、
-当該フェーズにおける注入パターンの傾きに係わるパラメータを入力するための表示部、
-当該フェーズの注入時間を入力するための表示部、および、
-当該フェーズの注入速度を入力するための表示部、
 のうち少なくとも1つを含む、方法。
C3. further,
e: a step of displaying a pop-up screen for an operator to create an injection pattern in one phase of the injection graph;
The pop-up screen
-A display for inputting parameters relating to the inclination of the implantation pattern in the phase;
-A display for entering the injection time of the phase, and
-A display for entering the injection rate of the phase,
A method comprising at least one of:
D1.1つまたは複数のコンピュータに、上記本発明の一形態に係る方法を実施させるためのコンピュータプログラム。 D1.1 A computer program for causing one or more computers to perform the method according to one aspect of the present invention.
E1.シリンジのピストン部材を動作させるピストン駆動機構と、所定の情報を表示するための表示ユニットと、その表示ユニットに表示する内容を制御する表示コントローラと、操作者からの入力を受け付ける入力装置と、を備えるシステムの動作方法であって、
a:表示コントローラが、前記表示ユニットに、複数の注入プロトコル設定モードの中から1つを選択するためのモード選択用表示部(363)を少なくとも含む設定用初期画面(360)を表示させるステップと、
b1:表示コントローラが、所定の注入プロトコル設定モードが選択された後、縦軸および横軸の一方が注入速度で他方が注入時間であり少なくとも1つのフェーズを含む注入グラフ(361)を表示させるステップと、
b2:入力装置が、上記注入グラフへの操作者からの注入パターンの入力を受け付けるステップと、
 を有する、システムの動作方法。
E1. A piston drive mechanism for operating the piston member of the syringe; a display unit for displaying predetermined information; a display controller for controlling the content displayed on the display unit; and an input device for receiving input from an operator. A system operating method comprising:
a: a step of causing the display controller to display an initial setting screen (360) including at least a mode selection display unit (363) for selecting one of a plurality of injection protocol setting modes on the display unit; ,
b1: After the predetermined injection protocol setting mode is selected, the display controller displays an injection graph (361) including at least one phase in which one of the vertical axis and the horizontal axis is the injection speed and the other is the injection time. When,
b2: a step in which the input device receives an input of an injection pattern from an operator to the injection graph;
A method of operating the system.
 さらに、コンピュータ(制御部)が、入力された注入パターンに基づいて注入プロトコルを作成するステップを有する、方法。 The method further comprises a step in which the computer (control unit) creates an injection protocol based on the input injection pattern.
100 薬液注入装置
102 ケーブル
110 注入ヘッド
120a 凹部
111 可動式スタンド
130 ピストン駆動機構
144 制御部
145 リーダ/ライタ
146 記憶部
150 コンソール(注入制御ユニット)
151 表示ユニット(表示デバイス)
153 制御部
154 記憶部
157 ハンドユニット
158 インターフェース端子
159 操作パネル
200 シリンジ
221 シリンダ部材
222 ピストン部材
225 ICタグ
230 延長チューブ
231a~231c チューブ
300 撮像装置
303a 制御部
300b 撮像部
304 ベッド
360 設定用初期画面
361 注入グラフ
362 パターンアイコン
363 モード選択用アイコン
364~366 アイコン
368a、368b 注入パターン
369a 中断アイコン
369b 時間表示部
369c 速度表示部
369d 注入量表示部
371 ポップアップ画面
371a~371c 表示部(入力部)
373 アイコン
374 エリア
500 シリンジ
501 シリンダ部材
502 ピストン部材
502a ピストンフランジ
508 分岐チューブ
100 Chemical Injection Device 102 Cable 110 Injection Head 120a Recess 111 Movable Stand 130 Piston Drive Mechanism 144 Control Unit 145 Reader / Writer 146 Storage Unit 150 Console (Injection Control Unit)
151 Display unit (display device)
153 Control unit 154 Storage unit 157 Hand unit 158 Interface terminal 159 Operation panel 200 Syringe 221 Cylinder member 222 Piston member 225 IC tag 230 Extension tube 231a to 231c Tube 300 Imaging device 303a Control unit 300b Imaging unit 304 Bed 360 Setting initial screen 361 Injection graph 362 Pattern icon 363 Mode selection icons 364 to 366 Icons 368a and 368b Injection pattern 369a Interruption icon 369b Time display unit 369c Speed display unit 369d Injection amount display unit 371 Pop-up screen 371a to 371c Display unit (input unit)
373 Icon 374 Area 500 Syringe 501 Cylinder member 502 Piston member 502a Piston flange 508 Branch tube

Claims (18)

  1.  シリンジのピストン部材を動作させるピストン駆動機構と、
     そのピストン駆動機構の動作を制御する制御部と、
     所定の情報を表示するための表示ユニットと、
     操作者からの入力を受け付ける入力装置と、
     を備える薬液注入装置であって、
     前記制御部は、
    a:前記表示ユニットに、複数の注入プロトコル設定モードの中から1つを選択するためのモード選択用表示部を少なくとも含む設定用初期画面を表示させ、
    b:所定の注入プロトコル設定モードが選択された後、縦軸および横軸の一方が注入速度で他方が注入時間であり少なくとも1つのフェーズを含む注入グラフへの操作者からの注入パターンの入力を受け付け、
    c:前記注入グラフ上に入力された注入パターンに基づいて薬液の注入プロトコルを作成し、
    d:作成された前記注入プロトコルに従って前記ピストン駆動機構を動作させ、薬液を注入する、
     薬液注入装置。
    A piston drive mechanism for operating the piston member of the syringe;
    A control unit for controlling the operation of the piston drive mechanism;
    A display unit for displaying predetermined information;
    An input device that receives input from the operator;
    A chemical injection device comprising:
    The controller is
    a: causing the display unit to display a setting initial screen including at least a mode selection display unit for selecting one of a plurality of injection protocol setting modes;
    b: After a predetermined injection protocol setting mode is selected, one of the vertical axis and the horizontal axis is the injection speed, the other is the injection time, and the input of the injection pattern from the operator to the injection graph including at least one phase. Accept,
    c: Create a chemical injection protocol based on the injection pattern entered on the injection graph,
    d: operating the piston drive mechanism in accordance with the created injection protocol to inject the chemical solution;
    Chemical injection device.
  2.  前記複数の注入プロトコル設定モードとして、
    (i)前記注入グラフ上の1つのフェーズまたは複数のフェーズに注入パターンを入力することで全体として1つの注入パターンが作成される、フローレートモードと、
    (ii)少なくとも患者の体重に基づいて薬液の造影量が予め決定され、次いで、前記注入グラフ上の1つのフェーズまたは複数のフェーズに注入パターンを入力することで全体として1つの注入パターンが作成される第1の体重入力モードと、
    (iii)少なくとも患者の体重に基づいて薬液の初速度が予め決定され、次いで、前記注入グラフ上の1つのフェーズまたは複数のフェーズに注入パターンを入力することで全体として1つの注入パターンが作成される第2の体重入力モードと、
     のうち少なくとも2つが選択可能である、請求項1に記載の薬液注入装置。
    As the plurality of injection protocol setting modes,
    (I) a flow rate mode in which an injection pattern is created as a whole by inputting an injection pattern in one phase or a plurality of phases on the injection graph;
    (Ii) The contrast amount of the drug solution is determined in advance based on at least the weight of the patient, and then an injection pattern is created as a whole by inputting the injection pattern in one phase or a plurality of phases on the injection graph. A first weight input mode,
    (Iii) The initial velocity of the drug solution is determined in advance based on at least the patient's weight, and then an injection pattern is created as a whole by inputting the injection pattern in one phase or a plurality of phases on the injection graph. A second weight input mode,
    The chemical injection device according to claim 1, wherein at least two of the two can be selected.
  3.  独立して動作する2つの前記ピストン駆動機構を備え、前記薬液として造影剤と生理食塩水とを注入するように構成され、
     前記制御部は、操作者が前記注入グラフの1フェーズにおいて注入パターンを作成するためのポップアップ画面を表示し、
     前記ポップアップ画面は、
    -当該フェーズにおける注入パターンの傾きに係わるパラメータを入力するための表示部、
    -当該フェーズの注入時間を入力するための表示部、および、
    -当該フェーズの注入速度を入力するための表示部、
     のうち少なくとも1つを含む、請求項1または2に記載の薬液注入装置。
    Comprising two piston drive mechanisms that operate independently, and configured to inject a contrast medium and physiological saline as the drug solution;
    The control unit displays a pop-up screen for an operator to create an injection pattern in one phase of the injection graph,
    The pop-up screen
    -A display for inputting parameters relating to the inclination of the implantation pattern in the phase;
    -A display for entering the injection time of the phase, and
    -A display for entering the injection rate of the phase,
    The medicinal-solution injecting device according to claim 1 or 2, comprising at least one of the above.
  4.  注入パターンの傾きに係わる前記パラメータが、注入速度の終速度と初速度との比として表わされる可変定数である、請求項3に記載の薬液注入装置。 The chemical injection device according to claim 3, wherein the parameter related to the inclination of the injection pattern is a variable constant expressed as a ratio between the final velocity and the initial velocity of the injection velocity.
  5.  独立して動作する2つの前記ピストン駆動機構を備え、前記薬液として造影剤と生理食塩水とを注入するように構成され、
     前記制御部は、操作者が前記注入グラフの1フェーズにおいて注入パターンを作成するためのポップアップ画面を表示し、
     前記ポップアップ画面は、
    -前記生理食塩水の注入パターンを作成するための表示部であって、造影剤の注入速度が一定速度の場合に当該表示部を選択すると、希釈注入を行うために、当該フェーズ内に一定速度の生理食塩水の注入パターンが表示される、希釈注入表示部を含む、
     請求項1~4のいずれか一項に記載の薬液注入装置。
    Comprising two piston drive mechanisms that operate independently, and configured to inject a contrast medium and physiological saline as the drug solution;
    The control unit displays a pop-up screen for an operator to create an injection pattern in one phase of the injection graph,
    The pop-up screen
    -A display unit for creating the saline injection pattern, wherein when the display unit is selected when the injection rate of the contrast medium is a constant rate, a constant rate is set within the phase to perform dilution injection. Including a dilute infusion display, where the saline infusion pattern is displayed,
    The chemical solution injection device according to any one of claims 1 to 4.
  6.  さらに、
     所定のフェーズ内で一定速度の造影剤の注入パターンと一定速度の生理食塩水の注入パターンとが表示されている場合に、前記希釈注入表示部を選択すると、造影剤と生理食塩水との混和比率を示す表示部が表示される、
     請求項5に記載の薬液注入装置。
    further,
    When a constant-rate contrast medium injection pattern and a constant-rate physiological saline injection pattern are displayed within a predetermined phase, when the dilution injection display section is selected, the contrast medium and the physiological saline are mixed. A display showing the ratio is displayed.
    The chemical | medical solution injection device of Claim 5.
  7.  さらに、
     造影剤の注入パターンが傾斜したパターンである場合に、前記希釈注入表示部を選択すると、造影剤の注入速度と生理食塩水の注入速度との和が当該フェーズにおいて実質的に一定となるように、所定の基準線を基準として前記造影剤の注入パターンと線対称形となる生理食塩水の注入パターンが表示される、
     請求項5または6に記載の薬液注入装置。
    further,
    When the contrast injection pattern is an inclined pattern, the sum of the contrast medium injection speed and the physiological saline injection speed is substantially constant in the phase when the dilution injection display section is selected. , A saline injection pattern that is symmetrical with the contrast agent injection pattern with respect to a predetermined reference line is displayed.
    The chemical | medical solution injection device of Claim 5 or 6.
  8.  独立して動作する2つの前記ピストン駆動機構を備え、前記薬液として造影剤と生理食塩水とを注入するように構成され、
     前記制御部は、操作者が前記注入グラフの1フェーズにおいて注入パターンを作成するためのポップアップ画面を表示し、
     前記ポップアップ画面は、
    -当該フェーズの次のフェーズ内に、生理食塩水によるフラッシュ注入のための注入パターンを追加するためのフラッシュ注入表示部を含む、
     請求項1~7のいずれか一項に記載の薬液注入装置。
    Comprising two piston drive mechanisms that operate independently, and configured to inject a contrast medium and physiological saline as the drug solution;
    The control unit displays a pop-up screen for an operator to create an injection pattern in one phase of the injection graph,
    The pop-up screen
    -In the next phase of the phase, including a flash infusion display for adding an infusion pattern for flush infusion with saline,
    The chemical solution injection device according to any one of claims 1 to 7.
  9.  独立して動作する2つの前記ピストン駆動機構を備え、前記薬液として造影剤と生理食塩水とを注入するように構成され、
     前記制御部は、操作者が前記注入グラフの1フェーズにおいて注入パターンを作成するためのポップアップ画面を表示し、
     前記ポップアップ画面は、
     造影剤の注入パターンを作成するための表示部であって、当該表示部を選択すると、速度が所定の初速度からゼロもしくは実質的ゼロの終速度へと変化するような形状の注入パターンが表示される、傾斜パターン表示部を含む、
     請求項1~5のいずれか一項に記載の薬液注入装置。
    Comprising two piston drive mechanisms that operate independently, and configured to inject a contrast medium and physiological saline as the drug solution;
    The control unit displays a pop-up screen for an operator to create an injection pattern in one phase of the injection graph,
    The pop-up screen
    A display unit for creating an injection pattern of contrast medium. When the display unit is selected, an injection pattern having a shape that changes from a predetermined initial speed to a zero or substantially zero final speed is displayed. Including an inclined pattern display,
    The chemical solution injection device according to any one of claims 1 to 5.
  10.  前記制御部が、さらに、
     検査対象となる患者の身体区分および撮像区分の少なくとも一方の情報の入力を受け付け、
     入力された身体区分または撮像区分の情報に少なくとも基づいて、患者に注入すべき注入量の計算を行う、
     請求項1~9のいずれか一項に記載の薬液注入装置。
    The control unit further includes:
    Accepts input of information on at least one of the body category and imaging category of the patient to be examined,
    Calculate the infusion volume to be infused into the patient based at least on the input body segment or imaging segment information;
    The drug solution injector according to any one of claims 1 to 9.
  11.  前記制御部が、さらに、
     患者の身体情報のうち少なくとも患者の体重の情報の入力を受け付け、
     入力された前記体重の情報に少なくとも基づいて、患者に注入すべき注入量の計算を行う、
     請求項1~10のいずれか一項に記載の薬液注入装置。
    The control unit further includes:
    Accept at least patient weight input from patient physical information,
    Calculating an infusion volume to be infused into the patient based at least on the inputted weight information;
    The chemical liquid injector according to any one of claims 1 to 10.
  12.  前記制御部が、さらに、
     造影剤のヨード量の情報の入力を受け付け、
     入力された前記ヨード量の情報に少なくとも基づいて、患者に注入すべき注入量の計算を行う、
     請求項1~11のいずれか一項に記載の薬液注入装置。
    The control unit further includes:
    Accept the input of the contrast medium iodine amount,
    Calculating an infusion volume to be infused into the patient based at least on the input iodine amount information;
    The chemical solution injection device according to any one of claims 1 to 11.
  13.  前記制御部が、さらに、
     患者の身体情報のうち少なくとも患者の体重の情報と、造影剤のヨード量の情報との入力を受け付け、
     入力されたそれらの情報に少なくとも基づいて造影剤の初速度の計算を行う、
     請求項1~12のいずれか一項に記載の薬液注入装置。
    The control unit further includes:
    Accept at least the patient's body weight information and the contrast medium iodine amount information of the patient's physical information,
    Calculate the initial velocity of the contrast agent based at least on those information entered,
    The chemical solution injection device according to any one of claims 1 to 12.
  14.  シリンジが取外し可能に装着される注入ヘッドと、
     その注入ヘッドに接続されたコンソールと、を備え、
     前記注入ヘッドが前記ピストン駆動機構を有し、前記コンソールが前記制御部を有する、請求項1~13のいずれか一項に記載の薬液注入装置。
    An injection head to which a syringe is detachably mounted;
    A console connected to the injection head,
    The chemical injection device according to any one of claims 1 to 13, wherein the injection head includes the piston drive mechanism, and the console includes the control unit.
  15.  前記コンソールが、前記入力装置としての機能も有する前記表示ユニットとして、タッチパネル式ディスプレイを有する、請求項14に記載の薬液注入装置。 The chemical injection device according to claim 14, wherein the console has a touch panel display as the display unit having a function as the input device.
  16.  前記シリンジが、シリンジ内に予め造影剤が充填されたプレフィルドタイプのシリンジである、請求項1に記載の薬液注入装置。 The chemical injection device according to claim 1, wherein the syringe is a prefilled type syringe in which a contrast medium is filled in advance.
  17.  前記シリンジがICタグ付きのシリンジである、請求項16に記載の薬液注入装置。 The chemical injection device according to claim 16, wherein the syringe is a syringe with an IC tag.
  18.  前記シリンジが、
     中空のシリンダ部材とそれにスライド自在に挿入されたピストン部材を有するものであり、
     前記シリンダ部材の端部のシリンダフランジに少なくとも1つの切欠き部が形成されている、請求項15または16に記載の薬液注入装置。
    The syringe is
    It has a hollow cylinder member and a piston member slidably inserted in it,
    The chemical | medical solution injection device of Claim 15 or 16 with which the at least 1 notch part is formed in the cylinder flange of the edge part of the said cylinder member.
PCT/JP2014/060415 2013-04-11 2014-04-10 Chemical injection device WO2014168210A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2015511299A JP6338190B2 (en) 2013-04-11 2014-04-10 Chemical injection device

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2013-083414 2013-04-11
JP2013083414 2013-04-11

Publications (1)

Publication Number Publication Date
WO2014168210A1 true WO2014168210A1 (en) 2014-10-16

Family

ID=51689614

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2014/060415 WO2014168210A1 (en) 2013-04-11 2014-04-10 Chemical injection device

Country Status (2)

Country Link
JP (2) JP6338190B2 (en)
WO (1) WO2014168210A1 (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017013967A1 (en) * 2015-07-17 2017-01-26 三菱重工業株式会社 Discharge device
WO2017038575A1 (en) * 2015-08-28 2017-03-09 株式会社根本杏林堂 Medicinal liquid injecting circuit, medicinal liquid injecting system provided with said medicinal liquid injecting circuit, and medical imaging system
JP2018064872A (en) * 2016-10-21 2018-04-26 株式会社メテク Infusion system
WO2019111995A1 (en) * 2017-12-08 2019-06-13 株式会社根本杏林堂 Drug solution infusion device
JP2019181165A (en) * 2018-04-10 2019-10-24 アイルン エルエルシーAilnh, Llc Gas removal apparatus and related methods
CN112461980A (en) * 2019-09-06 2021-03-09 株式会社岛津制作所 Analysis system, analysis support device, analysis method, and analysis support method
EP3831424A1 (en) * 2019-12-02 2021-06-09 Siemens Healthcare GmbH Controller for a contrast media power injector

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023106631A1 (en) * 2021-12-07 2023-06-15 사회복지법인 삼성생명공익재단 Drug administering device

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007116840A1 (en) * 2006-04-04 2007-10-18 Nemoto Kyorindo Co., Ltd. Drug solution injector
WO2008072636A1 (en) * 2006-12-14 2008-06-19 Nemoto Kyorindo Co., Ltd. Chemical dosing apparatus
WO2008078604A1 (en) * 2006-12-22 2008-07-03 Nemoto Kyorindo Co., Ltd. Chemical solution injection device
WO2008078605A1 (en) * 2006-12-22 2008-07-03 Nemoto Kyorindo Co., Ltd. Chemical solution injection device
WO2012071307A2 (en) * 2010-11-24 2012-05-31 Mallinckrodt Llc Medical fluid injector system
WO2012105577A1 (en) * 2011-02-01 2012-08-09 株式会社根本杏林堂 Drug solution injection device

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4593714B2 (en) * 2000-02-10 2010-12-08 株式会社根本杏林堂 Syringe outer cylinder, syringe holder, syringe piston and piston holder
JP5005678B2 (en) * 2006-04-06 2012-08-22 株式会社根本杏林堂 Chemical injection device

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007116840A1 (en) * 2006-04-04 2007-10-18 Nemoto Kyorindo Co., Ltd. Drug solution injector
WO2008072636A1 (en) * 2006-12-14 2008-06-19 Nemoto Kyorindo Co., Ltd. Chemical dosing apparatus
WO2008078604A1 (en) * 2006-12-22 2008-07-03 Nemoto Kyorindo Co., Ltd. Chemical solution injection device
WO2008078605A1 (en) * 2006-12-22 2008-07-03 Nemoto Kyorindo Co., Ltd. Chemical solution injection device
WO2012071307A2 (en) * 2010-11-24 2012-05-31 Mallinckrodt Llc Medical fluid injector system
WO2012105577A1 (en) * 2011-02-01 2012-08-09 株式会社根本杏林堂 Drug solution injection device

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017013967A1 (en) * 2015-07-17 2017-01-26 三菱重工業株式会社 Discharge device
WO2017038575A1 (en) * 2015-08-28 2017-03-09 株式会社根本杏林堂 Medicinal liquid injecting circuit, medicinal liquid injecting system provided with said medicinal liquid injecting circuit, and medical imaging system
JPWO2017038575A1 (en) * 2015-08-28 2018-06-14 株式会社根本杏林堂 Chemical injection circuit, chemical injection system equipped with the chemical injection circuit, and medical imaging system
JP2018064872A (en) * 2016-10-21 2018-04-26 株式会社メテク Infusion system
US20210228812A1 (en) * 2017-12-08 2021-07-29 Nemoto Kyorindo Co., Ltd. Drug solution infusion device
WO2019111995A1 (en) * 2017-12-08 2019-06-13 株式会社根本杏林堂 Drug solution infusion device
JP7387158B2 (en) 2017-12-08 2023-11-28 株式会社根本杏林堂 Chemical injection device
JPWO2019111995A1 (en) * 2017-12-08 2020-12-03 株式会社根本杏林堂 Chemical injection device
US11819672B2 (en) 2017-12-08 2023-11-21 Nemoto Kyorindo Co., Ltd. Chemical liquid injector
JP7137881B2 (en) 2018-04-10 2022-09-15 アイルン エルエルシー gas remover
JP7006945B2 (en) 2018-04-10 2022-01-24 アイルン エルエルシー Gas remover
JP2022031449A (en) * 2018-04-10 2022-02-18 アイルン エルエルシー Gas removal apparatus
JP2019181165A (en) * 2018-04-10 2019-10-24 アイルン エルエルシーAilnh, Llc Gas removal apparatus and related methods
CN112461980B (en) * 2019-09-06 2023-10-24 株式会社岛津制作所 Analysis system, analysis support device, analysis method, and analysis support method
CN112461980A (en) * 2019-09-06 2021-03-09 株式会社岛津制作所 Analysis system, analysis support device, analysis method, and analysis support method
EP3831424A1 (en) * 2019-12-02 2021-06-09 Siemens Healthcare GmbH Controller for a contrast media power injector

Also Published As

Publication number Publication date
JPWO2014168210A1 (en) 2017-02-16
JP6338190B2 (en) 2018-06-06
JP2018114351A (en) 2018-07-26

Similar Documents

Publication Publication Date Title
JP6338190B2 (en) Chemical injection device
JP7239223B2 (en) Chemical injection device and chemical injection system
JP6745847B2 (en) CT system, method for operating CT system, and one or more computer programs for executing method for operating CT system
JP6952357B2 (en) Data processing equipment, medical testing systems, and computer programs
US20120306881A1 (en) Chemical liquid injector
JP6723160B2 (en) Chemical injection device
JP6298811B2 (en) Chemical injection device
US20200030524A1 (en) Chemical liquid injector
JP2024040279A (en) Chemical injection device
JPWO2016152841A1 (en) Chemical injection device
JP6348722B2 (en) Chemical injection device and control method thereof
JP6570812B2 (en) Blood vessel state analysis apparatus and system including the same
JP6327632B2 (en) Chemical injection device
JP2023502787A (en) Systems and methods utilizing integrated cameras with fluid injectors
JP6618673B2 (en) Injection protocol setting device, chemical solution injection device, and medical system
JP2020032246A (en) Injection protocol setup device, medical solution injector, and medical system
JP7350284B2 (en) Chemical injection device and injection protocol setting program
JP2020124598A (en) Chemical injection device
JP2019195702A (en) Blood vessel state analyzer and system equipped with the same
KR20210073925A (en) Combination injector apparatus for medical imaging equipment
JP2018108498A (en) Chemical injection device

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 14783171

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2015511299

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 14783171

Country of ref document: EP

Kind code of ref document: A1